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Abstract 
 
 
Silica nanocapsules having core–shell architecture are of great interest in many current and 
emerging areas of technology. The core provides high-capacity loading of various actives, while 
the silica shell serves as protective envelope and diffusion barrier enabling controlled release of 
the active. Currently, production of silica nanocapsules is mainly based on templating methods 
using chemical surfactants to stabilize the template and to induce hydrolysis and condensation of 
silica precursors forming solid silica shell surrounding the template. Major drawbacks with the 
current methods are extreme pH conditions and/or elevated temperatures involving toxic chemicals 
that might pose undesirable environmental side effects and require tedious procedures for 
removing the chemicals. Inspired by Nature, biomimetic approaches have recently been developed 
to synthesize silica-based nanomaterials under mild physiological conditions through the use of 
biomolecules (i.e., peptides and proteins). This contrast in processing conditions and the growing 
demand for benign synthesis methods having minimum environmental risks have spurred much 
interest in biomimetic approaches. However, their utility is limited to biosilicification in bulk aqueous 
solution or at solid–liquid interfaces. There is no current biosilicification at oil–water interfaces, and 
thus fabrication of oil-core silica-shell nanocapsules using biomolecules has not been realized yet.  
 
This thesis addresses the question on benign synthesis method for forming biocompatible oil-core 
silica-shell nanocapsules, by designing and utilizing biomolecules, in lieu of chemical surfactants, 
to facilitate formation and stabilization of oil droplets and to direct nucleation and growth of silica 
shells at the oil–water interfaces. The major outcomes of the work presented in this thesis are: (1) 
development of a designed bifunctional modular peptide, SurSi, comprising a surface-active 
module and a biosilicification-active module that led to novel emulsion and biomimetic dual-
templating approach for making oil-core silica-shell nanocapsules with tunable silica shell 
thickness; (2) facile encapsulation and sustained release of model insecticide, fipronil, from the 
silica nanocapsules in vitro in water and in vivo against a model insect, termite; (3) development of 
a designed bifunctional modular protein, D4S2, for making silica nanocapsules, thereby extending 
conceptual design of SurSi peptide, so that the protein could be produced renewably through 
biological expression in industrially-relevant, microbial cell-factory Escherichia coli (E. coli); and (4) 
large-scale production of D4S2 protein for synthesis of fipronil-encapsulated silica nanocapsules 
which could then be used for termite field trial.  
 
This work introduces, to the best of our knowledge, the first design and use of bifunctional modular 
biomolecules for making oil-core silica-shell nanocapsules. The dual-templating method developed 
in this thesis represents a new strategy for forming silica nanocapsules using components and 
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processes expected to have minimal environment footprint. Active molecule can be easily 
encapsulated in silica nanocapsules with high encapsulation efficiency, by directly dissolving the 
active in the oil core prior to silica shell formation, and then released controllably from the 
nanocapsules with the release kinetics depending on the silica shell thicknesses. Furthermore, the 
use of bifunctional modular protein that can be produced through E. coli expression system has 
opened opportunities for sustainable and scalable bioprocess routes to produce oil-filled silica 
nanocapsules, thus makes the platform developed in this thesis suitable for large-scale 
applications especially in the fields of biomedical and agricultural applications that demand 
biocompatibility, high encapsulation efficiency and controlled-release properties. 
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Chapter 1 
 
Project overview  
 
 
1.1 Introduction 
 
Utilization of pesticides, including insecticides, herbicides, and fungicides, is indispensable, 
especially in countries with agriculture-driven economies. Approximately two million metric tons of 
pesticides are spent annually worldwide (worth US$ 35 billion) [1]. In practice, a significant proportion 
of pesticides undergo premature degradation (due to wind, sunlight or rain), evaporation or leaching 
[2], and therefore periodic application is required to achieve satisfactory treatment results. 
Consequently, excessive use of pesticides occurs which in turn increases the application costs and 
leads to undesirable environmental side effects including bioaccumulation, death of non-target 
organisms, development of pest resistance, and pollution of soil, air, ground- and surface-water. 
Given these harmful impacts that pesticides can cause to the environment, regulatory authorities 
have banned, or severely restricted, the use of certain pesticides and mandated stringent 
improvement for registered pesticides prior to their applications [3, 4].  
 
Most pesticide chemistries are designed to have selective toxicity [5] and limited solubility in aqueous 
solutions [6]. Nanotechnology has emerged to play pivotal roles in agriculture by providing 
nanocarrier systems [2, 6-11] to encapsulate and deliver such pesticides. The use of nanocarriers is 
expected to: (1) increase the bioavailability of pesticides; (2) protect the pesticides against rapid 
degradation; (3) protect the environment from the toxicity of the pesticides; and (4) release the 
pesticides in a sustained manner which would, in turn, prolong duration of their activity. Through the 
advances conferred by such nanocarriers, pesticide dosages and its environmental residues can be 
minimized. 
 
As nanocarriers offer exciting opportunities to address the challenges in agriculture, technology for 
their development must anticipate their possible harm, whether real or perceived, to people and the 
environment [12, 13]. Recent studies investigating the toxicity of some nanomaterials in cell cultures 
and animals have demonstrated that size, surface chemistry, surface area, and possibly shape play 
a role in determining the toxicity of nanomaterials [14, 15]. However, the degree of toxicity of 
nanomaterials is a multifaceted issue depending on, for example, their chemical composition, 
exposure routes and doses. For instance, mesoporous silica nanoparticles that still contained 
unremoved chemical surfactants originated from the synthetic procedures of the nanoparticles could 
cause severe cytotoxicity, yet these nanoparticles having complete removal of the bound surfactant 
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showed low cytotoxicity [16]. Therefore, it is appropriate to implement safe and sustainable 
nanotechnology during the manufacturing processes [17, 18]. This can be achieved through 
responsible nanomanufacturing practices which range from minimizing the use of toxic chemicals to 
selecting processes and materials in a conscious effort to minimize environmental contamination 
and associated toxicity [18]. 
 
In this thesis, a nanoemulsion system is researched and developed to solubilize insecticide having 
limited water-solubility, and then silica material is encased surrounding the nanoemulsion forming 
insecticide-encapsulated silica nanocapsules. Encapsulation and delivery of the insecticide via silica 
nanocapsules might be expected to increase its bioavailability in an aqueous-based environment, 
while also protecting the insecticide and allowing for its controlled release. To comply with stringent 
regulatory purposes, synthesis of the oil-filled silica nanocapsules should mainly involve 
biocompatible components. In parallel with biocompatibility, moderate temperature and pressure, 
and near-neutral pH in the absence of toxic organic solvents are often required.  
 
Nature provides an inspiration for bottom-up design and engineering of hierarchical silica-based 
nanomaterials in aqueous environments under mild physiological conditions as evident in the 
biosilicification of biological tissue like cell walls of diatoms and sponges [19, 20]. In Nature, peptides 
or proteins are the workhorses that control the formation of biological silica structures through their 
molecular-recognition ability to silica species. Therefore, the underlying biological principles used by 
the living organisms may inspire the synthesis of oil-filled silica nanocapsules. In the first instance, 
however, the peptides/proteins should be able to stabilize the oil droplet prior to silica formation. 
Recognizing these biomolecular and interfacial engineering challenges and opportunities, the central 
objective of this PhD thesis is to use biomolecules for synthesis of oil-core silica-shell nanocapsules 
under environmentally-friendly conditions, by stabilizing the nanoemulsion core and forming silica 
shell surrounding the core, and then to apply the developed silica nanocapsules for encapsulation 
and controlled release of an insecticide. Termites will be used as a model insect to demonstrate the 
applicability of the nanocarrier system developed in this thesis. 
 
1.1.1 Silica nanocapsules via emulsion templating 
 
Previous studies have shown the loading and release of various agrochemicals from silica-based 
nanomaterials, including non-porous silica nanoparticles [21], mesoporous silica nanoparticles [22-
25], and hollow-core silica-shell nanoparticles [26-30]. The core–shell morphology of a silica 
nanocapsule is beneficial as compared to non-porous and porous silica nanoparticles. The core 
provides higher loading-capacity of the active molecule than non-porous and porous silica 
nanoparticles [31] (Figure 1). With non-porous silica nanoparticles (Figure 1, left), the active 
molecule can only be attached on the nanoparticle surfaces, thus limiting the loading capacity. 
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Moreover, the active molecule is being exposed to the surrounding environment, thus reducing the 
flexibility to protect and release the active molecule. With porous silica nanoparticles (Figure 1, 
middle), the active molecule can bind on the nanoparticle surfaces after loading processes (by 
adsorption), thus increasing the probability of burst release effect and reducing its efficacy. With 
silica nanocapsules (Figure 1, right), the problems highlighted previously can be tackled. This is 
especially true when oil-in-water (O/W) emulsion is used as a template to synthesize oil-core silica-
shell nanocapsule. Emulsion templating facilitates solubilization of the active molecule in the oil core 
prior to silica shell formation. This avoids attachment of the active molecule on the nanocapsule 
exterior surfaces, and enables storage and protection of the active molecule in the nanocapsule oil 
cores. High-capacity loading of the active molecule can be achieved depending on solubility of the 
active molecule in the oil.  
 
 
Figure 1. Transmission electron microscopy (TEM) images of common silica nanospherical 
structures. From left to right, the figures represent non-porous silica nanoparticles, porous silica 
nanoparticles, and core–shell silica nanocapsules, respectively. Insets show schematic illustrations 
of the morphology. The figures were adapted from Stöber et al. [32] (left) and Chen et al. [16] (middle 
and right). 
 
Silica plays an important role as shell material in nanocapsules. Firstly, silica is biocompatible [33], 
thus it may impart biocompatibility for the insecticide delivery system. Since the biocompatibility of 
silica is affected by its concentration [16], silica nanocapsules which have lower silica content (only 
present at the shell) is clearly more biocompatible than non-porous and porous silica nanoparticles 
at a given volume (Figure 1). Secondly, silica surfaces can be easily functionalized through silane 
chemistry [34], opening opportunities to combine multiple functionalities in a single nanocapsule, 
including for bio-labelling, controlled release, and targeted delivery. Thirdly, the kinetics of silica 
growth is controllable meaning that the size of silica-based nanomaterials can possibly be adjusted 
by modifying reaction conditions [32]. Finally, silica layers can impart stability to the core materials 
in an aqueous media through electrostatic repulsion [35]. 
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As previously mentioned, an emulsion can be used as a template material to prepare silica 
nanocapsules [36-38]. It allows facile encapsulation of poorly-water soluble active molecules through 
solubilization of the active molecules in the oil cores prior to silica shells formation. However, current 
synthesis methods suffer from several drawbacks: (1) the reaction conditions for forming silica shells 
are often not compatible with the active molecules, e.g., elevated temperature and/or extreme pH; 
(2) the organic solvents and chemical surfactants used for inducing silica formation, as well as the 
oils are not biocompatible, which would subsequently require stringent monitoring procedures to 
ensure removal of the chemicals down to the levels that might be considered acceptable to 
regulatory bodies. It should be emphasized that incomplete removal of chemical surfactants from a 
final silica product has been shown to cause severe cytotoxicity [16]. Instead of using chemical 
surfactant, designed proteins/peptides, the key novel contribution of this PhD project, will be used to 
direct nucleation and growth of silica mimicking the capability of biosilicification-active proteins found 
in Nature. 
 
1.1.2 Nature as an inspiration for materials chemistry 
 
Hydrated silica (SiO2) formed in an amorphous state in living organisms [39, 40] serves as a 
mechanical or structural support, provides protection from predators, or acts as sensors [41] (Figure 
2). The silica exhibits complex hierarchical organization of particles and pores over several length 
scales ranging from tens of nanometres to tens or hundreds of micrometres. For example, silica in 
spicules of sponges has nanoparticle substructure with diameters from about 70 to 200 nm [42]. The 
biological-mediated assembly of the silica structures in the organisms originates from a similarly 
simple template: the amino acid sequence that controls nucleation and growth of amorphous silica. 
Amino acids are the functional building blocks of biological systems. Each amino acid imparts 
specific functionalities which in concert enable complex processes including biosilicification. Crucial 
to the processes are the interactions between amino acids and silica species to form amorphous 
siliceous parts in living organisms. Simply examining how individual amino acids are used by natural 
systems provides numerous ideas for the utilization of peptides or proteins in synthetic systems. 
Recently, three model systems have been used to study formation of silica nanostructures in vitro 
[43]: (1) proteins extracted from silica-forming organisms; (2) designed peptides that exhibit similar 
functionalities to the naturally occurring molecules; and (3) peptides with specific amino acid 
sequence identified by using combinatorial phage display libraries that can strongly bind to silica 
[44]. These studies have advanced the bio-inspired synthesis of silica-based nanomaterials. 
 
The use of proteins and peptides to direct the in vitro synthesis of silica-based nanomaterials is 
advantageous as compared to chemical surfactants involved in conventional production methods. 
This is because: (1) peptides/proteins can facilitate silica synthesis under environmentally-friendly 
conditions i.e., at or near room temperature and ambient pressure, at or near neutral pH, in aqueous 
- 5 - 
solutions and in the absence of toxic organic solvents, which makes the bio-inspired silicification 
inherently “green” processing; (2) the large diversity of amino acid chemistries that composed the 
biomolecules i.e., polarity, electrostatic, hydrophobicity, hydrophilicity, etc. offer the potential to 
produce materials with multiple functionalities; (3) the biomolecules can be easily processed and 
prepared through genetic engineering or by chemical synthesis; and (4) they are renewable and 
biodegradable as well as biocompatible [45]. 
 
 
Figure 2. Scanning electron microscopy (SEM) images of nanoscale architectures of cleaned 
diatom silica cell walls (frustules) from several different diatom species. The assembly of the 
complex silica structures is controlled under mild physiological conditions by proteins integrated in 
the cell walls of the living organisms. Scanning electron microscopy (SEM) images of the overall 
form of the frustule are presented in the top and middle rows, and higher-magnification images of 
frustule details are presented in the bottom row. The figures were adapted from Kröger [46]. 
 
Due to these reasons, peptides and proteins have been widely used to fabricate silica-based 
nanomaterials [41, 43, 45]. However, there is a gap in their utilities: the bio- inspired silicification has 
been largely studied on biomolecules that self-assembled in bulk aqueous solution or at solid–liquid 
interfaces, and there is no current biomimetic approach at oil–water interfaces. Aligned with the 
major aim of this PhD thesis to produce oil-filled silica nanocapsules, biomolecules able to induce 
silica formation at oil–water interfaces are required. Obviously, biomolecule-based silica 
nanocapsules encasing oil droplets should contain an amino acid residue sequence having an ability 
to facilitate stabilization of O/W emulsion. 
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Peptide surfactant AM1 (Ac-MKQLADS LHQLARQ VSRLEHA-CONH2) having high surface activity 
was designed based on biomimetic principles [47]. AM1 is composed of three heptads, and each 
heptad contains a seven residue repeating motif abcdefg, in which the a and d residues have 
hydrophobic amino acids (mainly are methionine (M), leucine (L) and valine (V)), while the remaining 
sites are predominantly hydrophilic. This alternate three and four residue spacing of hydrophobic 
moieties permits the formation of α-helical structure having distinct hydrophobic and hydrophilic 
faces that give rise to facial amphiphilicity of AM1. In this regards, AM1 can be rapidly adsorbed and 
orients parallel to a freshly formed oil–water interface, in which the hydrophobic parts of AM1 face 
toward the oil phase while the hydrophilic residues orient toward the bulk aqueous phase [48]. AM1 
is capable of reversibly and precisely controlling the stability of O/W emulsions [47] and has well 
characterized interfacial structure [48]. AM1 slows the coalescence of emulsions [49] by forming a 
cohesive interfacial film that is responsive to metal ion binding to histidine (H) residues in the peptide 
[50]. AM1-stabilized pharmaceutical grade Miglyol® 812 oil has been formulated to stabilize 
nanoemulsions loaded with curcumin [51] and ovalbumin [52].  
 
The ability of AM1 peptide surfactant to facilitate the formation of stable O/W nanoemulsions leads 
to the general question in the context of synthesis of oil-core silica-shell nanocapsules that this 
research addresses: is AM1 capable of directing nucleation and growth of silica at oil–water 
interfaces while maintaining nanoemulsion stability? If not, could the AM1 peptide be used for 
surface activity but be supplemented in such a way that it did drive interfacial silica formation? With 
this in mind, Professor Middelberg, who is also the supervisor of this PhD project, hypothesized that 
a modular molecule could be designed by joining a surface-active module (e.g., based on AM1 
peptide surfactant) with a module for biosilicification activity. The result would be a bifunctional 
modular biomolecule that would stabilize a nanoemulsion and also drive silica formation at the 
interface, thereby forming oil-core silica-shell nanocapsules (Figure 3). Specifically, the bifunctional 
modular biomolecule would undergo interfacial adsorption during emulsification and orient parallel 
to the nanoemulsion interface through its surface-active module, with the hydrophobic face attached 
to the oil phase and the hydrophilic face exposed to the bulk aqueous solution, which might then 
stabilize the nanoemulsion. Upon addition of silica precursors, the biosilicification-active module 
projecting towards the bulk aqueous phase would catalyze biomimetic silica growth at the oil–water 
interface hence forming a silica shell encapsulating the nanoemulsion core (Figure 3). A main aim 
of this thesis is to explore this hypothesis through multi-dimensional experimental and theoretical 
approaches, with a controlled-release application objective. 
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Figure 3. Conceptual design of a bifunctional modular biomolecule for synthesis of oil-core 
silica-shell nanocapsule under environmentally-friendly conditions. Bifunctional modular 
biomolecule comprises (1) a surface-active module that incorporates hydrophobic (in yellow) and 
hydrophilic (in blue) amino acids to impart facial amphiphatic character, hence promoting adsorption 
at the nanoemulsion interface; and (2) a biosilicification-active module that is rich in cationic amino 
acid side chains (in red) for directing nucleation and growth of silica at the oil–water interface. 
 
1.1.3 Controlled-release technology for termite control 
 
Termites are the chief decomposers of dead plant materials by digesting the cellulose, and their 
tunnelling efforts contribute significantly to the nutrient turnover of soil [53]. They are abundant in 
tropical and subtropical environments where they help in breaking down and recycling one third of 
the annual production of dead wood [54]. However, termites become economic pests when they feed 
on structural lumber on houses or man-made structures and most tropical agriculture e.g., forestry, 
sugar crops, cereal crops, oil crops, beverage crops, pastures, tuber crops, market gardens and fibre 
crops [55]. Based on the insecticide sales figures of 1999, the worldwide annual control and repair 
cost were estimated at US$22 billion. A similar estimate with 2010 data showed that the global 
economic impact of termite pests has increased to US$40 billion with subterranean termites 
accounting for approximately 80% of the costs [56]. In Australia only, an estimated 130,000 new 
infestations in houses are reported each year, and the average cost of rectification of termite-
damaged properties is in excess of AU$7,000 per house [57].  
 
Current methods to prevent termite infestation rely upon chemical soil barriers. The insecticides used 
in this method have low durability due to environmental and health concerns [58], which in turn 
necessitates periodic treatments and hence increases negative environmental side effects. As 
aforementioned, these consequences have led to the development of nanocarriers for storage, 
protection, and release of an insecticide in a sustained manner to control termite populations. These 
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nanocarriers are expected to have high-capacity loading and controlled-release properties capable 
of carrying high-amount of insecticide, and then releasing the insecticide slowly to achieve an 
effective local concentration in a prolonged duration. In addition, biocompatibility of the components 
composing the nanocarriers is substantially important as to minimize environmental risks. 
 
1.2 Thesis objectives 
 
The main goal of this PhD thesis is to synthesize oil-core silica-shell nanocapsules and to examine 
the application of the nanocapsules for controlled release of insecticide in the context of termite 
control. Within this central goal, there are four specific objectives of this thesis as described below. 
 
(1) To design a bifunctional modular peptide comprising a surface-active module and a 
biosilicification-active module for synthesis of oil-core silica-shell nanocapsules; 
(2) To evaluate encapsulation and controlled release of fipronil insecticide in vitro in water and in 
vivo against termites from biocompatible silica nanocapsules developed in objective (1) in a 
laboratory scale; 
(3) To design a bifunctional modular protein by extrapolating the modular design concept of 
bifunctional modular peptide developed in objective (1) so that the design can enable the protein 
to be produced using industrially-relevant microbial cell-factory Escherichia coli (E. coli) and 
used for synthesis of oil-core silica-shell nanocapsules;  
(4) To produce the bifunctional modular protein developed in objective (3) in a large scale for making 
fipronil-encapsulated silica nanocapsules and then used them for termite field trial. 
 
The rationale behind each of these research objectives is explained as follows. 
 
1.2.1 Design of a bifunctional modular peptide comprising a surface-active module and a 
biosilicification-active module for synthesis of oil-core silica-shell nanocapsules 
 
Biomimetic approaches have utilized a variety of amino acid sequences to biosilicification, but none 
of those have been used for biosilicification at oil–water interfaces [41, 43, 45]. On the other hand, 
few studies have demonstrated peptide surfactant for facilitating formation and stabilization of O/W 
emulsions [59], but none of those were used for directing nucleation and growth of silica at the 
interfaces. The study here aimed to bridging the gap on the utility of peptides that combine 
emulsification and biosilicification functionalities. Peptide surfactant AM1 was used as a starting 
peptide to facilitate emulsion stabilization. This then leads to important research questions: could 
AM1 attract silica precursor species from bulk solution to oil–water interfaces while maintaining its 
ability to stabilize the nanoemulsions? Could AM1 facilitate the silicification reaction preferentially at 
the interfaces rather than in bulk solutions? If AM1 then could not be proved to effectively form a 
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silica shell, bifunctional modular peptide could be designed based on the results of AM1 on interfacial 
biosilicification. Thence, the following question is: how to arrange amino acid sequences in the 
peptide so that it could stabilize nanoemulsions and, at the same time, induce silica formation 
effectively? Thus, this study evaluates AM1 and designed bifunctional modular peptide in order to 
develop emulsion and biomimetic dual-templating approach for synthesis of oil-core silica-shell 
nanocapsules. 
 
1.2.2 Applications of insecticide-encapsulated silica nanocapsules for termite control in a 
laboratory scale 
 
This study is motivated by an increasing need in termite control applications for an effective and 
efficient pesticide delivery system which left minimal environment footprint [6, 7]. The delivery system 
requires controlled-release properties to increase bio-efficacy with prolonged duration of activity. 
Therefore, biocompatible silica nanocapsules developed using bifunctional modular peptide in 
objective (1) are used to answer these needs. These lead to research questions: could an insecticide 
be encapsulated and released effectively in vitro in water from the silica nanocapsules? Would the 
insecticide-encapsulated silica nanocapsules demonstrate their efficacy when applied to a number 
of termites? Thus, this study is a proof-of-concept aimed to evaluate the performance of silica 
nanocapsules developed in objective (1) to encapsulate an insecticide with high-loading capacity 
and to release the insecticide in a sustained manner in vitro in water and in vivo against termites. 
 
1.2.3 Design and microbial-production of a bifunctional modular protein comprising a 
surface-active module and a biosilicification-active module for synthesis of oil-core silica-
shell nanocapsules 
 
This study is motivated by the practical need to develop a scalable and cost-effective method for 
production of bifunctional modular biomolecule used to make oil-core silica-shell nanocapsules. The 
development of high cell density culture technique for E. coli has made it possible to express modified 
variants containing bioactive motifs in amounts suitable for research, clinical and industrial purposes 
[60]. Synthetic DNA encoding amino acid sequence in the bifunctional modular peptide developed 
in objective (1) can be joined with bacterial DNA, and the resulting recombinant DNA can be inserted 
into microbial cell-factory E. coli, a process known as recombinant DNA technology [61]. However, 
expression of short recombinant peptides, though possible, is very challenging as it is unstable in 
bacterial host [62-64] because they may self-associate, be toxic, or be rapidly degraded by proteases 
within the cell. Therefore, this study addresses these challenges by combining the bifunctional 
modular peptide with DAMP4 protein (MD(PSMKQLADS-LHQLARQ-VSRLEHAD)4; M = 11.1 kDa) 
[65] as a protein carrier enabling expression of the recombinant protein in E. coli. DAMP4 is selected 
because it was able to be expressed at high yield as a soluble protein in E. coli with ease of 
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purification procedures, and demonstrated surface activity [65, 66]. This then leads to important 
questions: would the recombinant protein show dual-functionality that is able to stabilize emulsions 
and to form silica at the interface for synthesis of oil-core silica-shell nanocapsules? If not, is it 
possible to cleave the recombinant protein using a chemical or enzymatic reagent and obtain a 
shorter biomolecule than the recombinant protein, which still contains a surface-active module and 
biosilicification-active module close to the bifunctional modular peptide developed in objective (1)? 
This study aims to design a recombinant bifunctional protein comprising a surface-active module 
and a biosilicification-active module for synthesis of oil-core silica-shell nanocapsules, and develop 
a sustainable production of the recombinant protein through microbial cell-factory E. coli with the 
potential of process scale-up. 
 
1.2.4 Large-scale production and field application of insecticide-encapsulated silica 
nanocapsules for termite control 
 
Is it feasible to produce the insecticide-encapsulated silica nanocapsules for a field scale? Could 
they be cost-effectively applied to treat millions of termites that live in a mound [67]? This study is a 
combination of objective (2) and (3), but at a larger scale, to demonstrate the large-scale production 
of the bifunctional modular protein for making fipronil-encapsulated silica nanocapsules which could 
then be used in combination with α-cellulose as feeding bait for termite field trial (Figure 4).  
 
 
Figure 4. Photographic image of mound of termites from genus Coptotermes. The image also 
shows assembled devices of bait applications for termite field trial. 
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1.3 Thesis organization 
 
This PhD thesis consists of 6 chapters, in addition to this introductory chapter. 
 
Chapter 2 provides a literature survey on the progress made in chemical methods for synthesis of 
silica nanocapsules using chemical surfactants. Later in the chapter, biomimetic approaches for 
making silica-based nanomaterials using peptides and proteins are discussed. Theoretical 
backgrounds on the silica chemistry, formation and stability of nanoemulsions, microbial production 
of the peptides/proteins, which are relevant to the aforementioned research objectives, are also 
presented. 
 
Chapter 3 explores engineering of peptide sequences for their surface activity and biosilicification 
functionality, and experimentally demonstrates their abilities to stabilize nanoemulsions and to 
induce silica formation as described in objective (1). Key novel aspects of this thesis are presented 
in this chapter, including design and use of bifunctional modular peptide in emulsion and biomimetic 
dual-templating approach for making oil-core silica-shell nanocapsules under benign reaction 
conditions in the absence of toxic organic solvents.  
 
Chapter 4 centers on the application of the silica nanocapsules to encapsulate fipronil insecticide 
and to release the insecticide in a sustained manner in vitro in water and in vivo against termites as 
specified in objective (2). Two laboratory methods of termite control including direct treatment and 
feeding treatment are described to evaluate insecticidal effects of the fipronil-encapsulated silica 
nanocapsules. 
 
Chapter 5 presents the design and production of novel bifunctional modular protein through 
biological expression as specified in objective (3). It describes the bioprocess routes to obtain the 
recombinant protein with high purity using biochemical unit operations. Analytical procedures to 
confirm the identity of the protein are investigated. This chapter also discusses interfacial properties 
of the protein and demonstrates its capability for both stabilizing nanoemulsions and inducing silica 
formation surrounding the nanoemulsions. 
 
Chapter 6 concerns the large-scale production and field application of the insecticide-encapsulated 
silica nanocapsules for termite field trial as described in objective (4). 
 
Chapter 7 draws conclusions from the results accomplished in this project and outlines potential 
directions for further research. 
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Chapter 2 
 
Literature review 
 
 
2.1 Silica nanocapsules 
 
Silica nanocapsules having core–shell architecture have attracted academic and industrial interests 
[1-3]. Synthesis methods of such engineered silica nanostructure are commonly based on sol–gel 
reactions of silica precursors on colloidal core templates, i.e., gas bubbles [4, 5], nanoparticles [6-
10], and emulsion droplets [11-18], resulting in nucleation and growth of silica at the boundary of 
gas–liquid, solid–liquid, and liquid–liquid interfaces, respectively. The core–shell morphology of silica 
nanocapsules allows combination of core material functionalities and silica shell properties on a 
nanoscopic length scale. Various active materials can be encapsulated in the core of silica 
nanocapsules with higher loading capacity than solid- and porous-silica nanoparticles [19]. Silica 
nanocapsules have found diverse applications in fields of chemical, biomedical and agricultural 
applications depending on the types of the core materials. Encapsulating catalytic metals [7], 
semiconductor [8], fluorescent [9] and magnetic [17] nanoparticles, and enzymes [11] render silica 
nanocapsules to act as supports for enhancing long-term activity and/or compatibility of the active 
molecules in desired environment [20]. In addition, silica nanocapsules can also function as 
nanocarriers by encapsulating poorly water soluble active molecules, including drugs [14, 19] and 
pesticides [21], in the oil core for storage, protection, and release.  
 
Silica as a shell material for nanocapsules has a number of advantages, including its stability against 
aggregation, easy functionalization, biocompatibility, and optical transparency [2, 3]. The stability of 
silica layer stems from electrostatic repulsion, as the isoelectric point of silica is between 2 and 3 
due to the presence of surface hydroxyl groups, hence, the zeta potential of silica is negative under 
neutral pH [22]. Another benefit of using silica is that the surface chemistry is easily modified (surface 
functionalization of silica-based nanomaterials is reviewed by Chen and Shi et al. [23]). 
Functionalization of silica surfaces with optical, magnetic, and/or biological functionalities offers bio-
labelling, controlled release, and targeted delivery of active molecule [24], as well as allowing 
detailed surface engineering to circumvent unwanted biological interactions, facilitate bioavailability 
and cellular uptake [25]. Furthermore, amorphous silica is biocompatible [26-28] as it is considered 
as “Generally Recognized As Safe (GRAS)” material by the U.S. Food and Drug Administration 
(FDA) [29], thus suitable for biomedical and agricultural applications. However, it should be 
emphasized that not all types of silica-based nanomaterials can be considered biocompatible. 
Several researchers have investigated the level of toxicity of silica-based nanomaterials in vivo. It 
- 18 - 
has been found that their biocompatibility depends on the synthesis processes, particle sizes, 
morphologies, surface chemistries, doses, and even the administration routes [23, 30-35]. For 
example, incomplete removal of chemical surfactant, a structure-directing agent, during fabrication 
of silica-based nanomaterials could cause high cytotoxicity in mice [30, 33, 35]. Therefore, 
applications that demand biocompatibility of the nanocarriers mandate stringent monitoring 
procedures when toxic chemical compounds are involved for the synthesis of silica nanocapsules. 
This is to ensure complete removal of the residual toxic substances from the nanocapsules down to 
levels that might be considered acceptable by the regulatory authorities. 
 
As outlined in Chapter 1, the central objective of this thesis is to develop a novel emulsion and 
biomimetic dual-templating method for synthesizing oil-core silica-shell nanocapsules, and to 
examine applications of the nanocapsules for controlled release of active molecules. Fundamental 
knowledge and available research outcome that are relevant to the synthesis of oil-core silica-shell 
nanocapsules are reviewed in this chapter. Following significance of silica nanocapsules described 
in Section 2.1, this review systematically surveys the chemical approaches of making silica 
nanocapsules (Section 2.2). Theoretical background of sol–gel chemistry is also introduced to 
explain reactions of liquid silica precursor to form solid silica. Despite great progresses in the 
synthesis of silica nanocapsules, the chemical methods variously incorporate toxic chemical 
catalysts and organic solvents that would pose adverse environmental effects and influence the 
biocompatibility of the silica product, as previously mentioned. Biomimetic silicification offers an 
alternative way to produce silica-based nanomaterials under mild physiological conditions using 
biocompatible components including peptides and proteins. The biomimetic approach would 
potentially shift the current chemical method to a more environmentally-friendly method for the 
synthesis of engineered oil-core silica-shell nanostructures. This discussion is covered in Section 
2.3 along with key information on the availability of peptides and proteins for biosilicification, and 
detailed understanding of the interactions between their functional groups and silica species. 
Biosilicification has been largely studied in bulk aqueous solutions rather than at oil–water interfaces. 
Although a number of biomolecules including peptides and proteins has been demonstrated capable 
of facilitating formation and stabilization of nanoemulsions, they have not been reported to direct 
nucleation and growth of silica at the interfaces. Section 2.4 of this review explores the fundamental 
background on the factors that influence formation and stability of nanoemulsions. Then, the use of 
designed peptides/proteins as surface-active agents (surfactants) to form nanoemulsions is 
highlighted in Section 2.5, which can provide a key understanding of the design of bifunctional 
modular peptide/protein developed in this thesis for making oil-core silica-shell nanocapsules. 
Section 2.6 describes the biological production methods of peptides/proteins using industrially 
relevant cell-factory Escherichia coli (E. coli) which have potential for development of process scale 
up. This chapter concludes with a short summary about the synthesis of silica nanocapsules 
- 19 - 
indicating limitation in current methods, and the introduction of the novelty and significance of our 
work detailed in this thesis (Section 2.7). 
 
2.2 Silica nanocapsules based on sol–gel chemistry 
 
The successful deposition of silica species exclusively onto template to form a silica shell 
surrounding colloidal core template is determined by strong molecular interactions between the silica 
species and the surface functional groups of the template. In Section 2.2.1, a brief review is provided 
regarding current chemical approaches on the templating synthesis of silica nanocapsules. Next, 
Section 2.2.2 provides more detail information of silica chemistry describing that silica formation via 
chemical methods necessitates extreme pH conditions and/or elevated temperature in the presence 
of toxic organic solvents.  
 
2.2.1 Chemical methods for synthesis of silica nanocapsules 
 
Hard- and soft-templating methods are commonly used for synthesis of silica nanocapsules.  
 
2.2.1.1 Hard templating 
 
Hard-templating approaches have been developed to prepare silica nanocapsules [36, 37] (Figure 
1). Solid nanoparticles composed of, for example, poly(styrene) (PS) is widely used as hard template 
and can be prepared via emulsion polymerization [38]. The resulting negatively charged PS 
nanoparticles allow alternate adsorption of oppositely charged polyelectrolytes, and thus result in 
nanoparticles with multilayer shells surrounding the cores, an approach so-called layer-by-layer 
(LbL) assembly [39]. Several deposition cycles of poly(diallyl-dimethyl-ammonium chloride), a 
cationic binder, and negatively charged silica nanoparticles have been employed to form silica 
nanocapsules with final thickness depending on the number of the cycles [39]. Surface 
functionalization of PS with amine groups or zwitterionic molecules consisting of amine and 
carboxylate groups is, in some cases, necessary to facilitate silica growth by in situ polycondensation 
of sodium silicate precursor under alkaline conditions [40]. The classical Stöber synthesis [41] based 
on the sol–gel chemistry of silicon alkoxide precursor has also been utilized to grow silica layer onto 
PS template in alcoholic solutions at alkaline conditions [36, 42]. In this regards, cationic surfactants 
(e.g., cetyltrimethylammonium bromide [42]) or non-ionic surfactants (e.g., polyoxyethylene sorbitan 
monolaurate [36]) were used to direct the nucleation and growth of silica encapsulating the PS 
template. Another example of hard templates is calcium carbonate, which can be prepared by using 
either high gravity reactive precipitation technology [43] or gas diffusion approach [42] to obtain 
porous or non-porous templates in the nanosized range, respectively. Silica coating of calcium 
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carbonate template is usually conducted through sodium silicate water-glass methodology [43, 44] 
or Stöber synthesis [42]. 
 
Applications of nanocapsules are often associated with their ability to load and deliver active 
molecules (Figure 1). A common approach to load the active components into the nanocapsules 
synthesized using the hard template is mainly by tuning pore structure of the silica shell during 
synthesis, allowing for diffusion of the active molecules from surrounding medium in which the hollow 
silica nanocapsules are dispersed (i.e., cargo post-loading) (Figure 1a). Decomposition of organic 
compounds, i.e., polymeric [39] or surfactant materials [36, 42], via calcinations (at >500 °C) or 
chemical treatments (e.g., using dimethylsulfoxides) is necessary to remove the template and to 
subsequently produce hollow nanocapsules with porous silica shells for facilitating diffusion of the 
cargo into the nanocapsules. However, in most cases, the active molecule can only be deposited at 
the porous silica shell [44], and high pressure is required to force the active molecule to diffuse into 
the empty core domain [43]. Moreover, the high temperature applied for template removal, in some 
cases, could influence the shell integrity, and thus resulted in shell rupture [39]. Another method of 
encapsulation is to load the desired materials into porous calcium carbonate template prior to silica 
coating (i.e., cargo pre-loading) (Figure 1b) [42]. However, acidic chemicals used for the dissolution 
of the template could affect the stability of the pre-loaded material, which might be sensitive to such 
treatment. 
 
 
Figure 1. Strategies for synthesis of silica nanocapsules by hard-templating method and their 
cargo loading techniques. a) Cargo post-loading technique: (1) hard template preparation, (2) 
template surface modification (optional), (3) nucleation and growth of silica on the template surface, 
(4) template removal by chemical or thermal means, and (5) cargo loading. b) Cargo pre-loading 
technique: (1) cargo loading during hard template preparation, (2) template surface modification 
(optional), (3) nucleation and growth of silica on the template surface, and (4) template removal by 
chemical means. 
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2.2.1.2 Soft templating 
 
The hard-templating route suffers from disadvantages associated with template removal and cargo 
loading. Harsh processes are necessary for ensuring complete template removal in order to minimize 
potentially destructed template trapped inside the hollow spheres. The cargo loading into hard-
templated silica nanocapsules, although possible, is yet challenging. These difficulties have 
prompted interest in simpler synthetic approaches that exclude template removal step and permit an 
easy encapsulation of the functional materials. Soft templating by means of oil-in-water (O/W) 
emulsions seems promising in this context, thereby dissolution of the cargo in the emulsion droplets 
prior to silica shell formation.  
 
The formation of silica exclusively around the interface between the nanosized oil droplets and the 
aqueous phase of O/W emulsions has been developed in recent years (Table 1). In these 
approaches, the pre-requisite of co-organization is being fulfilled by electrostatic charge-density 
matching or hydrogen bonding between silica precursor and cationic [16, 17, 45, 46] or non-ionic 
[12, 13, 15, 18] surfactant molecules present on the surface of oil droplets, respectively. In addition, 
an organo-alkoxysilane is often utilized as a co-surfactant to form a thin film at the oil droplet interface 
and facilitate co-condensation with silicon alkoxide achieving a certain silica shell thickness [12, 13]. 
Furthermore, self-templating methods have also been reported, in which the oil droplet not only acts 
as a template but also as a silica precursor itself [14, 47-49]. Reaction time and concentration of an 
additive (e.g., ammonium hydroxide) are required to be adjusted to produce core–shell 
nanocapsules instead of solid nanospheres [14]. In another case of self-templating methods [47, 49], 
the formation of hollow silica nanospheres is achieved by extraction using alcohol to dissolve 
monomeric or oligomeric units of silica precursor in the core domain. 
 
Oil droplet encased in silica shell can be used directly, for example, as an adsorbent for the uptake 
of hydrophobic compounds, including bupivacaine [12] and quinoline [13]. However, encapsulation 
of active molecules can broaden its application. For example, lipase, an enzyme that catalyze the 
production of biodiesel from vegetable oils, has been immobilized within silica nanoshells to produce 
a reusable biocatalyst [11]. Rhodamine B (RB), a fluorescent dye molecule used as an imaging 
agent, or ibuprofen, a non-steroidal anti-inflammatory drug, can be protected by encapsulation with 
silica shells [14]. The encapsulation of RB or ibuprofen in the oil core of silica nanocapsules involves 
dissolving the active molecule in the oil phase which also acts as silica precursor (i.e., (3-
thiocyanatopropyl)triethoxysilane (TCPTES)). The subsequent hydrolysis and condensation of 
TCPTES droplets in ammonium hydroxide solutions under 100 °C yielded active molecule-loaded 
silica nanocapsules. An organic dye molecule, such as pyrene [16], has also been incorporated into 
the silica nanocapsules by taking advantage of an easy dissolution of the hydrophobic dye in the 
core domain. 
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Table 1. Representative soft-templating methods including the components and the 
conditions used for the formation of silica shells on various oil droplet templates 
Template Surfactant 
Silica 
precursor 
Cargo 
Reaction conditions 
Ref 
T (oC) pH 
P 
(bar) 
Additive 
Ethyl ether CTAB TEOS Pyrene RT n/a n/a NH4OH [16] 
TEOS and 
DMF 
CTAC TEOS Gold or 
magnetic 
nanoparticle 
RT n/a n/a Ethanol, 
Triethanol-
amine 
[17] 
n-Heptane 
and TEOS 
CTAB TEOS Gold 
nanoparticle 
(post-loaded) 
30 3.1–
3.9 
25–
50 
Com-
pressed 
CO2 
[46] 
Hexadecane Brij 97 OTMS 
and 
TMOS 
Bupivacaine 
 
65(E) 
RT 
(H, S) 
7.0(E) 
3.0(H) 
7.4(S) 
n/a Saline 
solutions 
(E, H, S), 
HEPES 
buffer (S) 
[12] 
Ethyl 
butyrate 
Tween-80 
and lecithin 
OTMS 
and 
TMOS 
Quinoline 
 
70 (E) 
RT 
(H, S) 
n/a(E) 
2.5(H) 
7.4(S) 
n/a Saline 
solutions 
(E, H, S), 
HEPES 
buffer (S) 
[13] 
Supercritical 
CO2 
PEO-PPO-
PEO 
TEOS n/a 40 n/a 200 HCl [15] 
Benzene  TX-100 TEOS n/a 25 (E) 
RT (S) 
n/a n/a NH4OH [18] 
TCPTES - TCPTES Rhodamine 
B, or 
ibuprofen 
100 
(E, S) 
n/a n/a NH4OH [14] 
PTMS - PTMS n/a 60 
(E, S) 
n/a n/a HNO3 (H) 
NH4OH (C) 
[47, 
49] 
DMDES - TEOS n/a RT n/a n/a NH4OH [48] 
Oleic acid - TEOS and 
APTES 
Candida 
antartica-
lipase A 
RT (E) 
50 (S) 
5.3 (E) 
9.6 (S) 
n/a - [11] 
 
E = emulsification; S = silicification; H = hydrolysis; C = condensation; RT = room temperature; TCPTES = (3-
thiocyanatopropyl) triethoxysilane; CTAB = cetyltrimethylammonium bromide; CTAC = 
cetyltrimethylammonium chloride; TMOS = tetramethoxysilane; TEOS = tetraethoxysilane; DMF = N, N-
dimethyl formamide; OTMS = octadecyltrimethoxysilane; PTMS = phenyltrimethoxysilane; PEO-PPO-PEO = 
poly(ethylene oxide)-b-poly(propyleneoxide)-b-poly(ethylene oxide); APTES = (3-
aminopropyl)trimethoxysilane; DMDES = dimethyldiethoxysilane; HEPES = sodium 4-(2-hydroxyethyl)-1-
piperazine ethanesulfonate; TX-100 = Triton X-100; n/a = not available. 
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Despite the possibility of easy encapsulation of desired materials, most of the soft-templating 
approaches involve the use of elevated temperatures or pressures and/or extreme pH conditions 
(Table 1), which may affect the stability of active molecules like biomolecules or chemical-sensitive 
agents. In addition, the inclusion of chemical surfactants, toxic organic solvents, and not-
pharmaceutical-graded oils may limit the applicability of soft-templating method for agricultural and 
biomedical applications which demand biocompatibility. To understand more about conditions and 
components involved during the reactions for silica formation, silica chemistry is described in detail 
as follows. 
 
2.2.2 Silica chemistry 
 
Strategies for silica deposition onto a template (Section 2.2.1) are basically based on sol–gel 
chemistry of a silica precursor [50-53], which certainly represents an important parameter in silica 
formation. 
 
2.2.2.1 Silica precursors 
 
Silicon alkoxides such as tetramethoxysilane (TMOS) and tetraethoxysilane (TEOS) are common 
silicon-containing precursors used to study silica formation and generate materials for technological 
applications [53-55]. They are water-insoluble, and their use over aqueous silica precursors (e.g., 
sodium silicate and silicon catecholate) mainly results from three major aspects [54]. First, silicon 
alkoxides are available as pure, single molecules of which the hydrolysis kinetics can be efficiently 
controlled. In contrast, aqueous silica precursors are in the form of metal salt solutions, which can 
be prepared in a limited range of pH and concentrations and may often contain a mixture of 
oligomeric species whose reactivity is more difficult to control [56]. Second, silicon alkoxides are 
mainly neutral species and can remain stable in neutral solutions from days to weeks depending on 
the water concentration and the length and bulkiness of the alkyl chain [53], whereas metal salts 
tend to form charged species upon dissolution in water and usually leading to precipitation upon 
solvent addition [54]. Finally, alkoxides are also available with non-hydrolyzable organic functional 
group (e.g., phenyl, methyl, and vinyl) allowing modification of surface chemistry of the silica [57]. 
Overall, the use of silicon alkoxides as precursors to form silica-based nanomaterials is more flexible 
than using aqueous silica precursors in terms of reaction conditions, functionality and reactivity. 
 
2.2.2.2 Hydrolysis and condensation of silicon alkoxide 
 
In order for solid silica to be produced from silicon alkoxide (Section 2.2.2.1), hydrolysis and 
condensation of the precursor must occur prior to concomitant nucleation and growth of solid silica. 
In general, the hydrolysis and condensation reactions occur based on bimolecular nucleophilic 
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substitution (SN2-type reaction). At the functional group level, three reactions are generally used to 
describe the sol–gel processes as shown below [52, 53],  
 
Hydrolysis: Si(OR)4 + xH2O ⇄ (RO)4-x–Si–(OH)x + xROH (Equation 1) 
Condensation:  ≡Si–OR + HO–Si≡ ⇄ ≡Si–O–Si≡ + ROH (Equation 2) 
 ≡Si–OH + HO–Si≡ ⇄ ≡Si–O–Si≡ + H2O (Equation 3) 
where R is an alkyl group (CxH2x+1).  
 
The hydrolysis reaction (Equation 1) replaces alkoxide groups (OR) with hydroxyl groups (OH) 
producing a monomer containing silanol groups (≡Si–OH). Complete hydrolysis produces silicic acid 
(Si(OH)4). However, under most conditions, condensation commences before hydrolysis completes 
[53]. The hydrolysis reaction is specific-acid-[H3O+] or specific-base-[OH–] catalyzed [51-53]. It 
proceeds by bimolecular nucleophilic displacement reactions involving formation of a transition state 
[53]. In acidic conditions, the alkoxide group is protonated forming a pentacoordinate intermediate 
molecule in a rapid first step. The protonated species withdraw electron density from the silicon atom 
within the intermediate molecule, making it more electrophilic, and thus more susceptible to 
nucleophilic attack by water. The water molecule acquires partial positive charge, and thus the 
positive charge of the protonated alkoxide within the intermediate molecule is reduced. Then, the 
transition state decays and followed by displacement of alkoxide with hydroxyl to form monomer 
containing silanol groups. In basic conditions, water molecule dissociates in a rapid first step to 
produce nucleophilic hydroxyl anion which then attacks the silicon atom and results in the formation 
of pentacoordinate intermediate molecule. Both the hydroxyl and the alkoxide within the intermediate 
molecule acquire partial negative charges. Then the intermediate decays, in which the hydroxyl 
displaces the alkoxide to form monomer containing silanol groups. 
 
The subsequent condensation reactions involving monomer with silanol groups produce dimer 
having siloxane bond (≡Si–O–Si≡) and the by-products alcohol (ROH) (Equation 2) or water 
(Equation 3). Similar to the hydrolysis reaction, the condensation reactions are also catalyzed by 
acid or base, and involve formation of a transition state. Below the isoelectric point of silica (< pH 2–
4.5, depending on the extent of condensation of the silanol species [53]), some silanol species in 
monomers are protonated which make the silicon more electrophilic, and thus more susceptible to 
nucleophilic attack by unionized silanol species. Above the isoelectric point of silica, species 
containing silanol deprotonate depending on their acidity, and produce negatively charged silicate 
species (≡Si–O–) which makes the silica species more nucleophilic and enable them to attack 
unionized silanol species. Overall, the condensation reactions occur through a bimolecular collision 
between the unionized and ionized monomers [51, 53]. 
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2.2.2.3 Nucleation and growth of silica 
 
As previously mentioned, the molecular mechanism for the condensation reaction involve a 
bimolecular collision between an ionized and an un-ionized silicic acid molecule (Section 2.2.2.2). 
After the initial condensation, polycondensation of silica species continues in such a way to produce 
a maximum number of siloxane bonds and a minimum number of uncondensed silanol groups [51]. 
Therefore, monomers and dimers cyclize and form cyclic trimer and cyclic tetramer, instead of 
forming linear oligomers. Once the cyclic species dominate, monomers and dimers react 
preferentially with these species to form higher order rings. The cyclization is due to the proximity of 
the chain ends and the substantial depletion of the monomer population [53]. Moreover, in the case 
where the silica species are ionized, the charge distribution in the cyclic species is more symmetrical 
and thus energetically favourable than the linear species [58]. The presence of the cyclic species 
during the polycondensation process has been detected experimentally by using various 
spectroscopy techniques, e.g., Fourier-transform infrared, UV-Raman and 29nuclear magnetic 
resonance [58-60]. Furthermore, quantum mechanical calculations using ab initio and semi-empirical 
methods have calculated and compared the structures, charge distributions and energies of the 
linear and ring structures of the silica species in which the formation of the cyclic species is 
energetically more favourable [61, 62], consistent with the published experimental results, with a little 
difference in stability for rings containing 3 and 6 Si atoms i.e., only 4 kcal/mol difference in the heat 
of formation per silica tetrahedral added [63, 64]. The rings form the basic framework of three-
dimensional internally condensed spherical poly(silicic acid) nanoparticles which can also be 
described as silica nuclei having size of 1–2 nm [51] (Figure 2).  
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Figure 2. Formation of silica nuclei through polycondensation of silicic acid monomers. 
Polycondensation of silicic acid monomers yields dimer, cyclic oligomers and subsequently highly 
condensed, spherical poly(silicic acid) nanoparticles having a homogeneous appearance in aqueous 
phase. The figure is not drawn to scale.  
 
The poly(silicic acid) nanoparticles (Figure 2) can continue growing through Ostwald ripening where 
the smaller nanoparticles, which are more soluble than the larger ones, dissolve and release silicic 
acid monomers that re-deposit onto the larger nanoparticles [65]. Silica growth requires both 
depolycondensation (ring opening) of the poly(silicic acid) nanoparticles and the availability of 
monomers, which are in solution equilibrium with the oligomeric species and/or generated by 
depolycondensation (reverse of Equation 2 and Equation 3) [52]. The silica keeps growing until 
reaching a final size which depends on the temperature, solution pH and ionic strength of the solution 
[66] (Figure 3).  
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Figure 3. A schematic illustration of silica growth. The schematic describes the formation of 
nanoparticles and aggregated structures as a function of pH and presence of salts. In basic solution, 
the nanoparticles grow in size with decrease in number. In acid solution or in the presence of salts, 
the nanoparticles aggregate into three-dimensional networks and form gels. The transmission 
electron microscopy (TEM) images were adapted from Belton et al. [55]. 
 
At pH < 7 and in the absence of salts, the negatively charged silanolate group (Si–O–) at the surfaces 
of poly(silicic acid) nanoparticles is protonated, in which the repulsion effect between individual 
nanoparticles is reduced and cause formation of a gel [51, 53]. At pH between pH 7 and 10 and in 
the presence of salts, the salts interact with the negatively charged silicate species and screen the 
surface charge of the nanoparticles which favour their gelation [67]. In both conditions (pH < 7 and 
7 < pH < 10 in the presence of salts), the nanoparticles can collide with each other forming dense 
3D networks (Figure 3). At pH between pH 7 and 10 and in the absence of salts, the nanoparticles 
become stable toward gelation due to mutual repulsion effects of the negatively charged silanolate 
groups resulted from deprotonated silanol groups (pKa 6.7) (Figure 3). The nanoparticles can 
continue growing as isolated nanoparticles until the concentrations of silicic acid approach the 
solubility limit of amorphous silica. However, the particle size can possibly be increased by 
supplementing with additional silicic acid monomers that can undergo polycondensation on the 
surfaces of the nanoparticles [51]. The growth of the nanoparticles stops when majority of the 
nanoparticles are too large to be re-dissolved and to take part in the Ostwald ripening process [68].  
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2.2.2.4 Factors governing kinetics of silica growth 
 
Other factors than pH and presence of salts that affect the formation kinetics of solid silica (Section 
2.2.2.3) include temperatures, presence of additives, identity of precursors, and type of solvents [53, 
55].  
 
The solubility of amorphous silica is enhanced with increasing temperature which, in turn, increases 
the rate of polycondensation and results in a larger particle size at a higher temperature. For 
example, silica nanoparticles having diameters in a range of 5–10 nm can be obtained at an ambient 
temperature, whereas silica nanoparticles with diameters up to 150 nm are formed at 350 °C in the 
same reaction period [68]. 
 
Additives such as cationic or hydrogen-bonding polymers can accelerate the condensation reactions 
leading to a phase separation and forming silica precipitates [51]. The mode of action involves 
polymer adsorption onto the silica nanoparticle surfaces that contain silanol and negatively charged 
silanolate groups, which reduces inter-particle electrostatic repulsion and then induces aggregation. 
If more polymers are adsorbed on the surfaces, the apparent charge of the nanoparticles is reversed 
to become positive and re-dispersed the aggregates [51]. Long-chain polymers may also bridge the 
nanoparticles together, which leads to flocculation and precipitation of silica.  
 
The reaction rate of hydrolysis and condensation is affected by the steric factor of silicon alkoxide 
precursors, i.e., alkyl chain length and degree of branching [53]. For example, the hydrolysis of 
TMOS (Si(OCH3)4) completes within minutes whereas the hydrolysis of TEOS (Si(OC2H5)4) occurs 
over several hours under similar conditions [69]. This is because the steric effect of ethoxide is 
greater than methoxide, as observed by the time needed to convert an emulsion of TEOS in water 
into a homogeneous solution. 
 
Homogenizing agent including alcohols, tetrahydrofuran or acetone is usually added to facilitate 
hydrolysis reaction due to the insolubility of silicon alkoxides precursor (Section 2.2.2.1) [52, 53]. 
Because sol–gel processes are hydroxyl or hydronium ion catalyzed, solvent molecules which form 
hydrogen bonding with hydroxyl ions or hydronium ions can reduce the catalytic activity under basic 
and acidic conditions, respectively. Therefore aprotic solvents (e.g., tetrahydrofuran and acetone), 
which do not form hydrogen bonding with hydroxyl ions, have the effect of making hydroxyl ions 
more nucleophilic, and thus promoting base-catalyzed hydrolysis, whereas protic solvents (e.g., 
alcohols) make hydronium ions more electrophilic, and thus promoting acid-catalyzed hydrolysis.  
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2.3 Bio-inspired silicification 
 
Nature’s ability to form silica with controlled structure and properties developed over millions years 
ago provides a new paradigm for developing silica-based nanomaterials. The biological systems in 
Nature can uptake silicon-containing compounds (in a form yet unknown) from its surrounding 
environments and organize them into complex, highly ordered structures of defined functionality [70]. 
There are many types of organisms having an endogenous silica, ranging from aquatic (e.g., 
diatoms, radiolarian, and sponges) and terrestrial (e.g., horsetail and rice leaves) organisms [71, 72] 
to plants [72]. The siliceous portions formed in the living organisms are hydrated silica (SiO2) that is 
in an amorphous state [73, 74]. They evidence in the cell walls of diatoms, the skeletons of marine 
sponges, and the leaves of plants, among others [75], which primarily serve as a mechanical or 
structural support for the organisms. Although silica provides essential life functions for many 
organisms, it is the inherently green synthesis with precise control of biosilicification that has 
garnered attention from the academic and industrial communities [71, 76-78]. Specifically, the 
biosilicification reactions proceed under aqueous conditions at ambient temperatures and pressures, 
and near-neutral pH in the absence of toxic organic compounds [79]. Successful identification of 
genes and isolation of the mineralizing proteins from the organisms while still maintaining their 
biosilicification functionality in vitro are crucial for elucidation of the mechanisms governing 
biosilicification [80, 81]. At the atomic scale, these biomolecules are able to recognize, interact with, 
and direct the nucleation and growth of silica species [76], thereby transforming silicon-containing 
compounds in aqueous solution to amorphous solid silica-based nanomaterial under mild 
physiological conditions [71, 82]. It is thus essential to understand the underlying mechanisms of the 
biosilicification by understanding the amino acid residue sequences composing those proteins that 
have molecular recognition to silica species [80, 81]. In turn, the biological principle in biosilicification 
may inspire “bottom-up” synthesis of silica-based nanomaterials in vitro by mimicking functionality of 
the mineralizing proteins in the organisms [83].  
 
In the following review, the proteins associated with silica formation in diatoms and sponges, the two 
most prominent source of inspiration for the applications of bio-inspired silicification, are discussed 
firstly. This provides fundamental understanding of the interactions between silica material and the 
proteins at the level of amino acids. Then, peptides derived from the naturally occurring mineralizing 
proteins, peptides obtained from combinatorial biology, and other peptides/proteins rationally 
designed for the synthesis of silica-based nanomaterials are presented in order to broaden the 
knowledge of different combinations of amino acid residue sequences that affects the biosilicification. 
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2.3.1 Silica-precipitating proteins extracted from living organisms 
 
Silicateins (for silica proteins), which belong to the cathepsin L class of the papain-like cysteine 
protease superfamily [84], was demonstrated to have biosilicification activity [80]. The entrapped 
proteins within the axial channel of the spicule could be isolated from the marine sponge, Tethya 
aurantia (T. aurantia) [80]—a sponge whose structure is defined by silica spicules that constitute up 
to 75% of its dry weight [84]. Three proteins were found by dissolution of the spicule in buffered 
hydrofluoric acid, and referred to silicatein α, β, γ [84]. The isolated silicatein filaments were observed 
to initiate hydrolysis and condensation of TEOS in vitro at neutral pH and ambient temperature, 
producing silica precipitates [80]. Biosilicification functionality of silicatein α, which comprises 70% 
of the silicatein filament mass in T. aurantia [84], was explored by first producing it through E. coli 
[80]. Hydrophobic amino acid residues in silicatein α could draw TEOS molecules closer to the 
protein [85]. Subsequently, the nucleophilic serine–histidine pair in silicatein α attacks silicon atom 
in TEOS molecule and initiates the hydrolysis and condensation reactions [80, 85, 86] (Figure 4). 
The close juxtaposition of serine-26 and histidine-165 in the active site of silicatein α enhances the 
efficiency of SN2-type nucleophilic attack [86]. The catalytic mechanism of silicatein α is similar to 
the well-characterized catalysis mechanism of the serine–histidine and cysteine–histidine pairs 
within proteases [87]. In addition to the biosilicification functionality, silicatein α was also found to 
serve as a scaffold by self-assembled into a fibrous structure that supports silica formation on their 
surfaces [80]. The acceleration of the hydrolysis and condensation of TEOS and structure-directing 
activities of silicatein α are also evident when used other silicon alkoxide precursors i.e., organically 
substituted triethoxysilane precursors having general structure of R–Si(OC2H5)3, where R represents 
phenyl and methyl [80]. 
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Figure 4. Hydrolysis of tetraethoxysilane (TEOS) through nucleophilic attack of serine–
histidine pair within silicateinα on silicon atom and the subsequent condensation reaction, 
as proposed by Cha et al. [80, 85]. Hydrogen bonding between hydroxyl and imidazole side chains 
of serine-26 and histidine-165, respectively, increases nucleophilicity of the serine oxygen atom to 
attack silicon atom on TEOS molecule and form a transitory protein–substrate intermediate that 
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would be stabilized as a pentavalent silicon species through a donor bond from the imidazole 
nitrogen atom. Hydrolysis of the intermediate releases monomer containing silanol group and 
regenerates serine–histidine pair. Condensation is initiated by nucleophilic attack of the silanol on 
the silicon of the second TEOS molecule which then forms dimer.  
 
A completely different type of protein than silicateins which is contributed to the cell walls of a diatom 
was recently shown to be associated with proteins called silaffins (for silica affinity) [81]. The 
mineralizing proteins, silaffin-1A1, -1A2, -1B, were generated in vivo through enzymatic cleavage of 
a single protopolypeptide (sil-1p) and were isolated from the diatom Cylindrotheca fusiformis by 
anhydrous hydrofluoric acid treatment. The silaffins are homologous polypeptides that are highly 
post-translationally modified and enriched in serine (S), lysine (K) and glycine (G) residues with many 
of the lysines modified to long-chain polyamine moieties and the serines phosphorylated [81, 88-90]. 
The silaffins were demonstrated to accelerate polycondensation of silicic acid at pH 5 forming silica 
nanospheres in vitro [81, 89]. The basic amino acid lysine (K) with its modified form, which increases 
the overall positive charge of the biomolecule at neutral pH, govern the electrostatic interaction with 
anionic silanolate species (≡Si–O–) [81]. The hydroxyl-rich domains in silaffins may contribute to form 
hydrogen bonding with silica species [81]. The potential capability of hydroxyl amino acids in diatom 
cell walls such as serine (S) and threonine (T), which can interact with the growing silica structure, 
was also previously suggested for the control of biosilicification [91-93]. Hecky et al. proposed that 
such hydroxyl-rich domains might align silicic acid monomers (Si(OH)4), either by condensing with 
them (with elimination of water) to form covalent adducts or by hydrogen bonding, thus bringing them 
into favourable juxtaposition for their condensation to form silica (Figure 5) [91]. Furthermore, the 
silaffins could self-assemble in aqueous solution to function as a template for silica deposition, thus 
directing spherical structure [89].  
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Figure 5. Hypothetical scheme of silicic acid condensation reactions in the diatom cell walls 
(frustule), as proposed by Hecky et al. [91]. A protein template, rich in serine (S), threonine (T) 
and glycine (G), is proposed to form hydrogen bonding with mono- or orthosilicic acid, followed by a 
condensation reaction to form initial layer of covalent C–O–Si linkages. This layer would then 
promote condensation with other silicic acid molecules, thereby “epitaxially” growing silica directly 
from the template. An outer layer of polysaccharide acts as a buffer against dissolution of the 
siliceous frustule. Other compounds, including lipids, metal ions, etc., are also present in the cell 
wall. Hatched lines represent hydrogen bonds. Tetrahedron emphasize the three-dimensionality of 
the silicic acid (and resulting silica) with Si in four-fold coordination with oxygen atoms at the points 
of the tetrahedra. 
 
In summary, the specificity of proteins extracted from Nature for silica species may originate from 
both chemical (nucleophilicity, hydrogen bonding, and charge effects) and structural (morphology) 
recognition mechanisms. It has been reported that (1) nucleophilic amino acids, including serine (S) 
and histidine (H) in silicatein α, play roles in the hydrolysis of water-insoluble silicon alkoxide; (2) the 
hydrolytic activity of serine (S) and histidine (H) in silicatein α necessitates the amino acids to be in 
the close juxtaposition in order to achieve efficient catalysis and produce high amount of silica 
precipitates; (3) amino acids having hydroxyl groups and positive charge at near-neutral pH play 
roles as nucleation sites promoting the interaction with soluble silica species through hydrogen 
bonding and electrostatic interactions, respectively; and (4) the structural complexity of the protein 
contributes primarily as a structure-directing agent through polycondensation of silica species 
forming a layer that follows the contours of the underlying protein structure, thus governing the 
morphology of the resulted silica-based materials.  
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2.3.2 Peptide/protein sequences programmed silica formation 
 
Mineralizing proteins obtained from organisms (Section 2.3.1) generally involve collection of the 
organisms, isolation of the siliceous part, and extraction of the proteins using hydrogen fluoride to 
dissolve silica that associates with the proteins [80, 81]. This extraction technique is a direct method 
useful for studying the biosilicification processes but limiting for practical applications. Therefore, a 
number of model systems have been used to study the formation of silica nanostructures (Table 2). 
 
Combinatorial phage peptide display and selection technique have been employed to identify 
consensus binding motifs for peptide–silica interactions [94] (Sim-n) (Table 2). The inclusion of 
amino acid residues having hydroxyl, imidazole, and cationic functional groups within the peptides 
were found effective to bind, nucleate, and grow silica from silicic acid solution at near-neutral pH 
[94]. 
 
Table 2. Amino acid motifs in designed (poly)peptides capable of directing nucleation and 
growth of silica under mild physiological conditions 
Peptide Sequence 
Silica 
precursor 
Morphology Ref 
Si3-3; 
Si3-4; 
Si3-8; 
Si4-1; 
Si4-3; 
Si4-7; 
Si4-8; 
Si4-10 
APPGHHHWHIHH; 
MSASSYASFSWS; 
KPSHHHHHTGAN; 
MSPHPHPRHHHT; 
MSPHHMHHSHGH; 
LPHHHHLHTKLP; 
APHHHHPHHLSR; 
RGRRRRLSCRLL 
Silicic acid Spheres [94] 
R5  SSKKSGSYSGSKGSKRRIL Silicic acid Spheres [81, 
95, 96] 
Mutants of R5 SGSKGSKRRIL; 
KSGSYSGSKGSKRRIL; 
SGSKGSKRR; 
SSKKSGSYSGSKGSK; 
LIRRSSKKSGSY; 
SSKKSGSYRRIL; 
Silicic acid Spheres [96] 
(N/A) NH2-NSGAITIG-CONH2; 
NH2-NTGAITIG-CONH2 
TEOS Fibrils [97] 
P11-3; 
P11-4 
QQRFQWQFQQQ; 
QQRFEWEFEQQ 
TEOS Fibrils [98] 
(N/A) YSDQPTQSSQRP; 
TYHSSQLQRPPL; 
SPLSIAASSPWP 
(N/A) (N/A) [99] 
SAFa 
 
KIAALKQKIASLKQEIDALEYENDALEQ- 
KIRRLKQKNARLKQEIAALEYEIAALEQ 
Silicic acid Tubes [100] 
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Continued Table 2 
PA1b; 
PA2b 
AAAAKKKK; 
AAAAHHHH 
TEOS Tubes [101] 
Arginine-based 
surfactantc 
R Sodium silicate Wormhole [102] 
DS202; 
DS189; 
DS30; 
DS250; 
DS256; 
DS262 
RLNPPSQMDPPF; 
QTWPPPLWFSTS; 
LTPHQTTMAHFL; 
APRDNFNTVNLL; 
MPAKEWLPKHNN; 
SVSVGMKPSPRP 
TMOS Highly-
porous 
spheres 
[103, 
104] 
1; 
2; 
3 
RLSKRVSAMQNSGVND; 
YGGFSKKKFMRF; 
SGGLHGVG 
TEOS Spheres [105] 
Block 
copolypeptided 
Poly((ʟ-Lys)x-b-(ʟ-Cys)y) 
(x = 200 or 400; y = 10, 30 or 60) 
TEOS Spheres; 
elongated 
globules; 
columns 
[106] 
Poly((ʟ-Ala)30-b-(ʟ-Lys)200); 
Poly((ʟ-Gln)30-b-(ʟ-Lys)200); 
Poly((ʟ-Ser)30-b-(ʟ-Lys)200); 
Poly((ʟ-Tyr)30-b-(ʟ-Lys)200); 
Poly((ʟ-Cys)30-b-(ʟ-Glu)200) 
TEOS Non-ordered [106] 
Poly((ʟ-Lys)x-b-(ʟ-Gly)y) 
(x = 110, 200, 320 or 340; y = 50, 85, 55 or 
160); 
Poly((ʟ-Lys)x-b-(ʟ-Ala)y) 
(x = 390 or 400; y = 65 or 100); 
Poly((ʟ-Lys)450) 
Silicic acid Platelets; 
spheres 
[107] 
ʟ-Lys23-b-ʟ-Phe23 Silicic acid Hollow 
spheres 
[108] 
KPn (see note e) KP56; KP300; KP530 TMOS Hexagonal 
plate 
[109] 
MAX1; 
MAX8 
VKVKVKVKVDPLPTKVKVKVKV; 
VKVKVKVKVDPLPTKVEVKVKV 
TEOS; 
TMOS 
Tubes [110] 
I3K IIIK TEOS Tubes [111] 
Lanreotide NH2-(D)Naph-Cys-Tyr-(D)Trp-Lys-Val-Cys-
Thr-CONH2 
TEOS Tube  [112] 
Peptide 1f CKKCKK TEOS Silver–silica 
core–shell 
spheres 
[113] 
 
a Self-assembling of SAF to peptide fibers is formed by block A (KIAALKQKIASLKQ) which complements D 
(EIAALEYEIAALEQ), and B (EIDALEYENDALEQ) which complements C (KIRRLKQKNARLKQ). This 
leads to sticky-ended dimers that assemble further into fibres. The register of the assembly is partly 
maintained by the asparagine residues. 
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b The N-terminus of PA1 and PA2 are from an alkyl chain, CH3(CH2)14CO–, introducing the amphiphilic nature 
to the peptide.  
c The N-terminus of the arginine-based surfactant is CnH2n-1 introducing the amphiphilic nature to the peptide.  
d The block copolypeptides were designed to contain covalently linked domains (blocks) of hydrophilic and 
hydrophobic polypeptides that gave the chains an amphiphilic character. Thus, the copolypeptides could 
self-assemble into structured aggregates (originated from hydrogen, or covalent bonding, or disulphide 
linkages forming intra and intermolecular bridges) that act as template for the formation of ordered silica-
based nanomaterials. Differences in silica morphologies when using block copolypeptide were observed 
due to different chemistry of hydrophobic block as well as solution compositions that influence their self-
assembly behaviour in solution. 
e  Ethylene glycol-modified polylysine with n represents number of residues. 
f The two tripeptides (CKK) of Peptide 1 are connected through a disulfide bridge (–S–S–). 
 
The nucleophilic sulfhydryl, amine, and hydroxyl functional groups on the side chains of cysteine (C), 
glutamine (Q), and tyrosine (Y) amino acid residues, respectively, have been reported able to 
nucleophilically attack silicon atom in TEOS, and thus initiate TEOS hydrolysis [106] (Table 2). 
Kasotakis and Mitraki [97] had proposed the effect of hydroxyl groups of serine (S) and threonine 
(T) with an amine group at the N-terminus of an octapeptide in initiating TEOS hydrolysis (Figure 6), 
which is close to the mechanism proposed by Cha et al. on silicatein α protein [80, 85]. At near-
neutral pH, the hydroxyl group of serine (S) or threonine (T) on the peptide undergoes deprotonation 
caused by the N-terminal amino group. The deprotonated hydroxyl group increases nucleophilicity 
of the serine or threonine oxygen, and allows the attack of the silicon atom in TEOS. Through this 
process, an ethanol molecule is produced along with the putative formation of a tetrahedral 
intermediate. The presence of a water molecule completes TEOS hydrolysis producing a monomer 
containing silanol group (≡Si–OH). A dimer with a siloxane bond (≡Si–O–Si≡) is formed after the 
attack of the silanol group to the second TEOS molecule. The polycondensation of silica species 
continues by forming poly(silicic acid) nanoparticles which accumulate and bind to the surfaces of 
the peptide fibrils via hydrogen bonding [97] (Figure 6).  
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Figure 6. Illustration of the effect of hydroxyl groups on peptide fibril surfaces to 
nucleophilically attack the silicon atom in tetraethoxysilane (TEOS) molecules, as proposed 
by Kasotakis and Mitraki [97]. The peptide molecules self-assemble to fibrils in aqueous solution 
and are shown as gray β-strands with the serine residues located in the loop. (1) TEOS hydrolysis 
is initiated at the fibrils surfaces by the serine (S) or threonine (T) residues to form silanol species 
(≡Si–OH). (2) The silanol species diffuse at the vicinity of the fibril where polycondensation begins 
and silica sols start to form. (3) The silica sols accumulate on the fibril surfaces. (4) In longer 
incubation times, the silica sols deposit further leading to the complete occlusion of the fibril in a 
tubular silica sheath. 
 
Amino acid residues with an amine group such as arginine (R) and lysine (K) play important roles in 
catalyzing silica formation. Example of a peptide composed of cationic amino acids is R5 peptide 
[114]. R5 peptide is derived from silaffins but lacks of the extensive post-translational modifications 
(i.e., phosphorylation, polyamine addition, and lysine methylation) that are unique to silaffins. R5 
peptide was shown able to initiate the nucleation and growth of silica from aqueous silicic acid at 
near-neutral pH and room temperature (Table 2) [81]. Knecht and Wright investigated a range of R5 
peptide variants, in which key amino acid residues within R5 peptide sequence were substituted, 
deleted, and/or re-arranged [96] (Table 2). The analysis of these peptides revealed that the C-
terminus peptide motif (i.e., RRIL) was important in the biosilicification of the peptide. As suggested 
by Mizutani et al. [115], molecules containing amine functional groups could act as an acid–base 
catalyst, in which deprotonated residues (base) accepts a proton from silicic acid (Si(OH)4) forming 
negatively charged silanolate group (≡Si–O–), and protonated residues (acid) would drive the release 
of water by protonation of silicic acid substrates. The positively charged patches along the molecules 
surfaces would interact electrostatically with the silanolate species to initiate condensation reactions. 
This hypothesis is supported by other researchers suggesting the effect of cationic amino acid 
residues in catalyzing polycondensation of silica species [81, 96, 101, 106, 111, 116, 117]. For 
example, cationic poly(ʟ-cysteine)-b-poly(ʟ-lysine) promoted interaction with anionic silanolate to 
form silica, whereas anionic poly(ʟ-cysteine)-b-poly(ʟ-glutamate) was unable to form silica [106]. The 
various modes of electrostatic interactions between silica species and proteins are illustrated in 
Figure 7 [68].  
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Figure 7. Illustration of the interactions of positively-charged functional groups on amino acid 
side chains with silica. a) Proteins having cationic functional groups bridge the negatively charged 
silica particles. b) Cationic patches of a protein interact with anionic silanolate species to initiate 
condensation reactions. c) Self-assembled proteins forming micelles with positively-charged 
functional groups on their surfaces act as templates for the formation of mesostructured silica. The 
figure was adapted from Coradin and Lopez [68]. 
 
Some area of applications for biomimetic approach have been developed in the process of making 
functional silica-based nanomaterials. The applications are mainly intended for enzyme 
immobilization. It has been achieved by adding aqueous silicic acid, as a silica precursor, and a 
silica-forming polycationic biomolecules to the solution of enzyme [118-123]. Another way is to fuse 
a silica-forming peptide, e.g., R5 peptide, with the enzyme before addition of silicic acid [124, 125]. 
The methods led to entrapment of the enzyme inside the mineral phase, and generally resulted in 
excellent retention and stabilization of the enzyme activities [126]. In addition, R5 peptide has been 
incorporated into a hologram to facilitate the formation silica layer, which can improve mechanical 
and optical properties of the polymeric device [127]. Moreover, anticancer proteins can be 
autonomously encapsulated within silica nanoparticles to sustain its activity when mixed the proteins 
with silicic acid solution [128]. The biosilicification activity of the proteins is due to specific sequences 
in the protein that are mainly composed of cationic amino acid residues, i.e., PTD (YGRKKRRQRRR) 
and BH3 (LRRFGDKLN). Further applications of designed peptides to mediate silicification are in 
the area of inorganic coating [113, 123]. Peptide 1 (Table 2) was designed to stabilize silver 
nanoparticles and to subsequently control the growth of a very thin silica layer encasing the silver 
nanoparticles [113]. The resulting silica layer protects the silver nanoparticles from chemical etching, 
allows their inclusion in other materials, and renders them biocompatible.  
 
In summary, three important amino acid residues properties that characteristically direct nucleation 
and growth of silica from silicon alkoxide precursors are nucleophilic, hydrogen-bond donor, and 
cationic at near-neutral pH. Biosilicification of the peptides/proteins containing these particular amino 
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acid residues has been developed based on self-assembly of the biomolecules in bulk aqueous 
solutions or at solid–liquid interfaces producing silica-based nanomaterials with various 
morphologies. Interactions between silica species and the peptides/proteins at oil–water interfaces 
have not been reported, and thus there are no current biomimetic routes to oil-filled silica 
nanocapsules. However, there are peptides that have been designed to be surface active, and 
capable of facilitating formation and stabilization of O/W nanoemulsions. Understanding the 
behaviour of such peptides at the interfaces coupled with peptide-directed biosilicification in bulk 
aqueous solution activity may provide an important knowledge for interfacial biosilicification. Prior to 
discuss designed peptides/proteins as surfactants, theoretical background of nanoemulsions, 
including their formation and stability, are described as follows. 
 
2.4 Nanoemulsions 
 
2.4.1 Nanoemulsion formation 
 
Combining oil and water in a container expectedly results in a layer of oil formed over a layer of water 
due to their density difference. This represents thermodynamically most stable state of a mixture of 
oil and water as it minimizes the contact area between the two phases, and hence minimizing their 
free energy. To form nanoemulsions, an input of free energy is required in order to overcome 
interfacial tension at the oil–water interfaces and to rupture larger droplets down to a smaller size, 
thereby creating a high total contact area between the two phases [129]. A surface-active agent 
(surfactant) is usually added to reduce interfacial tension and also to facilitate stabilization of 
nanoemulsions (see Section 2.5). At constant temperature, pressure, and chemical potential, the 
interfacial free energy can be expressed mathematically as follows [130], 
 
ΔG = ·ΔA (Equation 4) 
 
where ΔG is the change of the interfacial free energy (J or N/m), ΔA is the change of the contact 
area between oil and water phases (m2) and 𝛾 is the interfacial tension at oil–water interfaces (J/m2 
or mN/m). 
 
In the absence of any applied external forces, nanoemulsion droplets tend to be spherical because 
this shape minimizes the energetically unfavourable contact area between the oil and the water 
phases for a given volume [131]. The forces responsible for holding the droplets together and keep 
their spherical shape are referred to as interfacial forces. The interfacial forces are characterized by 
the Laplace pressure (∆𝑃𝐿, N/m
2), which is the pressure difference between the inside and the 
outside of the droplets across the oil–water interfaces. It can be expressed by the following equation 
[132, 133], 
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∆𝑃𝐿 =
4𝛾
𝑑
 
 (Equation 5) 
where 𝑑 is the droplet diameter (m). The equation clearly indicates that it becomes more difficult to 
disrupt droplets as their interfacial tension increases or their size decreases. A significant disruptive 
pressure must be generated in order to compensate or overcome the interfacial tension [134].  
 
One of the methods that allow generating intense disruptive forces for the emulsification is by using 
ultrasonic device. It is beneficial due to its lower energy consumption and its ability to achieve smaller 
droplet sizes while obtaining more homogeneous batches, as compared to conventional mechanical 
processes [135]. Ultrasonic devices include focusing horn and pointed tip as transducer that contains 
piezoelectric crystals. When a high-intensity electrical wave is applied to the transducer, the 
piezoelectric crystals are rapidly oscillated and generated an ultrasonic wave at ultrasonic 
frequencies, typically between 20 and 50 kHz [134, 136]. The ultrasonic wave is directed toward the 
tip of the transducer where it radiates into the surrounding liquids and generates intense pressure, 
causing extreme shear and cavitation [137-139]. In turn, it causes liquids to be deformed and 
disrupted into fine droplets [140]. Increasing the intensity or duration of the disruptive energy supplied 
during sonication can reduce droplets size [135, 141]. Ultrasound method is usually conducted for a 
period of few minutes in a number of short bursts because it can cause appreciable heating. It should 
be noted that prolonged exposure of certain proteins to high-intensity ultrasound could promote 
denaturation of the proteins [136]. 
 
2.4.2 Nanoemulsion stability 
 
Nanoemulsions are thermodynamically unstable systems. Thermodynamic stability of 
nanoemulsions is determined by the free energy between nanoemulsions and the separating phases 
(i.e., oil and water) [130]. Nanoemulsion systems tend to undergo transition from high free energy 
state to the lowest free energy state where it is the most thermodynamically stable. The rate at which 
this transition occurs determines kinetic stability of the nanoemulsion systems; the more stable the 
nanoemulsions, the longer the nanoemulsions persist. It is affected by (1) height of energy barriers 
(activation energies) that separates the two states; and (2) mass transport phenomena including 
diffusion and convection processes that determine how fast components in the nanoemulsion 
systems can move [130, 136]. Therefore, nanoemulsions are metastable systems as they will 
ultimately breakdown to separate phases given sufficient time. Difference between the 
thermodynamic stability and the kinetic stability of a nanoemulsion system is presented in Figure 8. 
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Figure 8. Schematic presentation of the difference between thermodynamic- and kinetic-
stability of a nanoemulsion system. Nanoemulsions are thermodynamically unstable and tend to 
revert to the state with the lowest free energy. Kinetically stable nanoemulsions can be achieved by 
ensuring that there is a sufficiently high energy barrier between the two states. The higher the energy 
barrier, the nanoemulsions are more kinetically stable and, hence, the longer the nanoemulsions will 
persist. Gf and Gi are free energy of the system in its final (after emulsification) and initial (before 
emulsification) states, respectively. G described the difference in the free energy between Gf and 
Gi. G* represents an activation energy that keep the system to be in a kinetically stable state. 
 
The height of energy barrier depends on the physicochemical properties of nanoemulsion surfaces 
that prevent destabilization of the nanoemulsions. These include repulsive hydrodynamic and 
colloidal interactions between the nanoemulsion droplets, which are strongly affected by the 
presence of surfactants [133, 136, 142-147]. The hydrodynamic interactions arise from relative 
motion of the droplets in a suspending medium. When the droplets approach each other in the 
suspending medium, the hydrodynamic resistance occurs depending on the interfacial film thickness 
and interfacial mechanical strength of the thin liquid film between them. On the other hand, the 
colloidal interactions depend on the surfactant chemistry which may cause steric and/or electrostatic 
repulsion between nanoemulsion droplets in an aqueous solution. Frequent collisions between 
droplets, which result from Brownian motion, applied shear or thermal energy, or gravitational forces, 
can reduce the kinetic stability of the nanoemulsions [131, 136]. To maximize the kinetic stability of 
nanoemulsion systems, it is necessary to understand physical mechanisms of nanoemulsion 
instability [136, 148] (Table 3).  
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Table 3. Physical mechanisms of nanoemulsion instability 
Type of physical instability of nanoemulsion droplets Principles 
Gravitational 
separation 
 
 
 
 
 Gravitational separation results from a 
density difference between the water (1) 
and oil (2) phases. 
 If 1 < 2, then oil droplets tend to move 
downward (i.e., sedimentation). 
 If 1 > 2, then oil droplets tend to move 
upward (i.e., creaming). 
Flocculation  
 
 
 
 Flocculation results from collisions between 
droplets, which is induced by Brownian 
motion, gravitational separation, or applied 
forces. The droplets can retain their 
individual integrity and result in a little 
change to their total interfacial area. 
 Droplets flocculation may either be (1) 
reversible (i.e., weak flocculation) which can 
be re-dispersed by changing 
physicochemical conditions (e.g., pH, ionic 
strength, solvent polarity, or temperature) or 
by applying mechanical agitation (e.g., 
stirring or sonication); or (2) irreversible (i.e., 
strong flocculation or coagulation). 
Coalescence  
 
 
 
 Coalescence may result from droplets 
collisions. As the droplets come to close 
contact, the thin film separating them is 
ruptured and the droplets are fused into a 
larger droplet hence reducing their total 
surface area.  
 Coalescence is an irreversible process. 
Ostwald ripening  
 
 
 
 Ostwald ripening is a process of gradual 
growth of the larger droplets at the expense 
of smaller ones due to mass transport of 
soluble dispersed phase (oil) through the 
continuous phase (water).  
 This process causes the small droplets to 
shrink and eventually disappear, and the 
large droplets to grow. Once occurred, this 
process cannot be reversed. 
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Gravitational separation causes droplets to come into close contact for extended periods which can 
lead to enhanced aggregation [133, 136], and eventually oiling off, that is, the formation of a layer of 
oil phase on top of the water phase [136]. According to Stokes [149], when a sphere submerged in 
a viscous liquid an upward gravitational force would act on it and a downward hydrodynamic frictional 
force would act retarding its motion. The sphere would accelerate until the forces acting on it are in 
balance, and thus the velocity rate of the sphere in highly dilute nanoemulsions can be obtained as 
follows, 
 
𝜈Stokes=−
2𝑔𝑟2(𝜌2 − 𝜌1)
9𝜂1
 
 (Equation 6) 
where 𝑟 is the radius of the droplet (m), 𝑔 is the acceleration due to gravity (m/s2), 𝜌 is the mass 
density (kg/m3), 𝜂 is the Newtonian shear viscosity (kg/m·s), and the subscript 1 and 2 refer to the 
continuous and dispersed phases, respectively. The sign of νStokes (m/s) determines whether the 
droplet moves upward (+) or downward (–). Equation 6 suggests that there are number of ways to 
reduce the gravitational separation rate: (1) reduction in droplet size (𝑟) by modification of energy 
input and type, and concentration of surfactants which allow more efficient oil disruption and 
resistance against droplet coalescence; (2) minimization of phase density difference (𝜌2 − 𝜌1) by 
adding an active molecule or a weighting agent to the oil phase to increase the oil density prior to 
the emulsification; and (3) increase of viscosity of the continuous phase by introducing a thickener 
or a gelling agent (e.g., biopolymer) in the continuous phase which decreases the velocity of the 
droplets. The Stoke’s equation applies only to highly dilute, non-interacting nanoemulsion system, 
and therefore is not applicable to concentrated, polydisperse or aggregated nanoemulsion systems. 
However, the parameters governing gravitational separation rate, as defined by the Stoke’s equation, 
could be applied non-quantitatively to improve nanoemulsion stability against creaming or 
sedimentation. 
 
Flocculation and coalescence are two types of aggregation. Aggregation occurs due to frequent 
collision between two or more droplets, and it depends on the nature of the colloidal and 
hydrodynamic interactions in the systems [133, 136, 142-147]. As the droplets come into close 
proximity, a relatively thin film of continuous phase is formed at oil–water interfaces. The thin 
interfacial film generates hydrodynamic resistance to droplets association and, depending on the 
level of energy barrier that separates the droplets, the thin film continues to thin up to a certain value 
after which aggregation may occur. At high energy barrier, droplets are finely dispersed in the 
aqueous phase; at slightly lower energy barrier, droplets are weakly flocculated, as the thin layer still 
exists; at low energy barrier, droplets are strongly flocculated with a very thin film existing between 
the droplets. Finally, as the energy barrier is so low, the surfaces between droplets become flattened 
and the thin film is eventually ruptured, which results in droplets coalescence. The rupture of the thin 
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film between droplets is caused by thermal energy or applied mechanical forces [150, 151]. The 
process involves hole formation in any remaining continuous phase between the droplets as well as 
in the adjacent surfactant layers at the interfaces, which may result in desorption of surfactant from 
the interfaces to the bulk solutions [133, 136].  
 
In general, aggregation can be prevented through proper selection of nanoemulsion ingredients, 
including type and concentration of surfactants or presence of additives, that could promote greater 
repulsive interactions than the attractive forces between droplets [136]. For example, too low 
concentration of surfactants may result in incomplete surface coverage of droplets and, as a result, 
the adsorbed surfactants attach to other droplet surfaces which then leads to bridging flocculation 
[152]. Presence of additives such as multivalent ions that have opposite charge can screen the 
surface charges and result in bridging flocculation [153]. Surfactants play an important role in 
reducing the coalescence rate by increasing interfacial film thickness [136] and interfacial 
mechanical strength [154].  
 
Ostwald ripening occurs when large droplets grow at the expense of smaller ones because of mass 
transport of dispersed phase from one droplet to another through the intervening continuous phase 
[155] (Table 3). This occurs because concentration gradient exists, which results from higher 
solubility of the dispersed phase within a small droplet than within a larger droplet [136, 144]. To 
control Ostwald ripening phenomena in nanoemulsion systems [155, 156], it is important to have 
nanoemulsion systems with narrow size distribution, low equilibrium solubility of the dispersed phase 
in the continuous phase, reduced interfacial tension, and high interfacial film thickness to reduce 
mass transport of molecules from one droplet to another droplet. These factors are largely influenced 
by surface-active agents. 
 
2.5 Peptides/proteins as surface-active agents 
 
Surface-active agents (surfactants) generally consist of hydrophobic and hydrophilic moieties. 
Because of their dual nature (amphiphilic), surfactants tend to adsorb at oil–water interfaces. 
Chemically, the hydrophobic moiety (referred to as the “tail”) is typically hydrocarbon, which can be 
either straight-chained or branched, or in some specialized surfactants, a fluorocarbon. The 
hydrophilic moiety (referred to as the “head”) covalently attached to the tail derives from a positive 
or negative charge (in the case of ionic surfactants), from extensive hydrogen bonding with aqueous 
phase (in the case of non-ionic surfactants), or from a strong dipole moment (in the case of 
zwitterionic surfactants) [157]. Besides chemical compounds, biological compounds including 
peptides/proteins have also been used as surfactants to stabilize O/W emulsions [158, 159]. The 
hydrophobic and hydrophilic moieties within the peptide surfactants are structurally different from the 
chemical surfactants [158]. They comprise polyamide backbone chirally decorated with hydrophobic 
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and hydrophilic side chains. The structural difference between peptide surfactants and conventional 
surfactants is illustrated in Figure 9.  
 
 
Figure 9. Structural compositions of chemical surfactant compared to peptide surfactant. a) 
The chemical surfactant comprises hydrophobic tail (shaded dark) and hydrophilic head (shaded 
light). b) The peptide surfactant composes of polyamide backbone having hydrogen bonding 
capacity to a defined sequence of hydrophilic (shaded light) and hydrophobic (shaded dark) side-
chains. The figure was inspired by Dexter and Middelberg [158]. 
 
In this section, designed peptide- and protein-surfactants used as the basis design of bifunctional 
modular peptide/protein in this study are discussed in detail as follows. 
 
2.5.1 Designed peptide surfactants 
 
A series of peptide surfactants have been designed and investigated in our lab for making oil-in-
water (O/W) emulsions including AM1 [160-163] and AFD4 [163]. Other peptides including peptides 
H, S and R [164], and peptides B-14, B-15, B16 and B17 [165] have also been researched by others 
(Table 4). Among them, AM1 has well characterized interfacial property and structure [166] and is 
capable of reversibly and precisely controlling the stability of O/W emulsions [160]. 
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Table 4. Examples of peptide surfactants capable of emulsifying oil phase 
Peptides Amino acid sequences 
Theoretical net 
charge at pH 7 
Stability mechanism 
at neutral pH 
Ref 
AM1a Ac-MKQLADSLHQLARQVSRLEHA-
CONH2 
+1.2 Cohesive interfacial film; 
electrostatic repulsion 
[160, 
161, 
167] 
AFD4a Ac-MKQLADSLHQLAHKVSHLEHA-
CONH2 
+0.4 Cohesive interfacial film; 
electrostatic repulsion 
[163, 
167] 
B-14b; 
B-15b; 
B-16b; 
B-17b 
Ac-PDFDFDFDP-CONH2; 
Ac-PHFHFHFHP-CONH2; 
Ac-PEFEFEFEP-CONH2; 
Ac-PKFKFKFKP-CONH2 
-4.0 
+0.02 
-4.0 
+4.0 
Electrostatic repulsion 
 
[165] 
Ha; 
Sa; 
Ra 
LEELLEELLEELLEEL; 
ELELELELELELELEL; 
LELLEEELLEEELLEL 
-8 
-8 
-8 
Electrostatic repulsion [164] 
 
 Secondary structures of the respected peptide are α-helix (a) and β-sheet (b). α-helix and β-sheet formation 
are achieved by manipulating the spacing of the hydrophobic residues within the sequence, i.e., (i, i + 3 
and i, i + 4) and (i, i + 2), respectively [168].  
 The peptide termini were capped by N-acetylation and C-amidation to avoid interactions between adjacent 
peptide termini; 
 
Peptide surfactant AM1 (Ac-MKQLADS LHQLARQ VSRLEHA-CONH2, M 2472.86 Da) [160] used 
in this study was designed based on a 21 amino-acid peptide Lac21 (Ac-MKQLADS LMQLARQ 
VSRLESA-CONH2) [169] which was derived from sequences contained in the tetramerization 
domain of the bacterial Lac repressor protein [169]. AM1 and Lac21 contain 21 amino acid residues 
comprising three repeating seven-residue motif (i.e., heptad), abcdefg, in which hydrophobic amino 
acid residues are located at positions a and d (mainly methionine (M), leucine (L) and valine (V)), 
while the remaining residues are predominantly hydrophilic amino acid residues. This alternate three 
and four residue spacing of hydrophobic moieties permits the formation of an α-helical structure 
having distinct hydrophobic and hydrophilic faces at the interface. In the presence of oil–water 
interface, either AM1 [160] or Lac21 [170] could adsorb to the interface; the hydrophobic face 
interacts with the oil phase and the hydrophilic residues on the opposite face of the helix contact the 
bulk aqueous phase. 
 
The key difference between AM1 and Lac21 is the inclusion of two metal-binding residues, histidine 
(H), in AM1 at position 9 and 20. The histidines are incorporated into the AM1 sequence such that 
they will be orientated toward other interfacially adsorbed peptide molecules, allowing for the 
formation of metal ion bridges (i.e., Zn2+–histidine) between the adsorbed peptide molecules, hence 
interfacial peptide network [167]. Such intermolecular crosslinking of the peptide molecules 
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generates a cohesive interfacial film that contributes significantly to the stability of O/W emulsions 
[166] (Figure 10). Furthermore, the stabilization of emulsions by AM1 can be switched off from film 
state to detergent state by adding acid (at pH < 4) or chelating ligand (e.g., 
ethylenediaminetetraacetic acid (EDTA)) in the bulk solutions to sequester the bridging between Zn2+ 
ions and histidine residues [160]. Thus, the histidine residues in AM1 molecules are no longer 
crosslinked to each other, which results in the reduction of the interfacial mechanical strength, and 
hence droplets coalescence (Figure 10).  
 
 
Figure 10. Modulation of the stability of emulsions by peptide surfactant. The peptides self-
assemble to α-helix structure at an oil–water interface with the hydrophobic face (shaded dark) 
oriented toward oil phase and the hydrophilic face (shaded light) oriented toward bulk water phase. 
In the presence of transition metal ions, crosslinking between the adsorbed peptides occur which 
increase cohesive monolayer at the interface hence stabilizing the nanoemulsions against 
coalescence. The cross-links are switched off when metal sequestering compound or acid is added, 
which result in droplets coalescence. The figure was inspired by Dexter and Middelberg [158]. 
 
To obtain better understanding of the interfacial properties of AM1 and the influence of added Zn2+ 
ions, AM1 adsorption at the air–water interface was investigated using Cambridge Interfacial 
Tensiometer (CIT) [171, 172], and the results showed that the formation of interfacial film (in the 
presence of Zn2+ ions) could transmit significant force in the plane of the interface when compared 
to its detergent state (in the absence of Zn2+ ions) [160]. At film state, the interfacial elasticity modulus 
and the interfacial tensile stress were 121 mN/m and 6.9 mN/m, respectively. When the interfacial 
network was switched off, the interfacial elasticity modulus and the interfacial tensile stress dropped 
significantly to 30 mN/m and 0.5 mN/m, respectively. Furthermore, neutron reflectometer studies 
demonstrated that AM1 folded into an α-helix structure during interfacial self-assembly, creating a 
thin, but strong, ordered layer at the interface in the presence of Zn2+ [166]. Interfacial film thickness 
of AM1 was measured to be approximately 15 Å with Young modulus of 80 MPa in the film state and 
less than 20 MPa in the detergent state [166]. In addition, interfacial molecular area and surface 
coverage of AM1 at the interface were 380 Å2/molecule and 55%, respectively, as characterized by 
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the neutron reflectometer [166]. Quantitative determination of the surface activity of AM1 showed a 
52.9 mN/m in interfacial tension (from the initial value of 73 mN/m) at AM1 concentration of 5 μM in 
the presence of added Zn2+ [160]. AM1 peptide molecules undergo only minimal self-assembly in 
bulk solution [167], thus are capable of rapidly adsorbing to the freshly formed air–water interface, 
and hence reducing interfacial tension. Apparently, switching the film state to the detergent state 
was not accompanied by significant changes in dynamic interfacial tension (as detergent state of 
AM1 gave 52.1 mN/m in interfacial tension under the same concentration) [160]. Similar dynamic 
interfacial tensions of AM1 at film and detergent states was because both states consisted of an 
approximate monolayer of the peptide with similar surface excess as studied using neutron 
reflectometer [166]. Therefore, the difference of interfacial properties of AM1 at the film and detergent 
states is due to changes in the interaction between the peptide molecules at the interface and the 
formation of cohesive interfacial network [160]. 
 
AM1 nanoemulsion has been developed in our lab as nanocarrier of curcumin for biomedical 
applications [161]. Curcumin, a lipophilic drug, could be co-delivered with bovine serum albumin 
(BSA), a model protein antigen, for specific inhibition of nuclear factor kappa B (NF-B), a therapeutic 
target for treating rheumatoid arthritis disease, in antigen presenting cells [161]. To co-deliver 
curcumin and BSA, curcumin-loaded nanoemulsions were first formed by directly dissolving 
curcumin into the oil phase, followed by sonicating the oil phase in AM1 peptide aqueous solution. 
The resulting nanoemulsions were then surface functionalized through electrostatic deposition of 
BSA at neutral pH, as positively charged AM1 nanoemulsions (+46 mV) could interact with negatively 
charged BSA molecules through electrostatic attraction. This resulted in the formation of negatively 
charged curcumin-loaded nanoemulsions (–40 mV) having BSA decorated on the droplet surfaces 
[161]. Although the zeta potential of the nanoemulsions was reduced to –13 mV under physiological 
conditions, the nanoemulsions demonstrated stability as BSA displayed at the interfaces provides 
steric barrier to flocculation. Further, the nanoemulsions were successfully internalized and well-
tolerated by model antigen presenting cells, and were able to suppress NF-B expression [161]. 
 
Use of AM1 nanoemulsions for biomedical applications has also been extended to the development 
of a targeted and immune-evading nanocarrier formed using “top-down non-covalent click self-
assembly” [162]. Ovalbumin was used as a model protein antigen that could be delivered to dendritic 
cells, a model target cells, in mice. To load ovalbumin into AM1 nanoemulsions, solid-in-oil (S/O) 
nanodispersion method [173] was used, thereby coating ovalbumin with hydrophobic surfactant via 
homogenization in an aqueous solvent to form protein–surfactant complexes. The complexes were 
then lyophilized to evaporate the solvent resulting in hydrophobic solid particles which could be 
dissolved in an oil phase to form S/O nanodispersions. The nanodispersions were mixed with AM1 
aqueous solution via sonication to form ovalbumin-loaded nanoemulsions. To efficiently deliver 
ovalbumin to dendritic cells in vivo, poly(ethylene glycol), an immune-evading molecule, and 
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monoclonal antibody Clec9A, a receptor-specific antibody element, conjugated to DAMP4 protein 
surfactant (detailed in Section 2.5.2) were displayed at the surfaces of the ovalbumin-loaded 
nanoemulsion resulted from non-covalent integration of DAMP4 present in bulk solution with AM1 at 
the interfaces (Figure 11) [162]. As a result, the nanoemulsions could be uptaken and correctly 
processed by the target cells in a receptor-targeted fashion. 
 
 
Figure 11. Application of designed AM1 peptide surfactant to facilitate formation of a targeted 
and immune-evading nanocarrier via top-down non-covalent click self-assembly, as 
proposed by Zeng et al. [162]. The figure shows PEG conjugated to DAMP4 protein is integrated 
onto surfaces of nanoemulsion that has been stabilized with AM1. The non-covalent integration of 
DAMP4 with AM1 results in the functional display of PEG at the interface separating the oil droplet 
from the bulk aqueous solution. This figure was adapted from Zeng et al. [162] 
 
In summary, AM1 has well characterized interfacial structure, and the stabilization mechanisms of 
nanoemulsions imparted by AM1 are well understood that is based on a combination of interfacial 
mechanical strength and charge. The AM1-stabilized nanoemulsions have been demonstrated able 
to be effectively loaded with either hydrophobic or hydrophilic active agents. With rich chemistry of 
amino acid residues contained within AM1 peptide, various molecules can be attached to AM1 at 
the oil–water interfaces, thus enhancing the nanoemulsion performances in biological systems (i.e., 
stability, immune-evading ability and targeted delivery). Therefore, peptide surfactant AM1-based 
nanoemulsions could be a promising candidate for performing biosilicification at oil–water interfaces 
to fabricate peptide-based silica nanocapsules encasing oil droplets. 
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2.5.2 Designed protein surfactants 
 
It is well known that many naturally occurring proteins including -lactoglobulin, whey proteins, 
lysozyme and caseins adsorb spontaneously at oil–water interfaces as a result of their intrinsically 
amphiphilic nature [159]. The use of these biomolecules as protein surfactants is because of their 
ability to (1) lower interfacial tension [170]; (2) form interfacial protein network [171, 172]; and (3) 
generate steric and electrostatic barriers to coalescence [159, 174, 175].  
 
Alternatively, surface active proteins can be rationally designed to contain variants of bioactive motif 
which can be produced by biological expression using microbial cell-factory (described in Section 
2.6). A protein surfactant DAMP4 (MD(PSMKQLADS LHQLARQ VSRLEHAD)4, M 11157.67 g/mol), 
was designed in our lab by joining four AM1 peptides through Asp-Pro-Ser (DPS) sequence [176]. 
The Asp-Pro-Ser linker in DAMP4 was incorporated (1) to promote electrostatic repulsion between 
adjacent loops through charged residue Asp; (2) to ensure helix termination between loops through 
Pro residue which has low helical propensity; and (3) to provide rotational freedom through Ser 
residue. These linkers along with the incorporation of four AM1 peptides give rise to the association 
of four amphiphilic α-helices interlocking the hydrophobic core, and thus folding into four-helix bundle 
structure in bulk aqueous solution [176].  
 
Dynamic interfacial tension studies showed that DAMP4 at a concentration of 8 μM and nearly 
neutral pH was able to lower the interfacial tension of air–water interface to 25 mN/m [176]. DAMP4 
was able to facilitate formation of foams, and the foam stability was maintained through electrostatic 
repulsion at or above pH 8.5 [176], as DAMP4 has isoelectric point (pI) of 6.7. Interfacial structure of 
DAMP4 at the air–water interface was studied using neutron reflectometer. The study suggested 
that DAMP4 could unfold and adsorb at the interface to form a monolayer of around 10–14 Å in 
thickness [177], which is approximately the same thickness as that of AM1 [166]. The unfolding 
behaviour of DAMP4 at the interface allows its hydrophobic face to orient away from the aqueous 
phase, while the hydrophilic face orients toward the aqueous phase (Figure 12) [176, 178].  
 
More importantly, DAMP4 can be produced at high levels of solubility in genetically-modified 
bacteria, and forms a four-helix bundle structure in bulk aqueous solutions (Figure 12a). Initial 
characterization has demonstrated that the structure of DAMP4 remains stable at high temperature 
(e.g., 90°C) [179]. This behaviour, which is unusual for a protein, confers a unique manufacturing 
advantage. Basically, after making the protein in genetically modified bacteria, simply heating the 
cells to high temperature in the solution used to grow the cells releases product into the solution 
phase and deposits cellular contaminants into a solid phase, allowing very simple centrifugal or 
filtration separation. This discovery opens the way to a unique and very cheap manufacturing method 
(detailed in Section 2.6).  
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Figure 12. The interfacial behaviours of DAMP4 providing its surfactant properties as 
determined based on neutron reflectrometry study by Dimitrijev-Dwyer et al. [177]. a) Four-
helix bundle motif of DAMP4 that fold in bulk aqueous solution. b) Unfolding of DAMP4 at air–water 
interfaces with the hydrophobic face oriented toward air phase and the hydrophilic face oriented 
toward water phase. This figure was adapted from Dimitrijev-Dwyer et al. [179]. 
 
2.6 Microbial bio-production of functional peptides/proteins 
 
(Poly)peptides having biosilicification activity (Table 2) and peptide surfactants with surface activity 
(Table 4) are mainly synthesized by using chemical methods. The chemical synthesis methods are 
rapid and effective for the production of specialized peptides in relatively small quantities [180, 181]. 
However, it is technically difficult and costly when large scale chemical production of the peptides is 
needed [182]. Recombinant DNA technology provides a way to produce biomolecules from bacteria, 
e.g., E. coli [180, 183] at low cost. One example of the widely and commercially used recombinant 
protein produced by genetically engineered E. coli is insulin [184], which has been proved to be safe 
enough to be injected in human [185].  
 
In general, recombinant DNA method involves insertion of a fragment of DNA containing gene of 
interest into a circular DNA molecule (i.e., vector) by cutting and joining the DNA using enzyme to 
produce a recombinant DNA molecule [186]. This recombinant DNA molecules are then transformed 
into a host cell, e.g., E. coli, so when the cell divides it will replicate the recombinant DNA molecules 
to the progenies; the process is so-called cloning. The cell then transcribes the recombinant DNA 
into messenger RNA as sets of three-nucleotide sequences (i.e., codons), each of which is translated 
to a particular amino acid. Cloning of genes that encode specific peptides/proteins having 
biosilicification or surface-active functionality, thus, permits their production through E. coli, which 
can provide assured and consistent source of the peptides/proteins. 
 
Production of peptides/proteins through recombinant DNA technology is beneficial because it is more 
sustainable than the chemical synthesis. The development of high cell density culture technique for 
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E. coli has made it possible to express modified variants containing bioactive motifs in amounts 
suitable for research, clinical and industrial purposes [187]. In addition, the use of recombinant DNA 
allows molecular design and hence the introduction of new function, allowing for engineering-based 
solutions to problems of yield, cost and process scale-up. A number of studies have used E. coli to 
produce recombinant peptides/proteins having either biosilicification functionality or surface activity 
(Table 5).  
 
Several challenges exist when expressing and purifying biomolecules in E. coli. It is especially the 
case when producing short recombinant peptides (10–30 amino acids). It has been shown that short 
recombinant peptide will be unstable in bacterial host [184, 188, 189] because they may self-
associate, be toxic, or be rapidly degraded by proteases within the cell. Therefore, peptide is usually 
fused to a larger carrier protein to mask the self-assembly characteristic and to improve the 
intracellular stability. The resulting recombinant biomolecules should be determined for their activity 
whether the additional amino acid residue sequences might have negative impact. When the 
additional amino acid residue sequence influence the activity of the target peptides/proteins, then 
purification methods involve cleavage and separation of the peptides/proteins of interest from the 
carrier protein.  
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Table 5. Production of recombinant peptides/proteins having biosilicification or surface-
active functionality in E. coli and their purification techniques 
Target 
peptide/ 
protein 
Expressed 
proteins 
Amino 
acids 
length 
M 
(kDa) 
Purification 
processes 
Final product 
and activity 
Ref 
15mer + R5 
peptide 
(His)6-MaSp1-R5 561 46.5 Immobilized-metal  
affinity 
chromatographya 
- (His)6-MaSp1-
R5 
- Biosilicification 
activity 
[190] 
284b (His)6-284  214 24.2 Immobilized-metal  
affinity 
chromatographyc 
- (His)6-284 
- Biosilicification 
activity 
[128, 
191] 
Silicatein α Silicatein α-MBPd  29 1. Maltose-affinity 
chromatographye; 
2. Enzymatic 
cleavage; 
3. Ion exchange 
chromatography; 
4. Size-exclusion 
chromatography 
- Silicatein α 
- Biosilicification 
activity 
[86, 
192] 
GAM1f MBP-s-TEV-GAM1 22 2.5 1. Maltose-affinity 
chromatographye; 
2. Enzymatic 
cleavage; 
3. Acid precipitation; 
4. Desalting 
- GAM1 
- Surface activity 
[193] 
DAMP4 DAMP4 98 11.1 - Chromatography 
method: 
1. Immobilized-metal  
affinity 
chromatographya; 
2. Ion-exhange 
chromatography; 
3. Reversed-phase 
chromatography 
Or 
- DAMP4 
- Surface activity 
[176, 
179] 
    - Bake-to-break and 
precipitate method: 
1. Heating/cell lysis 
and contaminant 
precipitation using 
sodium sulfate; 
2. Dilute precipitation; 
3. Membrane filtration 
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a The IMAC process uses nickel-charged affinity resin. It uses a chelating ligand nitrilotriacetic acid coupled 
to a cross-linked agarose. It allows for the specific binding of the 6×Histidine fusion tag. MaSp1 is major 
ampullate spidroin protein 1 of Nephila clavipes spider dragline silk. 
b 284 protein is an anticancer protein containing two PTD (YGRKKRRQRRR) and three BH3 (LRRFGDKLN) 
peptide motifs. The recombinant 284 proteins have demonstrated biosilicification functionality in bulk 
aqueous solution when reacted in a silicic acid solution at ambient temperature [128]. 
c The IMAC method uses cobalt-charged TALON® resin which is coupled to a cross-linked agarose. It allows 
binding to 6×Histidine fusion tag at the N-terminal of the protein. 
d MBP is a maltose binding protein with an amino acid length of 387 and a molecular mass of ~41 kDa. 
e Maltose-affinity chromatography uses amylose resin to capture maltose-binding protein (MBP). 
f MBP-s-TEV-GAM1 is composed of maltose-binding protein (MBP), a spacer (s), tobacco etch virus (TEV), 
glycine (G) and AM1 sequences. 
 
One recombinant peptide GAM1, which is surface active, was produced in E. coli [193]. It has a 
sequence equivalent to AM1 peptide surfactant [160] but with an N-terminal appended glycine 
residue and without N- and C-terminal capping (Table 5). Since the length of GAM1 (~2.5 kDa) is 
less than 30 amino acids, special design of the peptide is required to ensure successful expression 
of the peptide in E. coli and to enable its ease of purification. Maltose binding protein (MBP) having 
molecular mass of ~46 kDa was fused to the peptide in order to enhance solubility and enable high 
expression levels of the target peptide. The tagged protein is also useful to facilitate the purification 
by binding to the amylose resin through maltose-affinity chromatography. Tobacco etch virus (TEV) 
sequence (ENLYFQ) was added after MBP sequence to facilitate the release of the peptide from the 
fusion tag through the addition of tobacco etch virus protease (TEVp). Furthermore, a 14 amino acid 
unstructured spacer sequence (QTNSITSLYKSAGS) was inserted at the C- and N-terminal of the 
MBP sequence and TEVp cleavage site, respectively, to open the accessibility of the TEVp cleavage 
site. Additionally, glycine was introduced at the N-terminal of the original AM1 sequence to ensure 
more efficient cleavage by TEVp. Pure GAM1 peptides (>95% purity) were obtained after acid 
precipitation and desalting processes. In the presence of Zn2+, GAM1 was demonstrated to yield 
characteristic stress–strain curves of the tension-compression cycle to 300% strain indicating that 
they have assembled into a mechanically strong cohesive film state at air–water interfaces, and thus 
capable of stabilizing foams [193]. 
 
DAMP4 protein surfactant can be expressed in E. coli at high levels and solubility, and easily purified 
(Table 5) due to the four-helix bundle structure of DAMP4, as described previously (Section 2.5.2). 
Protein having four helix bundle structures are known to have good post-expression stability [194] 
and, due to this design, DAMP4 was expressed successfully without a fusion partner [176]. To purify 
DAMP4, chromatography-based purification processes, i.e., immobilized-metal affinity 
chromatography (IMAC), ion exchange chromatography and reversed phase chromatography, can 
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be conducted [176]. Although DAMP4 does not carry hexahistidine tag, it can be captured to the 
IMAC column through binding between histidine residues in DAMP4 and nickel ions in IMAC system. 
Another purification method, which is cheaper than chromatography, is by using bake-to-break 
precipitation method [179], thereby mixing the E. coli cells in a buffer containing high Na2SO4 
concentrations (up to 1 M) under high temperature (above 90 °C) to disrupt cell walls of E. coli 
containing DAMP4 and simultaneously precipitate the majority of contaminant proteins of E. coli 
while maintaining DAMP4 solubility. The thermal- and chemical denaturant-stability properties of 
DAMP4 are due to its four-helix bundle structure in bulk aqueous solution. Importantly, this simple 
purification still allows DAMP4 to maintain its surface activity [179]. Furthermore, the possibility to 
cleave DAMP4 at its DP sequence via acid hydrolysis opens opportunity to use DAMP4 as a carrier 
protein to potentially express a target peptide in E. coli at high levels and solubility and subsequently 
facilitate simple purification of the target peptide from the carrier DAMP4 protein.  
 
In summary, recombinant DNA technology allows manipulation of bacterial genetic material in order 
to express designed peptides/proteins of interest using E. coli. It is desirable that peptides/proteins 
are designed with special considerations prior to expression and purification in order to enhance 
solubility, ease of cleavage (when applicable), and purification. Availability of fusion tag protein, 
spacer, and cleavage sites are the factors that need to be considered, together with the sequence 
specific for surface activity and biosilicification functionality. More importantly, the functionalities of 
the final products of recombinant peptides/proteins should be tested whether all those additional 
sequences and processes affect the surface activity and/or biosilicification functionality of the 
biomolecules.  
 
2.7 Concluding remarks 
 
Silica nanocapsules have attracted considerable attention due to their core–shell morphology which 
provides feasible way to combine multiple functionalities of the core and the silica shell on a 
nanoscopic length scale (Section 2.1). Templating-based methods using hard and soft templates 
are commonly used to synthesize silica nanocapsules (Section 2.2). Soft template-based synthetic 
approaches are more advantageous as compared to hard-templating methods. Loading of an active 
cargo in soft template is simplified as it can be directly dissolved in the core prior to silica shell 
formation without the need for template removal. However, the methods contain several drawbacks 
associated with harsh reaction conditions including extreme pH conditions and elevated 
temperatures in the presence of toxic organic solvents. The drawbacks can potentially be overcome 
by using biomimetic approaches that utilize peptides or proteins to induce silica formation under 
environmentally-friendly conditions including at near-neutral pH and room temperature in the 
absence of toxic organic solvents (Section 2.3). In addition, peptides/proteins have advantages of 
renewability and high biodegradability, as well as a likely high biocompatibility. Literature shows 
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various amino acid residue motifs in peptides and proteins that have been used to induce nucleation 
and growth of silica from silica precursor to silica-based nanomaterials. However, peptides and 
proteins available in the biomimetic approaches are limited for the biosilicification in bulk aqueous 
solution or at solid–liquid interfaces. As a result, the fabrication of oil-core silica-shell nanocapsules 
using peptides/proteins has not been realized yet.  
 
In order to synthesize oil-core silica-shell nanocapsules, designed peptide and protein would be 
actively developed in this PhD project so that they have dual-functionality i.e., to facilitate formation 
and stabilization of nanoemulsion and to direct nucleation and growth of silica shell encapsulating 
the nanoemulsion core. Literatures suggest that only a few peptides with a surface activity that have 
been developed to emulsify oils (Section 2.5). Among designed surface-active peptides that are 
capable of stabilizing O/W nanoemulsions, AM1 designed in our lab has well characterized interfacial 
structure. The incorporation of specifically oriented functional groups in this helical peptide allows 
control over interfacial properties including charge and interfacial mechanical strength, resulting in 
the formation of switchable peptide-based emulsions. Building on the known surface-active peptide 
sequence of AM1 coupled with the knowledge of amino acid sequence specific for biosilicification 
(reviewed in this chapter), a bifunctional modular peptide would be designed to contain surface-
active module and biosilicification-active module. The modular combination design would allow 
stabilization of nanoemulsion core and formation of silica shell, thus emulsion and biomimetic dual-
templating approach for making oil-core silica-shell nanocapsules could be developed. This novel 
approach for making silica nanocapsules, as hypothesized in Chapter 1, will be experimentally 
researched and described in detail in Chapter 3. 
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inspired silicification 
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Abstract 
 
This chapter described a method for the synthesis of oil-core silica-shell nanocapsules using 
designed peptides, in lieu of chemical surfactants. This was motivated by the need to develop 
environmentally-friendly processes—i.e., nearly neutral pH and room temperature without using any 
toxic organic solvents—for making silica nanocapsules composed of biocompatible components, 
including pharmaceutically-grade oil (i.e., Miglyol® 812), peptide and amorphous silica. Surface-
active peptide, AM1, and a rationally-designed bifunctional modular peptide comprising a surface-
active module and a biosilicification-active module, as mentioned in Chapter 1, were evaluated for 
the effective formation of oil-core silica-shell nanocapsules. This was achieved by testing their 
abilities to facilitate formation and stabilization of nanoemulsions and to induce hydrolysis and 
polycondensation of silica precursor tetraethoxysilane at the oil–water interfaces. Reaction 
parameters for the interfacial biosilicification of the peptide were explored by controlling reaction pH, 
reaction times and silica precursor concentrations in order to obtain silica nanocapsules with different 
controlled-release properties. Additionally, characterizations of the resulting silica nanocapsules, 
including using dynamic light scattering and transmission electron microscopy, were discussed. 
Important for the studies in subsequent chapters, high-capacity loading of an active material in silica 
nanocapsules and its controlled release from the oil core to water phase were demonstrated. 
This journal is©The Royal Society of Chemistry 2014 Chem. Commun., 2014, 50, 11325--11328 | 11325
Cite this:Chem. Commun., 2014,
50, 11325
Emulsion-templated silica nanocapsules formed
using bio-inspired silicification†
David Wibowo, Chun-Xia Zhao and Anton P. J. Middelberg*
A novel, bio-inspired templating platform technology is reported for
the synthesis of biocompatible oil-core silica-shell nanocapsules
with tunable shell thickness by utilizing a designed bifunctional
peptide. Furthermore, facile encapsulation of an active molecule
and its sustained release are demonstrated.
Templated core–shell silica nanocapsule structures promise
great impact from the intersection of molecular and inorganic
chemistry.1 They allow encapsulation of fluorescent materials,2
magnetic nanoparticles,3 and active agents4 in the core domain for
imaging, sensing, and delivery, with a higher loading-capacity than
an equivalent solid nanoparticle. The silica shell is engineered
around the core to provide: (1) a protective envelope with chemical
and mechanical stability for storage and delivery; (2) accessible
pathways for adsorption, separation and sustained release; and (3)
ease of surfacemodificationwith optical,magnetic, and/or biological
functionalities enhancing the performance of nanocapsules for
applications including biolabelling, controlled release and targeted
delivery. Therefore, the fabrication of silica nanocapsules has
attracted much research and industrial interest.
Hard- and soft-templating approaches are commonly employed
to construct silica nanocapsules. Soft-templating methods offer a
number of advantages. Thermal decomposition or chemical dissolu-
tion necessary for complete removal of the solid core is avoided, and
the loading of an active cargo is simplified as it can be solubilized
in the core prior to silica shell formation.5 Sol–gel routes,5,6
including self-templating of an alkoxysilane5b,6a and interfacial
poly-condensation of hydrolyzed silicon alkoxide on ionic5a and
non-ionic surfactants,6b have been developed to synthesize silica
shells on oil-in-water (O/W) emulsions in the nanometer range.
However, these soft-templating approaches variously incorporate
the use of elevated temperature or extreme pH, or involve
chemicals that have limited biocompatibility. An alternative
pathway using more benign reaction conditions and biocompatible
components would, for some applications, remove limitations
embedded in current approaches.
Biomimetic templating offers mild routes to silica nano-
structures using biomolecules.7 Identification of amino acid
sequences from nature8 and combinatorial biology9 capable of
catalyzing silica formation has led to new strategies.10 These
involve biosilicification of the biomolecules in bulk aqueous
solution10a–c and at solid–fluid interfaces.10d Erni et al. reported the
synthesis of silica capsules at a scale of hundreds of micrometers by
silicification of cross-linked coacervate of gelatin and Acacia gum
around oil droplets.11 To the best of our knowledge, peptides or
proteins with modularized amino acid sequences capable of
both stabilizing an emulsion and inducing biosilicification at
the oil–water interface have not been reported, especially for the
fabrication of silica capsules of nanometer dimension. Here, we
designed a bifunctional peptide comprising one module capable
of forming a stable nanoemulsion core and another module
that induces biosilicification at oil–water interface to facilitate
formation of oil-filled silica nanocapsule. This work opens new
environmentally-friendly strategies for bio-inspired oil-core
silica-shell nanocapsule formation having wide potential utility.
We designed a bifunctional peptide (SurSi, Ac-MKQLAHSVSRLEHA
RKKRKKRKKRKKGGGY-CONH2) by modularizing part of peptide
surfactant AM1 (Ac-MKQLADSLHQLARQVSRLEHA-CONH2) for sur-
face activity12 (i.e., Sur module,MKQLAHSVSRLEHA) with a sequence
for biosilicification (i.e., Simodule, RKKRKKRKKRKKGGGY). Peptide
surfactant AM1 is capable of reversibly and precisely controlling the
stability of O/W emulsions12 by forming a cohesive interfacial film
responsive to metal ion binding to histidine (H) residues.13 Sur was
designed based on heptads of AM1 but without the second heptad
(i.e., LHQLARQ) and with the replacement of aspartic acid (D) with
histidine (H) in the first heptad. It is known that the molecular
weight of adsorbing peptide molecules at oil–water interfaces is
inversely proportional to the square of the interfacial adsorption rate
constant.14 Therefore, the incorporation of only two heptads, instead
of three heptads, of AM1 in Sur would promote more rapid
adsorption of the peptide at a freshly formed oil–water interface.
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Rapid interfacial adsorption facilitates efficient coverage of peptide
molecules onto oil droplets and hence formation and stabilization
of nanoscale emulsions.15 The replacement of aspartic acid (D)
with histidine (H) was designed to have the same number of
histidine residues as AM1, thus allowing the metal-ion-mediated
crosslinking between interfacially adsorbed peptide molecules and
the formation of a cohesive film state at the interface16 (Scheme 1).
Proteins and peptides having positively-charged amino acids
arginine (R) and lysine (K) can induce formation of silica under
mild conditions.8b,9a,10a The R- and K-rich Si module, based on a
sequence known to precipitate titania in bulk,17 is discovered
here to promote biosilicification at the oil–water interface when
modularized with Sur. A number of peptide- or protein-based
biomineralizationmechanisms have been proposed in literature,
including nucleophilic attack, hydrogen bonding, and electrostatic
attraction or ion-pairing. Cha et al. reported that polar amino
acid residues, including serine (S), tyrosine (Y), histidine (H) and
glutamine (Q), can promote nucleophilic attack, in which the
nucleophilicity of hydroxyl oxygen of serine can be enhanced by
the formation of hydrogen bond between serine and adjacent
histidine, on the silicon atom within tetraethoxysilane8a,10a
(TEOS) and thus may facilitate its hydrolysis to produce silanol
and negatively-charged silanolate (Scheme 1). Moreover, positively-
charged arginine (R) and lysine (K) may interact electrostatically with
silanolate at near-neutral pH, while the hydroxyls of serine (S) and
tyrosine (Y) promote hydrogen bonding with silanol8b (Scheme 1),
which in turn act as nucleation sites and direct silica growth through
poly-condensation of the silica species at the interface. Under these
possiblemechanisms, SurSi peptide would thus be expected tomake
silica nanocapsules at room temperature and near-neutral pH
without using any chemical-based catalysts.
Nanoemulsion was formed by sonication of Miglyols 812 oil in
SurSi solution, confirming surface activity due to the amphiphilic
Sur module. The addition of 32 mmol TEOS to dialyzed nano-
emulsion at pH 7.5 or 8 led to successful formation of silica
nanocapsule after 20 h, as evidenced by an electron-dense shell
(Fig. 1a and b). The outer diameter and the shell thickness of
nanocapsules formed at pH 7.5 as measured by transmission
electron microscopy (TEM) were 66  5 nm and 12  2 nm,
respectively (Fig. 1a). Dynamic light scattering (DLS) confirmed a
size increase in comparison with base nanoemulsion (Fig. S1a,
ESI†). Additionally, the z-potential of both the nanoemulsion
templates and the nanocapsules were measured. In contrast to
the nanoemulsions which had a positive zeta potential of +35 
5 mV because of the positively-charged SurSi peptide, the silica
nanocapsules exhibited a highly negative charge of 30  5 mV
as a result of silanolate groups on the silica surface. Further-
more, formation of a silica shell was confirmed by presence of
silicon and oxygen in the thick layer surrounding the oil core
using energy-dispersive X-ray spectroscopy (EDX) (Fig. 1c and d).
As a control experiment, AM1 was unable to demonstrate an
effective dual functionality of emulsion stabilization and silica shell
formation, as the silica was largely formed in bulk solutions rather
than at oil–water interfaces (Fig. S2, ESI†). Thus modularization of
a partial AM1 sequence with a specialized Si sequence was
considered essential for acceptable practical formation of nano-
capsules. The results confirm this is the case, with the desired
result achieved in a way not possible with AM1.
The silica shell thickness is tunable. Compared to reaction
at pH 7.5, reaction at pH 8 with 32 mmol TEOS for 20 h gave a
remarkable increase in silica shell thickness (27  6 nm)
(Fig. 1b). DLS also confirmed a size increase with increasing
reaction pH (Fig. S1b, ESI†). As increasing reaction pH assists
TEOS hydrolysis and generates a higher concentration of reactive
silica species, we hypothesized that increasing the concentration
of negatively-charged silanolate-rich species would favor their
attraction to the positively-charged nanoemulsion surface.
Scheme 1 Synthesis strategy of silica nanocapsule based on bio-inspired
silicification at an oil–water interface. Step (1) sonication of Miglyols 812
oil in a SurSi solution followed by dialysis at pH 7.5; step (2) addition of
tetraethoxysilane (TEOS) to nanoemulsion; and step (3) interfacial poly-
condensation of silica species. SurSi peptide operates synergistically by
(1) stabilizing a nanoemulsion core through a ‘‘Sur’’ module incorporating
hydrophobic amino acids (in yellow) to impart facial amphiphatic character
hence promoting adsorption at the nanoemulsion interface; and (2) directing
nucleation and growth of silica at the oil–water interface through a ‘‘Si’’ module.
Fig. 1 Silica nanocapsules formed using bio-inspired silicification. (a and b)
Transmission electron microscopy (TEM) images confirming the formation of a
nanostructured core–shell architecture after a 20 h biosilicification reaction of
SurSi-stabilized nanoemulsion with 32 mmol TEOS in 25 mM HEPES buffer at
pH 7.5 (a) or at pH 8 (b). (c and d) Representative TEM dark-field image (c) and
the corresponding energy-dispersive X-ray spectrum (d) of the nanocapsule
confirming existence of a silica shell. Scale bars are 200 nm.
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Then the positively-charged amino acids enriched at the oil–
water interface would generate highly localized electrostatic
forces to the silica species. Another silica species, silanol, could
also interact with hydrogen-bond donor amino acids at the
interface through hydrogen-bonding (Scheme 1). The attracted
silica species then could act as nucleation sites for further silica
growth forming the shell with thickness solely depending on
the local concentration of the silica species.
To further investigate silica formation and methods for
control of silica shell thickness, reaction time and TEOS
concentration were varied at pH 7.5 (Fig. 2a). Shell thicknesses
increased regularly with increasing reaction time and TEOS
concentration, as reflected by an increase in nanocapsule
diameter (Fig. 2b) shown in TEM. The boundary between core
and shell by TEM was more obvious after 30 h reaction (Fig. 2a),
and the silica shell thicknesses, as measured by TEM, were 5 
1 nm, 10 2 nm and 16 3 nm following reaction with 8 mmol,
16 mmol and 32 mmol TEOS, respectively. The surface of the
silica shell was rough, especially during the first 20 h, as
observed from TEM images (Fig. 2a). This roughness might
be due to the fact that the silica species were still undergoing
poly-condensation at the interface as the reaction proceeded.18
The silica shell kept on growing through further interfacial
biosilicification and poly-condensation, and became thicker
over time until TEOS was depleted (Fig. 2c–e). The evolution
of the silica growth during biosilicification reaction was also
monitored using DLS. An increase of the nanocapsule diameter
was observed at different reaction times (Fig. S3, ESI†). These results
demonstrate the possibility of obtainingwell-dispersed nanocapsules
(see PDIs in Table S1, ESI†) having different silica shell thicknesses
by controlling TEOS concentration and reaction time.
Silica nanocapsules can be used to encapsulate an activematerial
in the oil core for protection and/or to provide a diffusion barrier
through the silica shell for slow release of the active,5 thus enabling
applications in biomedical and agricultural domains. We demon-
strate facile encapsulation and sustained release profile associated
with the core–shell structure of a silica nanocapsule using fipronil as
a model of oil-soluble active molecules. Fipronil is a phenylpyrazole
insecticide that controls a broad spectrum of insect pests and
provides long-term protection for crops.19 Fipronil can be solubilized
in Miglyols 812 oil at high loading capacity (up to 10mgmL1). We
loaded 10 mg mL1 fipronil in oil to form a SurSi-stabilized
nanoemulsion. After a 30 h reaction with TEOS at pH 7.5, TEM
images (Fig. 3a–c) suggested the successful formation of silica
nanocapsules. The encapsulation efficiencies of fipronil in the silica
nanocapsules obtained at TEOS concentrations of 16 mmol, 32 mmol
and 96 mmol were 69.3%, 70.6% and 71.1%, respectively (see ESI†).
With a fipronil-loaded nanoemulsion, the silica shell thickness can
also be controlled by varying TEOS concentration (Fig. 3a–c).
Increase in TEOS concentration (16 mmol, 32 mmol and 96 mmol)
resulted in loaded nanocapsules with higher average diameters
(140  13 nm, 198  15 nm and 288  24 nm, respectively) and
thicker silica shells (8  2 nm, 25  3 nm and 44  7 nm,
respectively) (Fig. 3a–c).
We further investigated the sustained release of fipronil from
silica nanocapsules in water. Fig. 3 shows the fipronil release
profiles (Fig. 3d) for silica nanocapsules with shell thickness of
8 nm, 25 nm and 44 nm (Fig. 3a–c). The concentration of fipronil in
solution resulting from release from the silica nanocapsules to
water was normalized against the saturated concentration of
fipronil in water (2 mg mL1) to allow normalized comparison of
different nanocapsule designs. We observed the effect of silica shell
thickness on the release profile of fipronil. Silica nanocapsules with
8 nm shell thickness showed 3.1  0.6% release of fipronil at 2 h.
Fig. 2 Tunable silica shell thickness through control of biosilicification
reaction time (t) and TEOS concentration. (a) TEM images showing silica
nanocapsules produced at different reaction times and TEOS concentrations at
pH 7.5 (scale bars are 100 nm). (b) Increases in the average outer diameter
of nanocapsules reflected increases in silica shell thicknesses as calculated
from TEM based on the average value of at least 100 individual nano-
capsules. (c–e) Representative TEM images of individual nanocapsules
after a 50 h biosilicification reaction with 8 mmol (c), 16 mmol (d) and 32 mmol
(e) TEOS (scale bars are 50 nm).
Fig. 3 Encapsulation of fipronil in silica nanocapsules and its sustained
release profile. (a–c) TEM images showing fipronil-loaded silica nanocapsules
with 8 nm (a), 25 nm (b) and 44 nm (c) shell thicknesses (scale bars are 100 nm).
(d) Release profiles of fipronil-encapsulated nanocapsules with 8 nm (m),
25 nm (’) and 44 nm (K) silica shell thicknesses.
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Nanocapsules with a thicker shell, i.e. 25 nm and 44 nm,
demonstrated slower fipronil release which occurred at 4 h
and 8 h at 1.9  1.0% and 1.4  0.2%, respectively. The fipronil
release then gradually increased with time. The release of
fipronil decreased with increasing silica shell thickness, with
48.4  3.2%, 29.8  2.9% and 19.6  1.2% of fipronil released
from silica nanocapsules having 8 nm, 25 nm and 44 nm shell
thicknesses, respectively, at 142 h. TEM images (Fig. S4, ESI†)
showed that the shell morphology of the nanocapsules was still
intact before and after 142 h of study, indicating that the
release of fipronil from silica nanocapsules in water was
governed mainly by diffusion rather than by physical changes
to the silica nanoshell. This study demonstrated that the core–
shell structure of silica nanocapsules formed using bio-inspired
silicification can be used for encapsulation of active components
and thus their sustained release, and the release profile can be
controlled by the silica shell thickness.
To conclude, we demonstrated a novel and facile method for the
fabrication of silica nanocapsules using emulsion templating based
on bio-inspired silicification. Our approach was based on the novel
design of a bifunctional peptide by modularizing a surface-active
peptide sequence with a sequence having biosilicification activity,
thus achieving the formation of stable nanoemulsions followed
by the nucleation and growth of a defined and controllable
silica shell at the oil–water interface under benign conditions,
including room temperature, neutral pH and without use of
toxic reagents. Moreover, the silica shell thickness could be
tuned simply by controlling pH, reaction time and silica
precursor concentration. Active ingredient was encapsulated
effectively in the oil core of silica nanocapsules with a high
loading capacity, and was shown to have a sustained release
profile dependent on shell thickness. Therefore, the emulsion
and biomimetic dual-templating technology developed in this
work represents a new strategy for forming nanomaterials having
core–shell structure using components and processes expected to
have minimal environment footprint, opening opportunities
for further applications that demand biocompatibility, facile
manufacture and high loading capacity coupled with slow
release of an active agent.
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Experimental section 
Synthesis of silica nanocapsules: To synthesize silica nanocapsules, lyophilized SurSi peptide 
(Peptide 2.0 Inc., VA) was dissolved in sodium 4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonate (HEPES) buffer (25 mм, pH 7) in the presence of ZnCl2 (800 μм) to give a 
final peptide concentration of 400 μм. Then Miglyol® 812 (20 μL) was added into 1 mL of 
the solution. The mixture was sonicated at 10 W (Branson Sonifier 450 ultrasonicator) for 
four 30 s burst and interspersed in an ice bath for 60 s. Nanoemulsion (1 mL) was dialyzed 
against HEPES buffer (25 mм, 500 mL, pH 7.5) at 4°C for 20 h. An aliquot of the 
nanoemulsion (400 μL) was transferred into a 4-mL glass vial for biosilicification reaction 
with tetraethoxysilane (TEOS) under magnetic stirring for up to 50 h at room temperature. To 
investigate the effects of reaction time and silica precursor concentration, TEOS 
concentration was varied and samples were taken at various times for characterization. A 
control vial demonstrated stability of the nanoemulsion for the reaction period.  
 
Encapsulation efficiency: Encapsulation efficiency of fipronil (%EE) was characterized by 
the percentage between mass of fipronil in silica nanocapsules after the final TEOS removal 
step and initial mass of fipronil dissolved in the oil phase. To calculate %EE, silica 
nanocapsules containing fipronil were prepared as previously described. After TEOS removal 
step, the suspensions of silica nanocapsules were freeze-dried at 0.08 mbar and –55 °C for 20 
h. The freeze-dried samples were mixed with water, finely dispersed by sonication at 20 W 
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(Branson Sonifier 450 ultrasonicator) for 60 s, and subsequently added into acetonitrile with 
final acetonitrile concentration of 60 v/v%, as fipronil is soluble in acetonitrile (60 v/v%) as 
high as 71.5 mg mL-1, under vigorous stirring at room temperature for up to 72 h. The 
suspensions were centrifuged at an interval 24 h and the supernatants were collected, then 
fresh acetonitrile (60 v/v%) was added to the pellets. The releases of fipronil in the 
acetonitrile solutions were repeated until no residual fipronil in supernatants was detected. 
The fipronil concentrations in the supernatants were measured by RP-HPLC as described in 
the following section. Then, the encapsulation efficiencies of fipronil were calculated by 
using Eq. S1, where Cf is the fipronil concentration in release medium (mg mL-1), Vf is the 
volume of release medium (mL), Ci is the initial fipronil concentration in the Miglyol® 812 
oil (10 mg mL-1), Vi is the volume of the oil phase (mL) and n is the number of repeated-
release of fipronil. 
 
Encapsulation Efficiency: %EE = 
∑ (CfVf)jnj=1
CiVi
×100%    (Eq. S1) 
 
Sustained release study: To encapsulate fipronil, fipronil was first dissolved in Miglyol® 812 
(10 mg mL-1) used to form a nanoemulsion. Fipronil-loaded silica nanocapsules were then 
prepared by a reaction of dialyzed fipronil-loaded nanoemulsions with TEOS at concentration 
of 16 μmol, 32 μmol, or 96 μmol in 25 mм HEPES buffer at pH 7.5 for 30 h. The 10 mg mL-1 
fipronil-loaded nanocapsules with different silica shell thicknesses were then dialyzed in 
water at 4°C for 20 h to remove residual TEOS. Then, the release study was started by 
stirring the nanocapsules aqueous solution at room temperature. At different time intervals, 
aliquots of 200 μL were taken, replaced with water, and the aliquots were centrifuged to 
obtain clear supernatant. Fipronil in the supernatant was assayed by high-performance liquid 
chromatography (HPLC) using a Shimadzu system equipped with a reversed-phase C18 
column (Jupiter, 5 μm, 300 Å, 150 × 4.6 mm). Phosphoric acid 0.1 v/v% (A) and 90 v/v% 
acetonitrile, 0.1 v/v% phosphoric acid (B) were used as the mobile phases. A linear gradient 
from 50 to 70% B in 20 min at a flow rate of 1 mL min-1 was used with a monitoring 
wavelength set at 220 nm. The concentrations of fipronil released were reported relative to 
the saturation limit of fipronil in water (2 µg mL-1). To determine the concentration of 
fipronil, a standard curve was obtained by dissolving weighted amounts of fipronil powder in 
60 v/v% acetonitrile. 
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Characterization: Dynamic light scattering (DLS) was performed on Malvern Zetasizer Nano 
ZS at a scattering angle of 173° and a temperature of 25°C. Samples were diluted by a factor 
of 100 prior to the size and zeta potential measurements. Transmission electron microscopy 
(TEM) was carried out on a JEOL 1010 operated at 100 kV. Samples (2 μL) were deposited 
onto Formvar-coated copper grids, washed with water and left to air-dry prior to TEM 
examination, without the need for staining or cryopreservation. Energy dispersive X-ray 
spectroscopy (EDX) spectrum were obtained by using high-resolution (HR) TEM (JEOL 
2100, 200 kV accelerating voltage) equipped with an EDX detector.  
 
Supplementary figures 
 
Fig. S1 (a–b) Size distribution of SurSi-stabilized nanoemulsions and nanocapsule formed at 
pH 7.5 (a) and pH 8 (b) as determined by dynamic light scattering (DLS), after emulsification 
at pH 7 (– – –), after 20 h of dialysis at pH 7.5 (a) or pH 8 (b) (······), after 20 h of reaction 
with 32 μmol tetraethoxysilane (TEOS) at pH 7.5 (a) or pH 8 (b) (––––), and control SurSi-
stabilized nanoemulsion after 40 h of incubation at pH 7.5 (a) or pH 8 (b) (–·–·–·). 
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Fig. S2 Transmission electron microscopy (TEM) image taken after a 20-h reaction of the 
dialyzed AM1-stabilized nanoemulsions with 32 µmol tetraethoxysilane (TEOS) in 25 mм 
HEPES buffer pH 7.5 at room temperature. Scale bar is 200 nm. 
 
The procedure for the synthesis of silica nanocapsules by templating AM1-stabilized 
nanoemulsions was described in the Synthesis of silica nanocapsules (Experimental section) 
except that AM1 peptide was used instead of SurSi peptide. Despite the formation of silica 
nanocapsules by templating AM1-stabilized nanoemulsions, it led mainly to the formation of 
bulk silica nanoparticles (Fig. S2) indicating that the dual functionality of emulsion 
stabilization and silica shell formation cannot be effectively achieved by using AM1 as its 
surface activity is sacrificed during biosilicification reactions resulting in formation of silica 
largely in bulk solutions (Fig. S2). 
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Fig. S3 Dynamic light scattering (DLS) results presenting the correlograms (left) and the 
associated number-weighted size distributions (right). (a–f) DLS data of the silica 
nanocapsules were taken after reaction of SurSi-stabilized nanoemulsions with 
tetraethoxysilane (TEOS) at concentrations of 8 µmol (a, b), 16 µmol (c, d) and 32 µmol (e, 
f) in 25 mм HEPES buffer pH 7.5 for up to 50 h at room temperature. Samples of SurSi-
stabilized nanoemulsions before reaction with TEOS (*) and dialyzed SurSi-stabilized 
nanoemulsions incubated for 50 h (**) are included in the size distribution profiles (right) for 
comparison.  
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The correlograms show a typical single exponential decay of the scattered intensities over 
time due to the Brownian motion of the nanocapsules (Fig. S3a, c, e). However, the 
correlograms of the samples of silica nanocapsules obtained after reactions with 16 µmol 
TEOS for 50 h (Fig. S3c), and 32 µmol TEOS for 40 h and 50 h (Fig. S3e) show multiple 
peaks, i.e., substantial tail and non-flat baseline at the end of the decay, indicating the 
presence of aggregates. The decays of these samples show more extended slope suggesting 
their polydispersities. These are confirmed by the polydispersity index (PDI) values presented 
in Table S1. The number-weighted size distributions, which were calculated from the 
correlation functions by the zetasizer software, show only single peaks suggesting that the 
corresponding aggregates were present in trace amounts (Fig. S3b, d, f). Furthermore, the 
time at which the correlation function starts to decay over time gives an indication of the 
mean size of the nanocapsules in the suspensions. Increasing reaction times between SurSi-
stabilized nanoemulsions and TEOS produces larger silica nanocapsules which move more 
slowly in the suspensions and thus the correlation functions persist for longer time prior to 
the decay (Fig. S3a, c, e). The number-weighted size distributions show more clearly the 
increase in size as the reaction times were increased (Fig. S3b, d, f).  
 
 
Fig. S4 (a–c) Transmission electron microscopy (TEM) images of the silica nanocapsules 
having shell thickness of 8 nm (a), 25 nm (b) and 44 nm (c) before (1) and after (2) fipronil-
release study. Scale bars are 200 nm. 
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Supplementary table 
Table S1 Polydispersity index of nanocapsules as a function of reaction time and 
tetratethoxysilane (TEOS) concentration. 
                  Time  
 
molTEOS 
0 h 20 h 30 h 40 h 50 h 
0 μmol 0.293 0.318 - - - 
8 μmol - 0.216 0.184 0.150 0.140 
16 μmol - 0.168 0.140 0.154 0.345 
32 μmol - 0.146 0.180 0.468 0.651 
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Chapter 4 
 
Sustained release of fipronil insecticide in vitro and in vivo from 
biocompatible silica nanocapsules 
 
 
The research in this chapter consists of the peer-reviewed paper published as:  
 
Wibowo, D., C.-X. Zhao*, B.C. Peters, and A.P.J. Middelberg*, Sustained release of fipronil 
insecticide in vitro and in vivo from biocompatible silica nanocapsules. J. Agric. Food Chem., 2014. 
62(52): p. 12504–12511.  
 
The following modifications were made to the article: 
 Page numbers of the original article were crossed-out; and 
 Page numbers consistent with those on the remainder of the thesis pages were inserted. 
 
Abstract 
 
This chapter describes the applications of the bio-inspired oil-core silica-shell nanocapsules 
developed in Chapter 3, which include facile encapsulation of fipronil insecticide and its sustained 
release in vitro as well as in vivo against termites. Facile encapsulation of fipronil in the silica 
nanocapsules was demonstrated by first solubilizing fipronil in Miglyol® 812 oil (0.5 or 1 mg/mL), and 
then emulsifying the oil phase through sonication. Subsequently, the resulted fipronil-loaded 
nanoemulsions were dialyzed and then reacted with tetraethoxysilane (TEOS) by 30-h stirring at pH 
7.5 and room temperature for the biosilicification process. The resulted fipronil-encapsulated silica 
nanocapsules were characterized using dynamic light scattering, transmission electron microscopy, 
Fourier-transform infrared spectroscopy, and selected area electron diffraction. Tunability of silica 
shell thicknesses was easily achieved by varying TEOS concentrations. Controlled-release profiles 
of fipronil associated with the core–shell structure of the silica nanocapsules having different silica 
shell thicknesses were demonstrated in vitro in water. Two laboratory methods of termite control 
(i.e., direct- and feeding-treatment) were conducted for the in vivo experiments against economically 
important subterranean termites Coptotermes acinaciformis to further demonstrate the controlled-
release properties and insecticidal effect of the fipronil-encapsulated silica nanocapsules. 
Photographic images regarding termite collection and the in vivo studies against termites in this 
chapter were presented in Appendix A. 
Sustained Release of Fipronil Insecticide in Vitro and in Vivo from
Biocompatible Silica Nanocapsules
David Wibowo,† Chun-Xia Zhao,*,† Brenton C. Peters,‡ and Anton P. J. Middelberg*,†
†Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD 4072, Australia
‡Brenton Peters Consulting, Jindalee, QLD 4074, Australia
ABSTRACT: A pesticide delivery system made of biocompatible components and having sustained release properties is highly
desirable for agricultural applications. In this study, we report a new biocompatible oil-core silica-shell nanocapsule for sustained
release of fipronil insecticide. Silica nanocapsules were prepared by a recently reported emulsion and biomimetic dual-templating
approach under benign conditions and without using any toxic chemicals. The loading of fipronil was achieved by direct
dissolution in the oil core prior to biomimetic growth of a layer of silica shell surrounding the core, with encapsulation efficiency
as high as 73%. Sustained release of fipronil in vitro was tunable through control of the silica-shell thickness (i.e., 8−44 nm). In
vivo laboratory tests showed that the insecticidal effect of the fipronil-encapsulated silica nanocapsules against economically
important subterranean termites could be controlled by tuning the shell thickness. These studies demonstrated the effectiveness
and tunability of an environmentally friendly sustained release system for insecticide, which has great potential for broader
agricultural applications with minimal environmental risks.
KEYWORDS: silica, nanocapsules, sustained release, insecticides, fipronil, subterranean termites
■ INTRODUCTION
Over recent decades, there has been an increasing interest in
the development of pesticide delivery systems to prevent and
control pest populations, especially in countries with
agriculture-driven economies.1−5 Encapsulation and delivery
of active ingredients such as pesticides using carriers offer
substantial advantages, including protection of the actives
against premature decomposition (e.g., photolysis, hydrolysis,
microbial, or oxidation/reduction) and loss (e.g., evaporation
or leaching), protection of the environment against toxicity of
the actives, enhanced bioavailability especially for hydrophobic
actives, and the possibility of delivering high amounts of actives
in a sustained manner. Sustained release of pesticides is highly
desirable in agriculture as it likely reduces periodic applications
by maintaining an effective local concentration in a prolonged
duration, thereby lowering potential for development of pest
resistance and undesirable environmental side effects. Poly-
meric matrices,6−8 solid lipid particles9 and composites10,11 are
among commonly investigated carriers in pesticide delivery
systems.
Silica-based nanomaterials mainly evaluated for biomedical
applications12 have emerged as relatively new nanocarriers for
agricultural applications.13−25 Silica materials can offer distinct
advantages over other materials, as they provide more
mechanically stable structures than polymeric materials15 and
have structural flexibility in forming nanomaterials with high-
capacity loading of actives.26 Furthermore, silica in an
amorphous structure is biocompatible as it is categorized as a
“Generally Recognized As Safe (GRAS)” material by the U.S.
Food and Drug Administration.27 Previous studies have shown
the loading and release of various agrochemicals from silica-
based nanomaterials, including nonporous silica nanopar-
ticles,16 mesoporous silica nanoparticles17−20 and hollow-core
silica-shell nanoparticles.21−25 The latter are more advantageous
as the core provides higher loading capacity of actives than
nonporous and mesoporous silica nanoparticles.28 Generally,
there are two techniques of active-loading in core−shell silica
nanoparticles, i.e., postloading and preloading. The postloading
is based on diffusion of actives into the interior space via
immersion21,22 or high-pressure supercritical fluid.22−24 The
drawback with this method is that it promotes initial burst
release in aqueous-based environments due to the presence of
surface-associated active molecules,21−24 especially when water-
soluble actives were used.24 On the other hand, the preloading
technique is based on the solubilization of actives in template
materials prior to formation of silica shells,25 which is more
advantageous as to reduce the possibility of attachment of
actives at the external surfaces of the shells, thus increasing the
flexibility to protect and release the actives. Despite these
benefits, synthesis of the core−shell silica nanoparticles most
commonly involves chemical surfactants, templates and toxic
organic solvents which must then be completely removed from
the product.25 It has been shown that residual chemical
surfactants embedded in the silica-based nanomaterials can
cause severe cytotoxicity12 which would pose significant
environmental risks. In this respect, a superior strategy for
synthesis of nanocarriers should enable the preloading of
actives with high loading capacity and involve only biocompat-
ible components, thus avoiding time-consuming and tedious
monitoring-procedures for ensuring complete removal of
residual toxic components down to the levels that might be
considered as environmentally safe.
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Recently, we developed a novel emulsion and biomimetic
dual-templating approach to synthesize oil-core silica-shell
nanocapsules with tunable shell thickness.29 Bifunctional SurSi
peptide (Ac-MKQLAHSVSRLEHARKKRKKRKKRKKGGGY-
CONH2) was designed by modularizing a surface active peptide
sequence (Sur module, MKQLAHSVSRLEHA) with a
sequence for biosilicification (Si module, RKKRKKRKKR
KKGGGY). Typically, oil-in-water (O/W) nanoemulsions are
formed with a pharmaceutically safe oil, Miglyol 812, dispersed
in the SurSi aqueous solution. Then a silica precursor
tetraethoxysilane (TEOS) is added to facilitate the biosilicifi-
cation at the O/W interfaces forming the oil-core silica-shell
nanocapsules under room temperature, and at nearly neutral
pH without use of any toxic chemicals. In contrast to the
chemical methods mentioned above, our method is more
biocompatible and environmentally friendly. An additional
advantage of using peptide biosurfactant is the ability to be
produced renewably at large scale and relatively low cost using
biological expression.30,31 Furthermore, our dual-templating
approach offers easy preloading of active components by simply
dissolving in the oil phase with a high loading capacity. It has
been demonstrated that fipronil saturated in Miglyol 812 (at 10
mg·mL−1) was easily encapsulated in silica nanocapsules by a
preloading technique and without the need for template
removal.29
Fipronil (5-amino-1-[2,6-dichloro-4-(trifluoromethyl)-
phenyl]-4-[(trifluoromethyl)sulfinyl] pyrazole-3-carbonitrile)
is a systemic insecticide commonly used as soil treatment,
seed coating, or baits32 due to its nonrepellent property, broad-
spectrum activity against agricultural, forest, pastoral, domestic
and veterinary pests,33 and high specificity for insect pests over
mammalians.34 The biochemical mode of action of fipronil is by
blocking γ-aminobutyric acid (GABA) receptor of the GABA-
gated chloride channel, thereby disrupting central nervous
system activity and, at a sufficient dose, causing death.34 It has
low water solubility (∼2 μg·mL−1 at 25 °C) and low Henry’s
constant (6.6 × 10−6 m3·atm·mol−1 at 25 °C), suggesting low
volatility, and its soil organic carbon partition coefficient (Koc)
of 727 indicates low mobility in soil and, hence, low potential
for groundwater contamination.32,35
In this study, sustained release of fipronil in vitro and in vivo
from biocompatible oil-core silica-shell nanocapsules were
investigated and compared. Fipronil-encapsulated silica nano-
capsules with different shell thicknesses were synthesized using
the dual-templating approach aforementioned. The in vitro
release of fipronil was studied in water. The efficacy of the
fipronil-encapsulated silica nanocapsules was evaluated by
conducting in vivo laboratory tests, i.e., direct- and feeding-
treatments, against economically important subterranean
termites (i.e., Coptotermes acinaciformis). Subterranean termites
cause substantial damages to cultivated plants, wooden
structures, pastures, forests and other agricultural crops.36
Based on the sales estimation of insecticides in 2010, the
worldwide annual control and repair costs can reach US$40
billion with subterranean termites accounted for 80% of the
costs.37 This study would thus be expected to bring significant
impact in agricultural fields.
■ MATERIALS AND METHODS
Chemicals. SurSi peptide (Ac-MKQLAHSVSRLEHARKKRKK
RKKRKKGGGY-CONH2, Mw 3632 g·mol
−1) was custom synthesized
by Peptide 2.0 Inc. (Chantilly, VA, USA) with purity >95% and was
lyophilized prior to use. Fipronil in a powder form (C12H4Cl2F6N4OS,
Mw 437.15 g·mol
−1, mp 196−201 °C, and d 1.55 g·cm−3) was of
analytical standard obtained from Sigma-Aldrich. Miglyol 812 was
purchased from AXO Industry S.A. (Wavre, Belgium) and was passed
through heat-activated silica gel (Sigma-Aldrich) prior to use.
Termidor (9.1% fipronil in a form of suspension concentrate) was
obtained from BASF Australia Ltd. Water with >18.2 MΩ·cm
resistivity was obtained from a Milli-Q (Millipore, Australia) system
with a 0.22 μm filter. Other chemicals were of analytical grade
purchased from either Sigma-Aldrich or Merck and used as received.
Synthesis. Oil-core silica-shell nanocapsules were synthesized
using an emulsion and biomimetic dual-templating approach as we
previously reported.29 Briefly, fipronil was dissolved in Miglyol 812 oil
at a concentration of 0.05 mg·mL−1 or 1 mg·mL−1, and then the
fipronil-loaded oil was added into a solution of SurSi peptide (400
μM) containing ZnCl2 (800 μM) in sodium 4-(2-hydroxyethyl)-1-
piperazine ethanesulfonate (HEPES) buffer (25 mM, pH 7), and the
mixture was sonicated at 10 W (Branson Sonifier 450 ultrasonicator)
to obtain O/W nanoemulsions which were dialyzed against HEPES
buffer (25 mM, pH 7.5) at 4 °C for 20 h to remove residual peptide in
the bulk solution. Then the nanoemulsions (pH 7.5) were mixed with
tetraethoxysilane (TEOS) at a concentration of 16 μmol, 32 μmol or
96 μmol under stirring at room temperature for 30 h to form fipronil-
encapsulated silica nanocapsules having three different shell thick-
nesses. Subsequently, the nanocapsules were dialyzed against water at
4 °C for 20 h to remove the residual TEOS and prevent further growth
of the silica shell.
Characterization. Encapsulation Efficiency. The suspensions of
fipronil-encapsulated silica nanocapsules were freeze-dried for 20 h,
subsequently mixed with water and sonicated at 20 W (Branson
Sonifier 450 ultrasonicator) for 60 s to finely disperse the
nanocapsules. Subsequently, acetonitrile was added into the
suspensions with final acetonitrile concentration of 60 v/v%, and
vigorously stirred at room temperature for up to 72 h. At different time
intervals, the supernatants were collected by centrifugation, then fresh
acetonitrile (60 v/v%) was added to the pellets to repeat the release of
fipronil from the nanocapsules until no residual fipronil in the
supernatants was detected via reversed-phase high-performance liquid
chromatography (RP-HPLC).
Reversed-Phase High-Performance Liquid Chromatography (RP-
HPLC). Concentrations of fipronil were assayed by RP-HPLC using a
Shimadzu system equipped with a Jupiter C18 column (5 μm, 300 Å,
150 mm × 4.6 mm). Mobile phase A was water containing 0.1 v/v%
phosphoric acid, while phase B contained 90 v/v% acetonitrile and 0.1
v/v% phosphoric acid. The elution gradient was increased from 50% B
to 70% B over 20 min at a monitoring wavelength of 220 nm. The
concentration of fipronil was determined based on the peak area at
retention time of approximately 14.5 min according to calibration
curve obtained from standard solution of fipronil in acetonitrile
solution (60 v/v%).
Fourier Transform-Infrared (FT-IR) Spectroscopy. Silica nano-
capsules without and with fipronil in the oil cores were prepared as
described previously. The nanocapsules were washed twice with water
and subsequently freeze-dried. FT-IR spectra of lyophilized SurSi
peptide and the nanocapsules were determined by using a PerkinElmer
Spectrum 100 FT-IR Spectrometer equipped with a universal
attenuated total reflection (ATR) attachment. Spectra data were
collected in the transmission mode by averaging 135 scans over
wavenumber range 4000−600 cm−1 at a spectral resolution of 4 cm−1.
Dynamic Light Scattering (DLS). Size distributions of nano-
emulsions and nanocapsules were determined by DLS using Malvern
Zetasizer Nano ZS (Malvern Instrument Ltd., UK) at a scattering
angle of 173° and a temperature of 25 °C. Samples were diluted by a
factor of 100 prior to the measurements to avoid multiple scattering
effects.
Transmission Electron Microscopy (TEM). Morphology of the
fipronil-encapsulated silica nanocapsules was characterized by
depositing the suspension (2 μL) onto Formvar-coated copper grids
(ProSciTech Pty Ltd., Australia) and was then visualized via TEM
(JEOL 1010, accelerating voltage of 100 kV). Size of the nanocapsules
was analyzed using iTEM software (version 3.2, Soft Imaging System
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GmbH) equipped with the TEM. Structure of the silica shell was
determined using selected area electron diffraction (SAED) technique
via high-resolution (HR) TEM (JEOL 2100, accelerating voltage of
200 kV).
In Vitro Release Study of Fipronil into Water. Silica
nanocapsules with three different shell thicknesses encapsulating 1
mg·mL−1 fipronil in Miglyol 812 were used to study the release profile
of fipronil in vitro. The releases of fipronil from the silica nanocapsules
to water were carried out by stirring the suspensions at room
temperature for up to 142 h. At different time intervals, aliquots were
taken, replaced with fresh water and centrifuged to obtain clear
supernatants which were then analyzed using RP-HPLC.
In Vivo Study against Termites. Termites (C. acinaciformis) were
collected from field site in Esk (Queensland, Australia). Plastic
containers filled with moist wood were inverted (lid off) onto a
timber-filled trench known to contain termite infestation, and each
container was then covered with insulating material secured with soil.
After harvesting, actively moving termites were carefully selected from
the containers for in vivo tests.
Direct Treatment. Six samples, including water, nanoemulsions,
silica nanocapsules (encapsulating 0.05 mg·mL−1 fipronil in Miglyol
812) with three different shell thicknesses (8, 25, and 44 nm), and
Termidor were used in the direct treatment, and they all contained the
same final fipronil concentration except for the water sample. Water
was used as control, and nanoemulsion was used as nanocapsules with
zero silica-shell thickness. All six samples were used in five replicates
for the direct treatment. Prior to the treatment, termites were placed in
a group of ten termites in a Petri dish (92 mm × 16 mm), and
incubated at 2 °C for 2 min to slow their movement. Each of the
fipronil formulations or water (5.5 μL) was topically applied on the
dorsal thorax of the worker termite. The termites were then transferred
to clean Petri dishes containing a filter paper (42.5 mm, Whatman).
The Petri dishes were placed into a controlled-environment chamber
(65 cm × 47 cm × 37.5 cm) containing a thermometer, a lid and a
11.5-L metal container with water and heater to maintain the
temperature at 28 ± 1 °C and high humidity, and, once covered with
insulating material, total darkness (except during observation). At
different time intervals, the Petri dishes were removed from the
chamber, and the lids were opened with the least possible disturbance
in order to examine termite response (mortality). A termite was
considered dead when it was on its back or side (not supported by
legs) and not able to move even after prodding with a soft brush.
Feeding Treatment. Silica nanocapsules (encapsulating 1 mg·mL−1
fipronil in Miglyol 812) with the thickest shell (44 nm) were used in
the feeding treatment. Termidor with the same final fipronil
concentration and water were used as controls. Each fipronil
formulation and water samples were used in four and two replicates
for the feeding treatment, respectively. To mimic natural environment
of termite colonies, a 750 mL container was filled with Nasutitermes
magnus mound material (150 g) which was roasted (200 °C, 60 min),
ground and mixed with water (50 g) prior to use. A clear vinyl tubing
(150 mm × 6 mm) was connected from the container to a 70 mL
feeding vial containing α-cellulose (20 g) bait with a moisture content
of 70 w/w%. Then termites (7.5 g ≈ 1500 worker and soldier
termites) were placed into the container. Each of the assembled
feeding devices was placed into a controlled-environment chamber
having dimensions and conditions similar to that in the direct
treatment (described above). The termites in the ten assemblies were
allowed to acclimatize to these conditions for 4 days and began feeding
on the baits as indicated by the presence of enclosed tunnels and
chambers built in the baits. Then, 0.5 mL of the sample (water,
Termidor or the nanocapsule) was transferred into each feeding vial.
The assemblies were removed from the chamber and observed daily
with the least possible disturbance in order to detect movement of
living termites using a TermatracT3i device (Termatrac Pty Ltd.,
Australia). Lack of movement indicated 100% mortality of termites
and inspections in the containers were conducted to confirm. During
the treatment, termite groups in one container connected to
Termidor-treated bait and in two containers connected to nano-
capsule-treated baits remained alive for up to 8 days as the tube
entrances to the vials were blocked with mud built by the termites.
These containers were not considered for further study. Therefore,
three treatment results were included in the analysis for the Termidor-
treated baits and two treatment results for the nanocapsule-treated
baits. The termites in two containers connected to water-treated baits
survived throughout the study.
■ RESULTS AND DISCUSSION
Encapsulation of Fipronil in Silica Nanocapsules.
Fipronil was easily dissolved in Miglyol 812 due to its high
solubility in the oil (i.e., 10 mg·mL−1).29 The fipronil-loaded oil
was emulsified in the presence of SurSi peptide via sonication,
and nanoemulsions with narrow droplet size distribution were
obtained due to the presence of the surface active Sur module29
(Figure 1) in the emulsifying peptide. Following addition of the
silica precursor tetraethoxysilane (TEOS) to the nano-
emulsions, silica shell encasing the nanoemulsion core was
formed at near-neutral pH and room temperature without using
any toxic chemicals. The biosilicification process at the oil−
water interface was due to the catalytic role of densely packed
cationic arginine (R) and lysine (K) residues of Si module
(RKKRKKRKKRKKGGGY) as well as polar residues of Sur
module exposed toward the bulk aqueous solution that could
induce hydrolysis of TEOS and interfacial polycondensation of
the hydrolysis products i.e., silanol (≡Si−OH) and negatively
charged silanolate (≡Si−O−)29 (Figure 1).
In this study, fipronil dissolved in Miglyol 812 oil at a
concentration of 0.05 mg·mL−1 or 1 mg·mL−1 was encapsulated
in silica nanocapsules and used for the sustained release study
in vitro and in vivo. The amount of fipronil encapsulated in silica
nanocapsules was determined based on the lethal dose of
Figure 1. Illustration of the synthesis of fipronil-encapsulated silica
nanocapsules formed using an emulsion and biomimetic dual-
templating approach for sustained-release agroformulations against
termites. Step (I), solubilization of fipronil in Miglyol 812 oil; step
(II), sonication of the oil in SurSi peptide solution to form fipronil-
loaded nanoemulsions; step (III), addition of tetraethoxysilane
(TEOS) in the nanoemulsions to form a silica shell encapsulating
the nanoemulsion core; step (IV), in vivo efficacy tests of the fipronil-
encapsulated silica nanocapsules against economically important
subterranean termites.
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fipronil sufficient to eliminate a termite for the in vivo tests. It
has been reported that the lethal dose of fipronil for
Coptotermes spp. is in the range of 2−10 ng per termite.38,39
Based on this consideration, the encapsulated fipronil which
was dissolved in Miglyol 812 at concentrations of 0.05 mg·
mL−1 and 1 mg·mL−1 was equivalent to 1 ppm and 20 ppm in
the silica nanocapsule suspensions and, at an applied volume,
would give fipronil dose of around 6 ng/termite in the direct-
and feeding treatments, respectively.
The encapsulation efficiencies (%EE) of fipronil in silica
nanocapsules were determined by monitoring the concen-
tration of fipronil released in acetonitrile solution (60 v/v%)
over a period of time compared to initial concentration of
fipronil dissolved in Miglyol 812 oil. Higher solubility of
fipronil in acetonitrile (60 v/v%) i.e., 71.5 mg·mL−1 than in
Miglyol 812 i.e., 10 mg·mL−1 promotes easy partition of the
fipronil and its diffusion out of the silica nanocapsules. The
results of practical encapsulation efficiencies of fipronil were
calculated using eq 1:29
=
∑
×=EE
C V
C V
%
( )
100%j
n
j1 f f
i i (1)
where Cf (mg·mL
−1) and Vf (mL) are the fipronil concentration
released in acetonitrile solution and volume of the acetonitrile
solution, respectively, Ci (mg·mL
−1) and Vi (mL) are the initial
fipronil concentration in Miglyol 812 and volume of the
Miglyol 812, respectively, and n is the number of repeated-
release of fipronil. At an initial fipronil concentration of 0.05
mg·mL−1, %EE of fipronil in silica nanocapsules obtained at
reactions with 16 μmol, 32 μmol and 96 μmol of TEOS were
72.8%, 73.2%, and 73.6%, respectively, while similar %EE of
71.6%, 72.2%, and 72.9%, respectively, were obtained when
initial fipronil concentration of 1 mg·mL−1 was used. The
encapsulation of fipronil in the silica nanocapsules demon-
strated high encapsulation efficiency which is suitable for
agricultural applications.
Characterization of Silica Nanocapsules Containing
Fipronil. To determine the molecular components of fipronil-
encapsulated silica nanocapsules, SurSi peptide and silica
nanocapsules without and with fipronil in the oil cores were
analyzed using Fourier transform-infrared (FT-IR) spectrosco-
py, and the results were compared in Figure 2. For SurSi
peptide, four characteristic peaks of the peptide backbone were
observed (Figure 2a) which are assigned to amide A (N−H
stretch), amide B (N−H stretch), amide I (CO stretch), and
amide II (C−N stretch and N−H in-plane bend) at 3284, 3071,
1648, and 1542 cm−1, respectively.40 The functional groups of
peptide side chains can also be identified (Figure 2a) i.e., peak
at 1298 cm−1 corresponds to O−H deformation of hydroxyl
group of serine (S), shoulder at 1248 cm−1 and doublet at 837
and 800 cm−1 are associated with C−O stretch and phenyl ring
of tyrosine (Y), respectively, and doublet at 1180 and 1130
cm−1 can be attributed to NH3
+ rocking of lysine (K).40,41 FT-
IR spectrum of the silica nanocapsules without fipronil (Figure
2b) shows a broad signal centered at 3330 cm−1 which reflects
the vibration of O−H stretching of silanol group Si−OH. A
strong absorption band at about 1060 cm−1, with a shoulder at
1160 cm−1, and a band at 780 cm−1 correspond to asymmetric
and symmetric Si−O−Si stretching vibrations of siloxane
group, respectively. An absorption shoulder at 960 cm−1 arises
from the Si−O− stretching of Si−OH. The major peaks of N−
H stretch of peptide and other peptide side chains are
overlapped by the characteristic bands of silica and thus are
unobserved (Figure 2b). However, the presence of peptide in
the silica nanocapsules can still be characterized by the
absorption bands of amide I and amide II although the
intensities are significantly reduced. The FT-IR spectrum of
fipronil-encapsulated silica nanocapsules (Figure 2c) retained
most of the major peaks of the silica nanocapsules without
fipronil (Figure 2b). Additionally, new absorption bands appear
and are clearly discernible at 1320 and 888 cm−1 which can be
attributed to −CF3 stretching of trifluoromethyl group and C−
H out-of-plane bending of benzene ring42 of the fipronil
molecule, respectively (Figure 2c). These vibrational frequen-
Figure 2. FT-IR spectra of (a) SurSi peptide, (b) silica nanocapsules
without fipronil in the oil cores, and (c) fipronil-encapsulated silica
nanocapsules.
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cies further verify the incorporation of fipronil into silica
nanocapsules.
Morphology of silica nanocapsules can be visualized by using
TEM without the need for staining or cryo-preservation. The
TEM images showed morphology of a core−shell structure of
fipronil-encapsulated silica nanocapsules having three different
shell thicknesses (Figure 3a−c). In contrast, fipronil-loaded
nanoemulsion having no silica shell was hardly observed in
TEM as its structure was prone to disintegrate under high
vacuum and electron beam irradiation (data not shown). The
measured shell thicknesses, as determined by using TEM, of
silica nanocapsules obtained at TEOS concentrations of 16
μmol, 32 μmol and 96 μmol were 8 nm, 25 nm, and 44 nm,
respectively, while the outer diameters were 140 nm, 198 nm,
and 288 nm, respectively. These values are consistent with our
previously reported silica nanocapsules that encapsulated
fipronil at concentration of 10 mg·mL−1 in Miglyol 812.29
Additionally, the representative selected area electron diffrac-
tion (SAED) of silica nanocapsules shows diffuse ring pattern
(Figure 3d), indicating the amorphous structure of the silica
shell. The formation of amorphous silica via peptides has also
been reported for natural biogenic silica43,44 and biomimetic
silica.45
Dynamic light scattering (DLS) confirmed a size increase for
silica nanocapsules in comparison with the nanoemulsion
template (Figure 4). Furthermore, increasing TEOS concen-
trations corresponded to an increase in number-averaged
diameters of the nanocapsules (Figure 4a−c). The number-
weighted size distribution results showed that silica nano-
capsules having 8, 25, and 44 nm shells have narrow size
distributions (polydispersity index, PDI < 0.350).
Fipronil Release Study in Vitro. The release profiles of
fipronil in vitro from silica nanocapsules with three different
shell thicknesses encapsulating 1 mg·mL−1 fipronil in Miglyol
812 i.e., 1F-NC8, 1F-NC25 and 1F-NC44 are shown in Figure
5. The concentration of fipronil released in the water phase was
normalized against the saturated concentration of fipronil in
water considering the low solubility of fipronil in water (2 μg·
mL−1). The release of fipronil from 1F-NC8 was detected after
8 h of release study at 2.4%, while a longer lag time of 16 h was
observed for fipronil released at 2.5% and 1.6% from silica
nanocapsules having thicker shells i.e., 1F-NC25 and 1F-NC44,
respectively (Figure 5). After 142 h, fipronil was released at
percentages of 40.7%, 24.3% and 15.2% from 1F-NC8, 1F-
NC25 and 1F-NC44, respectively. The rates of fipronil released
in water show the order of 1F-NC8 > 1F-NC25 > 1F-NC44,
demonstrating that increasing shell thickness resulted in an
increased diffusion pathway and hence enhanced barrier to
diffusion of fipronil across the silica shell, thus the slower
release of fipronil.
Fipronil Release Study in Vivo. Sustained release of
fipronil from silica nanocapsules was also investigated in vivo
Figure 3. Fipronil-encapsulated silica nanocapsules with tunable shell
thickness. (a−c) Representative transmission electron microscopy
(TEM) images of fipronil-encapsulated silica nanocapsules having (a)
8 nm, (b) 25 nm, and (c) 44 nm shells. Scale bars are 200 nm. Arrows
indicate the boundary of the silica shell. (d) Representative selected
area electron diffraction (SAED) pattern of silica nanocapsules
confirmed the amorphous state of the silica shell.
Figure 4. Number-weighted size distributions of fipronil-encapsulated
silica nanocapsules and the nanoemulsion template. The measured
number-averaged diameters (dn) include silica nanocapsules having (a)
8 nm, (b) 25 nm, and (c) 44 nm shells, (*) fipronil-loaded
nanoemulsions before reaction with TEOS, and (**) control fipronil-
loaded nanoemulsions incubated over the reaction period.
Figure 5. In vitro release profile of fipronil from silica nanocapsules
having 8 nm (1F-NC8, ▲), 25 nm (1F-NC25, ■), and 44 nm (1F-
NC44, ●) shells into water.
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against termites. Two experiments were carried out, including
direct treatment and feeding treatment.
Direct treatment was demonstrated by topical application of
six different formulations including water, Termidor, nano-
emulsions (0.05F-NE), silica nanocapsules with three different
shell thicknesses of 8 nm (0.05F-NC8), 25 nm (0.05F-NC25)
and 44 nm (0.05F-NC44), on the dorsal thorax of worker
termite C. acinaciformis (Figure 6). Rapid mortality was
observed when termites were treated with commercial
Termidor or fipronil-loaded nanoemulsions having no silica
shells (0.05F-NE). The fipronil penetrated through the cuticle
layer on the body surface of worker termites and eventually
caused death depending the fipronil doses.39 Termidor gave
burst release of fipronil resulting in 50% mortality within the
first hour and 100% mortality at 4 h (Figure 6). Fipronil-loaded
nanoemulsions having no silica shells (0.05F-NE) exhibited a
two-step release profile; a significant initial burst effect, with
mortality of almost 50% within the first 4 h, and then more
sustained release over 22 h (Figure 6). In contrast, silica
nanocapsules showed sustained release as a result of the silica
shell. First mortality was at 4 h (6%), 6 h (4%), and 10 h (8%)
for silica nanocapsules having 8 nm (0.05F-NC8), 25 nm
(0.05F-NC25) and 44 nm (0.05F-NC44) shells, respectively
(Figure 6). Further, the termite mortality gradually increased in
a way dependent on shell thickness suggesting that the silica
shell provided an effective barrier for the controlled diffusion of
the encapsulated fipronil, which corresponds well with the in
vitro release study. The lag time, which was also observed in in
vitro experiments, prior to termite mortality in the topical
applications of silica nanocapsules strongly evidenced the
sustained release of fipronil from the nanocapsules with no
indication of burst release. Fipronil-encapsulated silica nano-
capsules having 44 nm shell demonstrated the most significant
delay in termite mortality and thus was chosen for the
subsequent in vivo test.
We further evaluated the sustained release performance of
fipronil-encapsulated silica nanocapsule having 44 nm shell (1F-
NC44) in vivo by remote feeding treatment against C.
acinaciformis. Prior to the treatment, groups of orphaned
worker and soldier termites (≈1500) were allowed to adapt to
the living conditions maintaining their biological activities in a
container filled with nutritious materials at set temperature.46
Food in the form of α-cellulose was supplied in peripheral
feeding vials which were accessible through clear vinyl tubes.
After 4 days, we observed that termites built mud and cellulose
surrounding the interior space of the connector tubes as well as
galleries within the baits, indicating that termites were
responding to the α-cellulose. The α-cellulose in the feeding
vials was then treated with water containing no fipronil,
Termidor or 1F-NC44. As termites foraged in the feeding vials,
they acquired and carried the α-cellulose back to the container,
and inadvertently transferred it to other termites within the
groups. These interactions could be through trophallaxis in
which foraging worker termites feed other termites that do not
or cannot forage on their own including soldier termites due to
their anatomical and behavioral specializations.47 Termidor-
treated α-cellulose caused 100% mortality to termite groups
after 3 days, whereas more delayed 100% mortality (6 days)
was observed after treatment using nanocapsule-treated α-
cellulose (Figure 7). The α-cellulose treated with water
containing no fipronil in the feeding vials caused negligible
termite mortality during the 8 days of the test. The feeding
experiment results further confirmed the sustained release
property of silica nanocapsules as a result of the presence of
silica shell which plays a role as barrier to diffusion of fipronil.
Dead and decaying bodies of termites can elicit avoidance
behavior of other termites,48,49 and consequently any trans-
mission through those termites is ineffective.39 Therefore, the
sustained release property of the fipronil-encapsulated silica
nanocapsules is important to ensure constant exposure of
fipronil to the termites in the colony until 100% mortality of
the colony can be achieved. Furthermore, the more delaying
insecticidal effect demonstrated by the silica nanocapsules as
compared to the commercial fipronil formulation would be
highly desirable, as it increases the likelihood of horizontal
transfer of fipronil, hence allowing improved areawide control
of larger populations of termite colonies.
Figure 6. In vivo efficacy test via topical application on the dorsal
thorax of worker termites. Fipronil-encapsulated silica nanocapsules
having 8 nm (0.05F-NC8, ▲), 25 nm (0.05F-NC25, ■), and 44 nm
(0.05F-NC44, ●) shells are tested in comparison with fipronil-loaded
nanoemulsions without silica shells (0.05F-NE, □), Termidor (○),
and water containing no fipronil (control, Δ). The lines are drawn to
assist in reading the trends.
Figure 7. In vivo efficacy test via feeding treatment against groups of
≈1500 worker and soldier termites. The delayed 100% mortality of the
termite groups caused by fipronil-encapsulated silica nanocapsules
having a 44 nm shell (1F-NC44) is presented as compared to
Termidor.
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■ CONCLUSION
Biocompatible oil-core silica-shell nanocapsules synthesized
using an emulsion and biomimetic dual-templating approach
under environmentally friendly conditions were investigated as
nanocarriers for the sustained release of fipronil insecticide. In
vitro release studies of fipronil showed decreased release rate
with increasing the shell thickness. In vivo direct treatment
experiments using silica nanocapsules with three different shell
thicknesses (8, 25, and 44 nm) against worker termites
demonstrated that the time interval between the application of
the nanocapsules and the occurrence of the termite mortality
could be prolonged in a way dependent on silica-shell thickness
as compared to the commercial formulation Termidor and
fipronil-loaded nanoemulsions having no silica shells. The in
vivo efficacy of 44-nm-shell nanocapsules against orphaned
groups of ≈1500 worker and soldier termites by dispersing the
nanocapsules in α-cellulose feeding bait proved that the silica
nanocapsules could be taken up from the bait vials by foraging
workers, transmitted to recipient termites in the groups
probably through horizontal transfer, and eventually caused
100% mortality of the termite groups in 6 days after the
application, which was 3 days longer than the commercial
Termidor. Both the in vitro and in vivo fipronil-released studies
presented in this paper demonstrated the effectiveness of a
pesticide delivery system having biocompatibility, high
encapsulation efficiency, and sustained release property, which
open potential utilities of the silica nanocapsules for other
agricultural applications.
■ AUTHOR INFORMATION
Corresponding Authors
* Phone: +61-7-3346-4189. Fax: +61-7-3346-4197. E-mail:
z.chunxia@uq.edu.au.
* Phone: +61-7-3346-4189. Fax: +61-7-3346-4197. E-mail:
a.middelberg@uq.edu.au.
Funding
This work was supported by the Australian Research Council
(grants DP1093056 and 120103683). D.W. acknowledges a
scholarship from The University of Queensland. C.X.Z.
acknowledges financial support from the Australian Research
Council in the form of an Australian Postdoctoral Fellow
(DP110100394). A.P.J.M. acknowledges support from the
Queensland Government through award of the 2010 Queens-
land Premier’s Science Fellowship.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
The authors thank Lei Yu for taking the SAED images as well as
the facilities and the scientific and technical assistance of the
Australian Microscopy & Microanalysis Research Facility at the
Centre for Microscopy and Microanalysis, The University of
Queensland. Termatrac Pty Ltd., Beenleigh QLD (Australia), is
thanked for the use of the Termatrac T3i device.
■ ABBREVIATIONS USED
Ac, acetyl; M, methionine; K, lysine; Q, glutamine; L, leucine;
A, alanine; H, histidine; S, serine; V, valine; R, arginine; E,
glutamic acid; G, glycine; Y, tyrosine; O/W, oil-in-water; Mw,
molecular weight; mp, melting point; d, density; TEOS,
tetraethoxysilane; HEPES, sodium 4-(2-hydroxyethyl)-1-piper-
azine ethanesulfonate; 0.05F-NE, nanoemulsions loaded with
0.05 mg·mL−1 fipronil in Miglyol 812 oil; xF-NCy, silica
nanocapsules (encapsulating x mg·mL−1 fipronil in Miglyol 812
oil) with shell thickness of y nm; TEM, transmission electron
microscopy; HR-TEM, high-resolution transmission electron
microscopy; SAED, selected area electron diffraction; DLS,
dynamic light scattering; FT-IR, Fourier transform-infrared;
RP-HPLC, reversed-phase high-performance liquid chromatog-
raphy
■ REFERENCES
(1) Mulqueen, P. Recent advances in agrochemical formulation. Adv.
Colloid Interface Sci. 2003, 106, 83−107.
(2) Ghormade, V.; Deshpande, M. V.; Paknikar, K. M. Perspectives
for nano-biotechnology enabled protection and nutrition of plants.
Biotechnol. Adv. 2011, 29, 792−803.
(3) Gogos, A.; Knauer, K.; Bucheli, T. D. Nanomaterials in plant
protection and fertilization: current state, foreseen applications, and
research priorities. J. Agric. Food Chem. 2012, 60, 9781−9792.
(4) Rai, M.; Ingle, A. Role of nanotechnology in agriculture with
special reference to management of insect pests. Appl. Microbiol.
Biotechnol. 2012, 94, 287−293.
(5) Kah, M.; Hofmann, T. Nanopesticide research: current trends
and future priorities. Environ. Int. 2014, 63, 224−235.
(6) Asrar, J.; Ding, Y. W.; La Monica, R. E.; Ness, L. C. Controlled
release of tebuconazole from a polymer matrix microparticle: release
kinetics and length of efficacy. J. Agric. Food Chem. 2004, 52, 4814−
4820.
(7) Sopena, F.; Cabrera, A.; Maqueda, C.; Morillo, E. Controlled
release of the herbicide norflurazon into water from ethylcellulose
formulations. J. Agric. Food Chem. 2005, 53, 3540−3547.
(8) Stloukal, P.; Kucharczyk, P.; Sedlarik, V.; Bazant, P.; Koutny, M.
Low molecular weight poly(lactic acid) microparticles for controlled
release of the herbicide metazachlor: preparation, morphology, and
release kinetics. J. Agric. Food Chem. 2012, 60, 4111−4119.
(9) Frederiksen, H. K.; Kristenson, H. G.; Pedersen, M. Solid lipid
microparticle formulations of the pyrethroid gamma-cyhalothrin-
incompatibility of the lipid and the pyrethroid and biological
properties of the formulations. J. Controlled Release 2003, 86, 243−252.
(10) Garrido-Herrera, F. J.; Gonzalez-Pradas, E.; Fernandez-Perez,
M. Controlled release of isoproturon, imidacloprid, and cyromazine
from alginate-bentonite-activated carbon formulations. J. Agric. Food
Chem. 2006, 54, 10053−10060.
(11) Ziv, D.; Mishael, Y. G. Herbicide solubilization in micelle-clay
composites as a basis for controlled release sulfentrazone and
metolachlor formulations. J. Agric. Food Chem. 2008, 56, 9159−9165.
(12) Chen, Y.; Chen, H.; Shi, J. In vivo bio-safety evaluations and
diagnostic/therapeutic applications of chemically designed mesopo-
rous silica nanoparticles. Adv. Mater. 2013, 25, 3144−3176.
(13) Hussain, H. I.; Yi, Z.; Rookes, J. E.; Kong, L. X.; Cahill, D. M.
Mesoporous silica nanoparticles as a biomolecule delivery vehicle in
plants. J. Nanopart. Res. 2013, 15.
(14) Martin-Ortigosa, S.; Valenstein, J. S.; Lin, V. S. Y.; Trewyn, B.
G.; Wang, K. Gold functionalized mesoporous silica nanoparticle
mediated protein and DNA codelivery to plant cells via the biolistic
method. Adv. Funct. Mater. 2012, 22, 3576−3582.
(15) Torney, F.; Trewyn, B. G.; Lin, V. S. Y.; Wang, K. Mesoporous
silica nanoparticles deliver DNA and chemicals into plants. Nat.
Nanotechnol. 2007, 2, 295−300.
(16) Ao, M. M.; Zhu, Y. C.; He, S.; Li, D. G.; Li, P. L.; Li, J. Q.; Cao,
Y. S. Preparation and characterization of 1-naphthylacetic acid-silica
conjugated nanospheres for enhancement of controlled-release
performance. Nanotechnology 2013, 24, 1−8.
(17) Chen, J.; Wang, W.; Xu, Y.; Zhang, X. Slow-release formulation
of a new biological pesticide, pyoluteorin, with mesoporous silica. J.
Agric. Food Chem. 2011, 59, 307−311.
(18) Popat, A.; Liu, J.; Hu, Q.; Kennedy, M.; Peters, B.; Lu, G. Q.;
Qiao, S. Z. Adsorption and release of biocides with mesoporous silica
nanoparticles. Nanoscale 2012, 4, 970−975.
Journal of Agricultural and Food Chemistry Article
dx.doi.org/10.1021/jf504455x | J. Agric. Food Chem. 2014, 62, 12504−1251112510
- 89 -
(19) Wanyika, H.; Gatebe, E.; Kioni, P.; Tang, Z.; Gao, Y.
Mesoporous silica nanoparticles carrier for urea: potential applications
in agrochemical delivery systems. J. Nanosci. Nanotechnol. 2012, 12,
2221−2228.
(20) Wanyika, H. Sustained release of fungicide metalaxyl by
mesoporous silica nanospheres. J. Nanopart. Res. 2013, 15.
(21) Wen, L. X.; Li, Z. Z.; Zou, H. K.; Liu, A. Q.; Chen, J. F.
Controlled release of avermectin from porous hollow silica nano-
particles. Pest. Manag. Sci. 2005, 61, 583−590.
(22) Tan, W. M.; Hou, N.; Pang, S.; Zhu, X. F.; Li, Z. H.; Wen, L. X.;
Duan, L. S. Improved biological effects of uniconazole using porous
hollow silica nanoparticles as carriers. Pest. Manag. Sci. 2012, 68, 437−
443.
(23) Li, Z. Z.; Xu, S. A.; Wen, L. X.; Liu, F.; Liu, A. Q.; Wang, Q.;
Sun, H. Y.; Yu, W.; Chen, J. F. Controlled release of avermectin from
porous hollow silica nanoparticles: influence of shell thickness on
loading efficiency, UV-shielding property and release. J. Controlled
Release 2006, 111, 81−88.
(24) Liu, F.; Wen, L.-X.; Li, Z.-Z.; Yu, W.; Sun, H.-Y.; Chen, J.-F.
Porous hollow silica nanoparticles as controlled delivery system for
water-soluble pesticide. Mater. Res. Bull. 2006, 41, 2268−2275.
(25) Qian, K.; Shi, T. Y.; He, S.; Luo, L. X.; Liu, X. L.; Cao, Y. S.
Release kinetics of tebuconazole from porous hollow silica nano-
spheres prepared by miniemulsion method. Microporous Mesoporous
Mater. 2013, 169, 1−6.
(26) Lou, X. W.; Archer, L. A.; Yang, Z. C. Hollow micro-/
nanostructures: synthesis and applications. Adv. Mater. 2008, 20,
3987−4019.
(27) U.S. Food and Drug Administration’s Website. GRN No. 321:
Synthetic amorphous silica, http://www.accessdata.fda.gov/scripts/fcn/
gras_notices/GRN000321.pdf (21 May 2014).
(28) Zhu, Y. F.; Shi, J. L.; Shen, W. H.; Dong, X. P.; Feng, J. W.;
Ruan, M. L.; Li, Y. S. Stimuli-responsive controlled drug release from a
hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell
structure. Angew. Chem., Int. Ed. 2005, 44, 5083−5087.
(29) Wibowo, D.; Zhao, C.-X.; Middelberg, A. P. J. Emulsion-
templated silica nanocapsules formed using bio-inspired silicification.
Chem. Commun. 2014, 50, 11325−11328.
(30) Kyle, S.; Aggeli, A.; Ingham, E.; McPherson, M. J. Production of
self-assembling biomaterials for tissue engineering. Trends Biotechnol.
2009, 27, 423−433.
(31) Morreale, G.; Lee, E. G.; Jones, D. B.; Middelberg, A. P. J.
Bioprocess-centered molecular design (BMD) for the efficient
production of an interfacially active peptide. Biotechnol. Bioeng. 2004,
87, 912−923.
(32) Tingle, C. C. D.; Rother, J. A.; Dewhurst, C. F.; Lauer, S.; King,
W. J. Fipronil: environmental fate, ecotoxicology, and human health
concerns. Rev. Environ. Contam. Toxicol. 2003, 176, 1−66.
(33) Colliot, F.; Kukorowski, K. A.; Hawkins, D. W.; Roberts, D. A.
Fipronil: A New Soil and Foliar Broad Spectrum Insecticide; British Crop
Protection Council: 2000.
(34) Cole, L. M.; Nicholson, R. A.; Casida, J. E. Action of
phenylpyrazole insecticides at the gaba-gated chloride channel. Pestic.
Biochem. Physiol. 1993, 46, 47−54.
(35) Ngim, K. K.; Crosby, D. G. Abiotic processes influencing
fipronil and desthiofipronil dissipation in California, USA, rice fields.
Environ. Toxicol. Chem. 2001, 20, 972−977.
(36) Rouland-Lefevre, C. Termites as Pests of Agriculture. In Biology
of Termites: A Modern Synthesis; Bignell, D. E., Roisin, Y., Lo, N., Eds.;
Springer: London, U.K., 2011; pp 499−517.
(37) Rust, M. K.; Su, N.-Y. Managing social insects of urban
importance. Annu. Rev. Entomol. 2012, 57, 355−375.
(38) Song, D. L.; Hu, X. P. Effects of dose, donor-recipient
interaction time and ratio on fipronil transmission among the
Formosan subterranean termite nestmates (Isoptera: Rhinotermiti-
dae). Sociobiology 2006, 48, 237−246.
(39) Ibrahim, S. A.; Henderson, G.; Fei, H. X. Toxicity, repellency,
and horizontal transmission of fipronil in the formosan subterranean
termite (Isoptera: Rhinotermitidae). J. Econ. Entomol. 2003, 96, 461−
467.
(40) Krimm, S.; Bandekar, J. Vibrational spectroscopy and
conformation of peptides, polypeptides, and proteins. Adv. Protein
Chem. 1986, 38, 181−364.
(41) Hernandez, B.; Pfluger, F.; Derbel, N.; De Coninck, J.; Ghomi,
M. Vibrational Analysis of Amino Acids and Short Peptides in
Hydrated Media. VI. Amino Acids with Positively Charged Side
Chains: L-Lysine and L-Arginine. J. Phys. Chem. B 2010, 114, 1077−
1088.
(42) Gauglitz, G.; Moore, D. S. Handbook of Spectroscopy, 2nd ed.;
Wiley-VCH: Germany, 2014; Vol. 1.
(43) Hildebrand, M. Diatoms, biomineralization processes, and
genomics. Chem. Rev. 2008, 108, 4855−4874.
(44) Müller, W. E. G.; Belikov, S. I.; Tremel, W.; Perry, C. C.;
Gieskes, W. W. C.; Boreiko, A.; Schröder, H. C. Siliceous spicules in
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Chapter 5 
 
Interfacial biomimetic synthesis of silica nanocapsules using a 
recombinant catalytic modular protein 
 
 
The research in this chapter consists of the peer-reviewed paper published as:  
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Abstract 
 
This chapter describes the design of a bifunctional modular protein, D4S2, by extrapolating the 
design principle of the bifunctional modular peptide developed in Chapter 3, for the synthesis of oil-
core silica-shell nanocapsules. The 116-residue protein was designed by fusing the Si module rich 
in cationic amino acids known for biosilicification activity derived from SurSi peptide (Chapter 3), 
with a four-helix bundle structure DAMP4 variant module as carrier protein derived from recombinant 
DAMP4 protein which has known surface activity. The modular combination design would enable 
expression of D4S2 in industrially-relevant, microbial cell-factory Escherichia coli at high solubility 
while potentially allowing for easy process-scale manufacture as in DAMP4. Moreover, it also 
allowed simplified purification process conferred by its thermal- and chemical-stability properties. 
Purification methods to obtain high purity D4S2 and analyses of the purified protein were discussed. 
Protein behaviors at the macroscopic interface were investigated using dynamic interfacial tension 
and thin film pressure balance. Finally, functionalities of D4S2 for making silica nanocapsules were 
demonstrated through synergistic activities of surface-active and biosilicification-active modules 
within D4S2. This chapter introduces biomolecular protein design for the development of sustainable 
production of bifunctional modular protein, which is important for the subsequent chapter. 
 
 
Interfacial Biomimetic Synthesis of Silica Nanocapsules Using a
Recombinant Catalytic Modular Protein
David Wibowo, Chun-Xia Zhao, and Anton P. J. Middelberg*
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ABSTRACT: This paper reports interfacially driven synthesis of oil-core
silica-shell nanocapsules using a rationally designed recombinant catalytic
modular protein (ReCaMoP), in lieu of a conventional chemical surfactant. A
116-residue protein, D4S2, was designed by modularizing a surface-active
protein module having four-helix bundle structure in bulk and a
biosilicification-active peptide module rich in cationic residues. This modular
combination design allowed the protein to be produced via the industrially
relevant cell factory Escherichia coli with simplified purification conferred by
thermostability engineered in design. Dynamic interfacial tension and thin film
pressure balance were used to gain an overview of the protein behavior at
macroscopic interfaces. Functionalities of D4S2 to make silica nanocapsules were demonstrated by facilitating formation and
stabilization of pharmaceutically grade oil droplets through its surface-active module and then by directing nucleation and growth
of a silica shell at the oil−water interface through its biosilicification-active module. Through these synergistic activities in D4S2,
silica nanocapsules could be formed at near-neutral pH and ambient temperature without using any organic solvents that might
have negative environmental and sustainability impacts. This work introduces parallelization of biomolecular, scale-up and
interfacial catalytic design strategies for the ultimate development of sustainable and scalable production of a recombinant
modular protein that is able to catalyze synthesis of oil-filled silica nanocapsules under environmentally friendly conditions,
suitable for use as controlled-release nanocarriers of various actives in biomedical and agricultural applications.
■ INTRODUCTION
Advances in interfacial chemistry have enabled synthesis of
silica nanocapsules having core−shell architecture.1,2 The
synthesis methods involve sol−gel reactions of aqueous silica
precursor on colloidal core templates, i.e., gas bubbles,3,4
nanoparticles,5−11 and emulsion droplets,12−20 resulting in
nucleation and growth of silica at the boundary of gas−liquid,
solid−liquid, and liquid−liquid interfaces, respectively. With
silica shells encapsulating the core materials, the nanocapsules
combine properties of silica, i.e., biocompatibility, easy
functionalization, mechanical stability, and optical trans-
parency,1,21 and tunable functionalities of the core. Depending
on the core’s type, silica nanocapsules have found diverse
applications in fields of chemical, biomedical, and agricultural
applications, for example, as nanoreactors;5 as supports of
catalytic metals,6 semiconductor,7 fluorescent8 and magnetic9
nanoparticles, and enzymes12 for their long-term activity and/
or dispersibility in aqueous environment; as adsorbents;13,14
and as nanocarriers of drugs15 and pesticides16 for their storage,
protection, and release.
Surface chemistry of the colloidal core templates plays
important roles for the synthesis of silica nanocapsules,1,2
thereby maintaining template stability and concurrently
catalyzing silica formation preferentially at the interface.
Therefore, various chemicals have been decorated surrounding
the template surfaces via adsorption, including cationic
surfactants (e.g., tetradecyltrimethylammonium bromide,6
cetyltrimethylammonium bromide,3,18 and cetyltrimethylam-
monium chloride19), nonionic surfactants (e.g., Brij 97,13
Tween 80,14 and Triton X-10020), and polymers (e.g.,
poly(acrylic acid),5 poly(vinylpyrrolidone),10 and poly(ethylene
oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)17).
Despite great progress in the interfacial synthesis of silica
nanocapsules, the aforementioned chemical methods12−15,17−20
variously incorporate toxic chemical catalysts and organic
solvents that would pose adverse environmental effects. An
alternative way to construct silica nanocapsules using
biocompatible components and benign conditions is still highly
desired especially for biomedical and agricultural applications.
Nature’s ability to form silica using biomolecules as in cell
walls of diatoms22 and spicules of sponges23 provides an
example for “green” synthesis of silica-based nanomaterials. The
biomolecules play important roles in biosilicification by
inducing nucleation and growth of silica species in aqueous
solution under physiological conditions.24 To mimic the
naturally occurring biomolecules, many studies have used
short peptides for biosilicification in bulk aqueous solu-
tions,25−28 but very few studies report biosilicification at
biphasic interfaces.11,16 Graf et al. used two tripeptides (CKK)
connected with a disulfide bridge to facilitate formation of silica
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shell encapsulating a silver nanoparticle core.11 We recently
reported synthesis of oil-core silica-shell nanocapsules via a
novel emulsion and biomimetic dual-templating approach16
using bifunctional SurSi peptide (Ac-MKQLAHS VSRLEHA
RKKRKKRKKRKKGGGY-CONH2) that modularized a sur-
face-active sequence (Sur module, MKQLAHS VSRLEHA)
capable of stabilizing pharmaceutically grade oil droplets with a
sequence for catalyzing biosilicification at the oil−water
interfaces (Si module, RKKRKKRKKRKKGGGY).
Synthesis of oil-core silica-shell nanocapsules using bio-
molecular engineering16 instead of chemical surfactant
approaches12−20 may contribute substantially to the develop-
ment of an environmentally friendly approach to produce
biocompatible nanocarriers having controlled-release proper-
ties. Various hydrophobic actives could potentially be
encapsulated in the nanocapsules’ core with high encapsulation
efficiency, thus broadening opportunities to wide range of
applications especially in biomedical and agricultural fields. In
turn, sustainable and scalable processes of making such
nanocapsules would be highly demanded. Peptide surfactant,
a key ingredient in the synthesis of silica nanocapsules using
this new approach,16 is currently produced based on solid-phase
chemistry29 which is useful for research but limiting for large-
scale production.30 Recombinant peptide production offers the
potential of process scale-up using established bioprocess unit
operations,31 for example, by expression of recombinant DNA
encoding expression of the peptide via the low-cost “cell
factory” Escherichia coli (E.coli).32 Significant challenges may
exist during peptide expression as peptides may self-associate
forming insoluble aggregated materials33 and undergo intra-
cellular degradation.34 To counter these problems, peptides are
commonly fused to carrier proteins to mask the self-assembly
characteristic and improve the intracellular stability.35 Design of
fusion protein combining the peptide with a carrier protein
should enable its expression in E. coli, allowing peptide cleavage
from the carrier protein if necessary, to facilitate simplified
purification.
In this study, we designed a-116 residue protein, D4S2, by
fusing the Si module of the SurSi peptide, known for its
biosilicification activity,16 with a helical DAMP4 variant module
as carrier protein derived from recombinant DAMP4 protein
which has known surface activity.36 This modular combination
design would enable expression of D4S2 in E. coli at high
solubility while potentially allowing easy process-scale
manufacture as demonstrated for DAMP4.37 We hypothesized
that this strategy would allow the purified D4S2 to be directly
used for making silica nanocapsules without the need for
peptide cleavage from the carrier protein. In addition, the
recombinant D4S2 would be expected capable of (1) facilitating
formation and stabilization of nanoemulsions through its
surface-active module and (2) catalyzing biosilicification at
the oil−water interfaces through its biosilicification-active
module, forming oil-core silica-shell nanocapsules at room
temperature and nearly neutral pH in the absence of any toxic
organic solvents. To the best of our knowledge, this is the first
report of parallel biomolecular, scale-up, and interfacial catalytic
design strategies for the development of a sustainable and
scalable production route to a recombinant catalytic modular
protein (ReCaMoP) that is able to catalyze interfacial synthesis
of silica nanocapsules under environmentally friendly con-
ditions.
■ EXPERIMENTAL SECTION
Materials.Miglyol 812 purchased from AXO Industry S.A. (Wavre,
Belgium) was passed through heat-activated silica gel (Sigma-Aldrich)
prior to use. Water with >18.2 MΩ cm resistivity was obtained from a
Milli-Q system with a 0.22 μm filter (Millipore, Australia). Other
chemicals were of analytical grade purchased from either Sigma-
Aldrich or Merck and used as received unless otherwise stated.
Protein Expression, Purification, and Characterization.
Plasmid pET-48b(+) composed of nucleotide sequence encoding for
D4S2 protein (Protein Expression Facility, The University of
Queensland) was transformed into chemically competent E. coli
BL21(DE3) (Novagen, Merck KGaA, Germany). Production of D4S2
protein was through expression of recombinant DNA in E. coli
controlled by the T7 promoter. Purification was based on the reported
precipitation process for DAMP4 protein37 (Figures S1 and S2) and
chromatography techniques (Figure S3) to obtain high purity of D4S2.
Detailed transformation, expression, and purification can be found in
the Supporting Information.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
(SDS-PAGE). Qualitative analysis of protein samples was performed
using NuPAGE 4−12% Bis-Tris gels (Life Technologies, Australia)
mounted in a Bio-Rad XCell 3 system (Bio-Rad, Hercules, CA).
Procedures for sample preparation, gel staining and destaining, and gel
imaging are provided in the Supporting Information.
Reversed-Phase High-Performance Liquid Chromatography (RP-
HPLC). To determine concentration of D4S2 protein, RP-HPLC
equipped with a Jupiter C18 column (5 μm, 300 Å, 150 mm × 4.6 mm)
(Phenomenex, Torrance, CA) and connected to an LC-10AVP series
HPLC system (Shimadzu, Japan) was used. Buffer A was 0.1% v/v
trifluoroacetic acid (TFA) in water, and buffer B was 90% v/v
acetonitrile and 0.1% v/v TFA in water. Gradient conditions applied in
the analysis were from 30 to 65% of buffer B in 35 min at a flow rate of
1 mL/min and a set detection wavelength of 214 nm.
Liquid Chromatography−Mass Spectrometry (LC-MS). LC-MS
was performed using a Waters Alliance HPLC system (Waters,
Milford, MA) linked with a Quattro Micro API Quadrupole system to
determine molecular mass of D4S2. The LC was equipped with a
Kinetex C18 column (2.6 μm, 100 Å, 100 mm × 4.6 mm)
(Phenomenex, Torrance, CA) with a mobile phase A, 0.01% v/v
TFA in water, and mobile phase B, 90% v/v acetonitrile, 0.01% v/v
TFA in water. An applied gradient from 30 to 65% B in 35 min at a
flow rate of 0.6 mL/min was used. For mass analysis, an electrospray
mass spectrometry in positive-ion mode was performed with capillary,
cone, extractor, and a radio frequency lens voltages set at 3 kV, 24 V, 3
V, and 0 V, respectively.
Circular Dichroism (CD). To determine the secondary structure of
D4S2, CD spectroscopy (Jasco 810, Easton, MD) was performed on
0.025 mg/mL D4S2 filled in a 1 cm path length quartz cell (Starna,
Australia) at 20 and 90 °C. Water was used to dissolve D4S2 in order
to eliminate the effect of buffer salts on the CD signal. Far-UV CD
spectra were recorded from 260 to 190 nm using 0.1 nm data pitch, 50
nm/s scan speed, 2 s response time, 1 nm bandwidth, and 10
accumulations. The obtained raw ellipticity was converted to molar
ellipticity by the equation38
θ θ= M
cl
[ ]
10
mrm
where [θ] is molar ellipticity (deg cm2/dmol), θ is raw ellipticity
(mdeg), c is protein concentration (mg/mL), l is cell path length
(cm), andMmrm is mean residue molecular mass, i.e., protein molecular
mass/number of residues.
Interfacial Tension. Oil−water interfacial tension studies
employed droplet tensiometry with a Krüss drop shape analysis
system DSA-10 (Krüss GmbH, Germany). Protein solution of either
D4S2 or DAMP4 (8 mL, 0.1 mg/mL) in HEPES buffer (25 mM, pH
7.5) was filled in an 8 mL quartz cuvette (Hellma, Germany), and an
oil droplet (Miglyol 812) was formed manually via a glass syringe
connected to a U-shaped stainless steel capillary of known diameter
submerged in the protein solution. Measurements of the interfacial
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tension were made automatically over 1000 s following initial oil
droplet formation. Prior to measurement, the interfacial tension of
Miglyol 812 oil in the buffer was measured at approximately 30 mN/m
and remained constant for at least 10 min to ensure correct
functioning, focusing, and cleanliness of the instrument.
Thin Film Experiment. The thin film pressure balance technique39
was used to determine the surface forces in a liquid film stabilized by
either D4S2 or DAMP4 (1.53 mg/mL) in HEPES buffer (25 mM, pH
7.5) under controlled capillary pressure. A liquid film was formed
using a microfabricated bike-wheel microcell, designed for uniform
radial drainage,40 with diameter of the central hole inside the microcell
of 0.75 mm. A vapor-saturated chamber inserted with the film holder
was placed on an inverted microscopic stage (Olympus IX51).
Temperature was maintained at 22 ± 0.1 °C using a water jacket, and
the air pressure inside the chamber was controlled by using a 100 mL
gastight syringe (SGE, Australia) driven by a micropositioner (M4454,
Parker) as described by Wang and Yoon.41 To record images of the
films, a digital video camera was used at a rate of 30 frames/s.
Synthesis and Characterization of Oil-Core Silica-Shell
Nanocapsules. Lyophilized D4S2 protein was dissolved in HEPES
buffer (25 mM, pH 7.5) to prepare D4S2 solutions from 0.47 to 2.5
mg/mL. Miglyol 812 (10% v/v) was added to the D4S2 solutions (1
mL) and homogenized using a Branson Sonifier 450 ultrasonicator for
four 30 s bursts at 20 W and interspersed in an ice bath for 60 s. The
nanoemulsion aliquot (400 μL) was transferred into a 4 mL glass vial
containing weighed tetraethoxysilane (TEOS, 32 μmol). Interfacially
catalyzed reaction with TEOS was conducted under magnetic stirring
at room temperature for 20 h.
Dynamic Light Scattering (DLS). Size distribution and zeta
potential were determined by DLS using a Malvern Zetasizer Nano
ZS (Malvern Instrument, UK) at a scattering angle of 173° and a
temperature of 25 °C. Samples were diluted by a factor of 100 prior to
measurement to avoid multiple scattering effects.
Transmission Electron Microscopy (TEM). Morphology of the silica
nanocapsules was visualized by TEM using a JEOL 1010 (JEOL,
Japan) operated at 100 kV. Samples (2 μL) were deposited onto
Formvar-coated copper grids (ProSciTech, Australia). The size of the
nanocapsules was analyzed by using iTEM software (version 3.2, Soft
Imaging System GmbH).
■ RESULTS AND DISCUSSION
Protein Design. The aim of the reported research was to
synthesize oil-core silica-shell nanocapsules based on protein
supramolecular chemistry allowing sustainable and scalable
protein production via expression in the cell factory E. coli.
Design of the protein followed the concept of our recently
reported bifunctional SurSi peptide, thereby modularizing a
surface-active module with a module for biosilicification.16
Synergistic combination of both modules was considered
essential to stabilize nanoemulsions and concurrently induce
nucleation and growth of silica forming silica nanocapsules.
Figure 1. Design of recombinant catalytic modular protein (ReCaMoP), D4S2. (a) Schematic amino acid sequence of DAMP4, DAMP4 variant, and
D4S2 proteins. The proteins consist of four AM1 peptides42 (dark blue rectangle) comprising three heptads with repeating motif abcdefg in each, in
which the alternate three and four spacing residues (a and d) have hydrophobic side chains (mainly methionine (M), leucine (L), and valine (V)),
while the remaining sites are predominantly hydrophilic, allowing formation of α-helix structure. (b) End-on view helical wheel projection of
DAMP4 variant module in D4S2 with its four-α-helical structure interlocking of hydrophobic residues at the core that might be expected to give rise
to the protein stability. (c) Molecular D4S2 modularizing DAMP4 variant module (dark blue) forming four-helix bundle in bulk and Si module (light
blue) projecting toward bulk aqueous phase.
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This was confirmed by the fact that AM1 peptide (Ac-
MKQLADS LHQLARQ VSRLEHA-CONH2)known for its
surface activity42 and ability to stabilize nanoemulsions43was
unable to effectively produce silica nanocapsules as the silica
was largely form in bulk solution rather than at oil−water
interfaces.16
D4S2 protein (M DPS MKQLADSLHQLARQVSRLEHA
DPS MKQLADSLHQLARQVSRLEHA DPS MKQLADSLH-
QLARQVSRLEHA DPS MKQLADSLHQLARQVSRLEHA
EPS RKKRKKRKKRKKGGGY), having theoretical molecular
mass 13.3 kDa and pI 10.9, was designed by modularizing
DAMP4 variant module (M DPS MKQLADSLHQLARQ-
VSRLEHA DPS MKQLADSLHQLARQVSRLEHA DPS
MKQLADSLHQLARQVSRLEHA DPS MKQLADSLHQLA-
RQVSRLEHA EPS) with Si peptide module (RKKRKKRK-
KRKKGGGY) (Figure 1). Si peptide rich in cationic amino
acid side chains known for its biosilicification activity was
derived from SurSi peptide.16 DAMP4 variant module was
derived from four-helix bundle DAMP4 protein (MD(PS
MKQLADS LHQLARQ VSRLEHAD)4) known for its surface
activity,36 except that the aspartic acid (D) residue at C-
terminal DAMP4 was replaced with glutamic acid (E) residue
followed by addition of proline (P) and serine (S) residues in
order to provide molecular flexibility to the Si module
projecting toward the bulk aqueous phase (Figure 1c).
DAMP4, designed by connecting four surface-active AM1
peptide42 via Asp-Pro-Ser (DPS) linkers, has been shown to
have surface activity similar to the AM1 peptide36 and was used
as a basis for the design of surface-active module of D4S2.
Several other reasons were also considered when selected
DAMP4. First, DAMP4 has been proved to be successfully
produced in E. coli at high levels and solubility.36,37 Second,
DAMP4 has demonstrated stability at high temperature (above
90 °C) and Na2SO4 concentrations (up to 1 M)
37 due to its
four-helix bundle structure in bulk (Figure 1b), useful for
disruption of the cell walls releasing the intracellular proteins
and precipitation of the contaminant proteins while maintain-
ing DAMP4 solubility, respectively. These properties allow
simple separation of DAMP4 from contaminant proteins
without losing its surface activity.37 Finally, DAMP4 could be
cleaved, if necessary or desired, at its DP sequence via acid
hydrolysis,44 and the resulting individual DAMP1 peptide (PS
MKQLADS LHQLARQ VSRLEHA D) has been demonstrated
to have surface activity as well.44 In the case where peptide
cleavage from the carrier protein is required for D4S2, acid
digestion of D4S2 would cleave the DP sequence while the EP
sequence would be more stable against the acid, thus resulting
in a sequence comprising DAMP1 variant peptide (PS
M K Q L A D S L H Q L A R Q V S R L E H A E P S
RKKRKKRKKRKKGGGY), expected to have surface activity
close to DAMP1 peptide,44 and biosilicification-active Si
peptide.16
Based on these considerations, incorporation of DAMP4
variant module in D4S2 would be expected to form four-helix
bundle protein structure and impart surface activity, while the
Si module would provide biosilicification activity for D4S2
(Figure 1). We hypothesized that the surface-active module of
D4S2 would undergo interfacial adsorption to the freshly
formed droplet (Miglyol 812 oil) surfaces upon sonication,
during which the four-helix bundle of D4S2 unfolds at the
interface, causing the hydrophobic residues to face the oil phase
while the hydrophilic residues face toward bulk aqueous phase
and stabilize the droplets. This hypothesis is based on
extrapolation of the known physical chemistry of DAMP4.45
Upon addition of silica precursor tetraethoxysilane (TEOS)
molecules, the biosilicification module of D4S2 oriented within
the subinterfacial region toward bulk solution would act as a
catalytic site for nucleation and growth of silica layer
surrounding the droplets forming oil-core silica-shell nano-
capsules at near neutral pH and room temperature and without
using any toxic organic solvents.
Protein Production and Characterization. To recover
D4S2 from E. coli cell pellet, a purification process was
developed based on the bake-to-break and precipitate method
of the DAMP4 purification process,37 thereby heating the
resuspended cell pellet in a buffer containing 1 M Na2SO4 at 90
°C for 30 min (Figure S1). Under such high temperature, the
cell walls disrupted and the intracellular proteins including
D4S2 released into the bulk phase. In the presence of Na2SO4,
most proteins precipitated (Figure 2, lane 2), whereas D4S2
remained soluble (Figure 2, lane 3) as concentrated Na2SO4
salted-in the four-helix bundle structure37 of D4S2. The protein
solution contained high levels DNA (Table S1) which derived
from either the expression construct or the genomic DNA.46
Protein and DNA may form noncovalent complexes via
electrostatic interactions between anionic phosphate groups
on the DNA and cationic functional groups on protein at
physiological pH.47,48 Binding of DNA to protein could alter
protein properties (e.g., charge and size) and may cause
increased viscosity of the protein solution. To separate D4S2
from DNA, the solution was diluted with water to lower
Na2SO4 concentration and adjusted to pH 3.5 (i.e., dilute
precipitation process), which is well below the isoelectric points
of both D4S2 and DNA,49 thus inducing charge−charge
repulsion between D4S2 and DNA. Under this condition, D4S2
precipitated from the solution as the Na2SO4 concentration was
Figure 2. SDS-PAGE analysis of D4S2 protein after heating/cell lysis,
contaminant precipitation and dilute precipitation steps, and IMAC
purification step: (lane 1) total protein; (lane 2) resuspended
precipitate and (lane 3) supernatant after heating/cell lysis and
contaminant precipitation step; (lane 4) solubilized precipitate after
dilute precipitation step; (lane 5) passed-through fraction, (lane 6)
washed fraction, and (lane 7) eluted fraction after IMAC process;
(lane 8) Novex sharp prestain protein standard.
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insufficient to salt-in D4S2, while most DNA separated from
the precipitate and remained in the aqueous phase. At this
stage, DNA concentration of the solubilized D4S2 (Figure 1,
lane 4) reduced by approximately 95% (Table S1). Prior to the
functionality test of D4S2, the protein solution was filtered and
passed through desalting chromatography. Then, purified D4S2
was used to form nanoemulsions via sonication in HEPES
buffer (25 mM, pH 7.5). Although D4S2 is rich in cationic
amino acids (theoretical pI 10.9), the resulting nanoemulsions
unexpectedly had negative zeta potentials at pH 7.5. This is
probably because the anionic DNA residues were still present in
an amount sufficient to cover the cationic protein side chains at
the oil−water interfaces. As a consequence, the nanoemulsions
were unable to react with silica precursor tetraethoxysilane
(TEOS) molecules and form a silica shell at pH 7.5 as both
nanoemulsion surfaces and silica species50 bore negative
charges.
To further remove DNA from D4S2, immobilized-metal
affinity chromatography (IMAC) was used applying high salt
concentration (1.2 M NaCl) (Figure S4a) followed by desalting
chromatography (Figure S4b). D4S2 bound to the IMAC
column through its high intrinsic histidine content by forming
coordination bonds with Ni2+ ions immobilized on the column.
DNA dissociated from the bound D4S2 and passed through the
column as the electrostatic interactions between D4S2 and
DNA were screened under the high salt concentration. D4S2
could then be eluted from the column using imidazole (Figure
2, lane 7) and passed through desalting chromatography to
obtain high-purity D4S2 protein (Figure 3a), with a reduction
of DNA concentration by approximately 97% as compared to
the sample before load to the IMAC column. The calculated
molecular mass of D4S2 protein based on the mass spectrum is
13308.2 Da (Figure 3b), which is very close to its theoretical
molecular mass, i.e., 13299.3 Da, confirming the correct protein
sequence. The far-UV circular dichroism (CD) measurements
for D4S2 at 20 and 90 °C showed nearly identical spectra
(Figure 3c) dominated by a double minimum at 208 and 222
nm and a maximum near 195 nm, typical of α-helical
conformation.51 The ability of D4S2 to maintain the helical
structure at a temperature up to 90 °C suggests that D4S2 has
thermal stability properties likely due to the four-helix bundle
structure that formed through association of four amphiphilic
α-helices interlocking the hydrophobic core within D4S2
(Figure 1b). Proteins having four-helix bundle structure have
been recognized for their high molecular stability including to
temperature52 and chemical denaturants,53 and their design and
utility have been an area of intense and expanding research.54
Surface Activity. Initial surface-active studies focused on
the interfacial tension of D4S2 solution against a Miglyol 812
oil droplet and in comparison with DAMP4. Oil−water
dynamic interfacial tension data were recorded at the low
weight concentration of 0.1 mg/mL in HEPES buffer (25 mM)
at pH 7.5, corresponding to the pH value for biosilicification
reaction,16 to follow adsorption events at an earlier period
(Figure 4). It is clear that D4S2 is surface-active as it
spontaneously adsorbed to the oil−water interface and lowered
the interfacial tension (γ), despite the high temperature and
high salt concentrations applied for its purification. The surface
activity of D4S2 was likely due to α-helical structure of D4S2
(Figure 3c) giving rise to its amphiphilic character that allowed
D4S2 to unfold upon interfacial adsorption, thus oriented the
hydrophobic residues toward the oil phase, while the
hydrophilic sites faced toward the bulk aqueous phase. The
interfacial tension of D4S2 approached equilibrium at 18.6 ±
0.3 mN/m, while DAMP4 showed increased interfacial
adsorption as the equilibrium interfacial tension reached 16.5
± 0.4 mN/m. D4S2 showed approximately 81% of the decrease
in interfacial tension occurred after 50 s, while DAMP4 gave
more rapid adsorption, with 93% of the decrease in interfacial
tension seen in the first 50 s. The slower interfacial adsorption
indicates existence of energy barriers to protein adsorption that
can be affected by molecular mass45 and net electrical charge of
the protein.55 D4S2 has higher molecular mass (M 13 308.2
Da) (Figure 3b) than DAMP4 (M 11 116.5 Da)36 which results
in a lower bulk diffusion coefficient (D) of D4S2, since D ∼
M−1/3,45,56 hence lowering the relative adsorption rate. With the
D4S2 theoretical isoelectric point being 10.9 in bulk solution,
Figure 3. Characterization of D4S2. (a) Reversed-phase high-
performance liquid chromatography showing high purity of D4S2.
(b) Mass spectrum determining D4S2 molecular mass of 13 308.2 Da.
(c) Circular dichroism spectra showing secondary structure of D4S2 in
water (0.025 mg/mL) at 20 and 90 °C.
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D4S2 would be expected to carry more positive charges than
DAMP4 (theoretical pI 6.7) at pH 7.5, thus yielding an
increased charge−charge repulsion causing slower interfacial
saturation and conformational changes at the oil−water
interfaces upon interfacial adsorption.
To understand macroscopic stability of a colloidal system, it
is important to understand surface forces of the building blocks,
i.e., a single thin liquid film that separates the dispersed phase in
a continuous phase.57 In this study, the thin liquid film was
studied by using a thin film pressure balance technique39 on a
free-standing horizontal liquid foam film, as a model system,
that is compressed under controlled-capillary pressure (Pc).
Typical images of D4S2 films (Figure 5a) were placed side by
side to indicate visual changes in the thin films as the capillary
pressure were increased progressively to reach instrument-limit
pressure of 2500 Pa, as compared to DAMP4 films (Figure 5b).
A weight concentration of 1.53 mg/mL protein solution in 25
mM buffer pH 7.5 was used similar to that used for emulsion
preparation using D4S2. Both D4S2 and DAMP4 films
exhibited heterogeneous film thickness as evident from the
presence of dark and bright area. The bright phase regions are
indicative of thicker surface materials, which can be due to the
presence of protein aggregates at the film surfaces,58 while the
black areas can be considered as domains with a reduced
thickness. D4S2 films were stable as the shape integrity
remained intact at increasing pressure even when pressure
reached 2500 Pa (Figure 5a). In contrast, increasing capillary
pressure on DAMP4 films triggered formation of a dark hole at
the top edge of the surface films that grew larger occupying half
of the film, an initiation of film rupture, upon increasing the
pressure to 2500 Pa (Figure 5b). It is evident that surface films
of D4S2 demonstrated higher stability than of DAMP4, which
bears a positive charge and a near-zero charge, respectively, at
pH 7.5, during film compression as a result of higher charge−
charge repulsion of positively charged D4S2 at the investigated
pH and hence increased mechanical resistance of the film.
DAMP4 protein bearing near-zero charge has been reported to
have low film stability44 and that the film stability could be
enhanced by increasing its positive charges through addition of
Zn2+ ions which bound to histidine (H) residues within
DAMP4.
Emulsification Activity. The surface activity of D4S2 was
tested further for emulsifying Miglyol 812 oil, i.e., whether
D4S2 is able to facilitate disruption of the oil phase into small
emulsion droplets upon sonication and stabilization of the
droplets from aggregating with neighboring droplets. Emulsions
of 10% v/v Miglyol 812 oil were prepared in various
concentrations of D4S2 protein solutions (0.47−2.50 mg/
mL) in HEPES buffer (25 mM, pH 7.5) via sonication that
yielded emulsions having different physical properties (Figure
6). The size of emulsions produced at a D4S2 concentration of
0.47 mg/mL was 555 ± 25 nm with a dispersity (Đ) of 0.822,
and the size decreased to 415 ± 8 nm (Đ = 0.440) when D4S2
concentration was increased to 0.93 mg/mL. The high Đ’s
indicate aggregation probably because the protein was
insufficiently available to adsorb at oil−water interfaces, thus
leaving gaps at the interfaces and, when two gaps on different
droplets came into close proximity, resulting in droplet
coalescence. Increasing D4S2 concentration to 1.53 mg/mL
substantially decreased the droplet size to 203 ± 3 nm (Đ =
0.210). Further increase of D4S2 concentration resulted in only
a slight decrease in size. Overall, D4S2 formed sufficiently
stable emulsions at 1.53 mg/mL with highly positive charges
(zeta potential = +38 mV), suggesting that electrostatic
repulsion is a key mode of stabilization for D4S2.
Figure 4. Dynamic interfacial tension of protein solutions vs Miglyol
812 oil. Proteins were 0.1 mg/mL in 25 mM HEPES buffer at pH 7.5.
Figure 5. Surface visualization of thin liquid films: (a) D4S2 films; (b) DAMP4 films. Proteins were 1.53 mg/mL in 25 mM HEPES buffer pH 7.5. Pc
is the capillary pressure applied to compress the films with maximum pressure reached at 2500 Pa.
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Biomimetic Silicification Activity. To determine the
effectiveness of D4S2 for making silica nanocapsules, the
nanoemulsions formed using 1.53 mg/mL D4S2 in HEPES
buffer (25 mM, pH 7.5) were reacted with silica precursor
tetraethoxysilane (TEOS) molecules. Following addition of
TEOS to the nanoemulsions, silica nanocapsule was formed
after 20 h reaction at pH 7.5 and room temperature (Figure 7).
The outer diameter and shell thickness of the nanocapsules as
measured by TEM were 249 ± 29 and 26 ± 2 nm, respectively.
The biosilicification process at the oil−water interface was due
to the catalytic role of Si module, which comprises densely
packed cationic arginine (R) and lysine (K) residues, projecting
toward bulk aqueous phase as well as polar residues of DAMP4
variant module that induced hydrolysis of TEOS and
polycondensation at the oil−water interfaces forming silica
shell encapsulating the oil core.
■ CONCLUSIONS
This study demonstrates the parallel biomolecular, scale-up,
and interfacial catalytic design strategies for development of a
116-residue protein, D4S2, to catalyze interfacial synthesis of
silica nanocapsules. D4S2 was designed, at the molecular level,
by modularizing a DAMP4 variant protein, expected to have
four-helix bundle structure and surface activity as imparted by
DAMP4 protein, with a Si peptide rich in cationic amino acids
known for biosilicification activity derived from SurSi peptide.
This modular protein could be synthesized in cell factory
Escherichia coli and extracted from the cells by heating and
mixing with a suitably high concentration of Na2SO4 to disrupt
the cells and precipitate most protein contaminants while
maintaining D4S2 solubility, respectively. The stability of D4S2
to high temperature and chemical denaturant was related to its
four-helix bundle structure in bulk, as designed. D4S2 protein
was further purified by means of immobilized-metal affinity
chromatography and then desalting chromatography to remove
DNAs and salts. Properties of the purified D4S2 including
molecular mass (13.3 kDa) and secondary structure (α-helix)
were confirmed by using mass spectrometry and circular
dichroism spectroscopy, respectively. Surface activity of D4S2
was evidenced as it substantially lowered the dynamic interfacial
tension of freshly formed Miglyol 812 oil droplet upon
interfacial adsorption. Thin film of D4S2 demonstrated stability
against rupture when compressed at increasing pressure likely
due to high electrostatic repulsion of D4S2 at the pH that
imparted mechanical resistance to the film. Finally, D4S2 was
shown able to facilitate formation and stabilization of
nanoemulsions through its surface-active module and, upon
addition of silica precursor tetraethoxysilane (TEOS), direct
nucleation and growth of a silica layer encasing the nano-
emulsion core through its biosilicification-active module under
near-neutral pH and ambient temperature without using any
toxic organic solvents. The present work provides an
environmentally friendly approach to synthesize biocompatible
oil-core silica-shell nanocapsules using a recombinant catalytic
modular protein (ReCaMoP) offering the advantages of
sustainable and scalable bioproduction, suitable for use as
controlled-release nanocarrier of various actives in biomedical
and agricultural fields.
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Figure 6. Dependence of number-averaged diameter (dn, ●) and the
corresponding dispersity (Đ, ○) of emulsion droplets formed at
various concentration of D4S2 in HEPES buffer (25 mM, pH 7.5) as
determined by using dynamic light scattering (DLS).
Figure 7. Silica nanocapsules formed after reaction of nanoemulsions
stabilized by D4S2 (1.53 mg/mL) with TEOS (32 μmol) in HEPES
buffer (25 mM) at pH 7.5 and room temperature for 20 h. (a)
Transmission electron microscopy (TEM) image of the silica
nanocapsules (scale bar is 200 nm). (b) Dynamic light scattering
(DLS) showing size distribution profiles of the silica nanocapsules.
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EXPERIMENTAL SECTION 
Analytical methods. Qualitative analysis of protein was performed using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples (15 μL) were mixed 
with 5× sample buffer (3 μL) (225 mM Tris–HCl pH 6.8, 50 v/v% glycerol, 173 mM SDS, 0.746 
mM bromophenol blue, 250 mM dithiothreitol), heated to 95 °C for 5 min, and then filled into 
the NuPAGE® 4–12% Bis-Tris gels (Life Technologies, Australia). Novex® sharp pre-stained 
protein standard was used as a marker. Then, electrophoresis was performed using a Bio-Rad 
XCell 3 system (Bio-Rad, CA, USA) at 200 V for 35 min. Following electrophoresis, the gel was 
stained in staining buffer (45 v/v% methanol, 45 v/v% water, 10 v/v% acetic acid, 2.4 mM 
coomassie brilliant blue R-250) for 1 h. Subsequently, the gel was destained in destaining buffer 
(45 v/v% methanol, 45 v/v% water, 10 v/v% acetic acid) for 1 h, incubated overnight in water, 
and imaged with a ChemiDocTM MP Imaging System (Bio-Rad, CA, USA). 
DNA concentrations in D4S2 protein samples were determined by fluorescence measurement 
using Infinite® M200 Pro plate reader (Tecan, Switzerland). SYBR® Safe (Life Technologies, 
Australia) was used as the fluorescent dye. It is a cyanine-based dye having cationic core 
structure with N-n-propyl on the quinolinium ring system.1 The binding modes of the dye and 
DNA are by intercalation of the dye into the base pair stack at the core of the DNA, and by 
insertion of the dye into the minor groove of the DNA.2 For DNA quantitation, each solution 
(standards, sample and blank) was prepared in a volume of 100 μL in a 96-well plate with flat 
bottom and white polystyrol (Greiner Bio-One, Germany). Subsequently, a 100 μL SYBR® Safe 
(available commercially in concentration of 10 000×) with concentration of 1× was added into 
each individual well. The plate was then incubated for 5 min in a dark room at room temperature, 
followed by fluorescence measurement at excitation and emission wavelengths of 502 nm and 
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530 nm, respectively. As standard DNA, plasmid pET-48b(+) with inserted D4S2 nucleotide 
sequence (Protein Expression Facility, University of Queensland) was used. It was obtained after 
transformation in E. coli XL1-Blue competent cells (Novagen, Merck KGaA, Germany). 
Extraction and purification of the DNA was performed using PureLink™ Quick Plasmid 
Miniprep Kit (Invitrogen, CA, USA) following instructions from the manufacturer. Existence of 
the pure plasmid DNA was confirmed by A260/A280 ratio value of 1.8 as measured by UV 
absorbance at 260 nm using NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, DE, 
USA). A serial dilution of pre-determined concentration of the standard DNA (0–50 ng/mL) was 
used, and the mean fluorescence intensity across a duplicate for each concentration of the DNA 
was corrected by subtracting the fluorescence intensity of the blank (i.e., the relative fluorescent 
units (RFU)) to construct a calibration curve (i.e., relationship of RFU to concentration) having a 
regression linear of y = 822.5x + 1500 and a coefficient of determination (R2) of 0.9948. DNA 
concentration in a protein sample can then be calculated by inserting its RFU into the regression 
linear equation. 
Recombinant DNA transformation. Plasmid pET-48b(+) with nucleotide sequence 
encoding for D4S2 protein (1 μL) (Protein Expression Facility, The University of Queensland) 
was added into E. coli BL21(DE3) competent cells (50 μL) (Novagen, Merck KGaA, Germany) 
and incubated on ice for 30 min, heat-shocked at 42 °C for 45 s, and incubated on ice for further 
2 min. Then, 0.95 mL Luria Bertani (LB) medium (10 g/L NaCl, 10 g/L tryptone, 5 g/L yeast 
extract, water) was added into the cell suspension and incubated at 37 °C, 220 rpm for 1 h. The 
cell suspension (100 μL) was plated on LB agar (10 g/L NaCl, 10 g/L tryptone, 5 g/L yeast 
extract, 15 g/L agar, water) and incubated at 37 °C, 180 rpm for 16 h. Following transformation, 
a single colony was picked from the plate, placed in 5 mL 2× yeast extract and tryptone (2YT) 
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medium (5 g/L NaCl, 16 g/L tryptone, 10 g/L yeast extract, water), and incubated at 37 °C, 180 
rpm for 16 h. The LB agar and 2YT media were supplemented with 15 μg/mL antibiotic (i.e., 
kanamycin sulfate) (Life Technologies, CA, USA). To preserve the clones, the overnight culture 
(0.5 mL) and 60 v/v% glycerol (0.5 mL) were mixed well, frozen in liquid nitrogen, and stored at 
–80 °C for later use. 
Protein expression. A single colony from a freshly streaked plate was inoculated into 5 mL 
2YT medium and incubated at 30 °C, 180 rpm for 16 h. After overnight culture, an optical 
density at a wavelength of 600 nm (OD600) was obtained at approximately 2 by using UV-visible 
spectrophotometer (UV-2450) (Shimadzu, Japan). 2YT medium (800 mL) was inoculated with 
800 μL of the overnight culture in a 2.5 L-baffled shake flask and incubated at 37 °C, 180 rpm 
until OD600 reached approximately 0.5. Protein expression was induced by adding isopropyl β-D-
1-thiogalactopyranoside (IPTG) (Astral Scientific, Australia) to a final concentration of 1 mM, 
and then incubated at 37 °C, 180 rpm for a further 4 h. A final OD600 of approximately 2 was 
routinely obtained. Cell pellet was harvested by centrifugation at 4 °C, 6250 ×g for 10 min, 
washed with the supernatant (40 mL) and then centrifuged at 4 °C, 4700 ×g for 10 min. The cell 
pellet was stored at –80 °C until further processing. All media for cultures were supplemented 
with 15 μg/mL kanamycin sulfate. 
Protein purification. To purify D4S2 protein from E. coli, a precipitation-based process i.e., 
heating/cell lysis, contaminant precipitation, and dilute precipitation (Figure S1) was conducted 
based on intensified purification process of DAMP4.3  
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Figure S1. Block flow diagram of precipitation-based purification process of D4S2.  
Initial heating/cell lysis and contaminant precipitation tests: To determine optimum 
concentration of Na2SO4 precipitating cellular protein contaminants, initial heating/cell lysis and 
contaminant precipitation tests were performed on cell pellet containing expressed D4S2. The 
cell pellet was re-suspended in 80 mL buffer (25 mM sodium phosphate, 1.2 M NaCl, pH 7.5), 
and five samples of 500 µL were taken. To one of these samples, 500 µL of water was added and 
used as the reference for soluble and insoluble cell contents. To the remaining four samples, 
Na2SO4 solution was added to achieve Na2SO4 concentrations of 0.3 M, 0.5 M, 0.8 M, and 1 M, 
respectively, with a final volume of 1 mL in each. All samples were heated in a heating block 
(model DBH20D, Ratek Instruments, Australia) at 90 °C for 30 min, and then centrifuged. SDS-
PAGE was performed to qualitatively analyze the supernatant and the pellet fractions which 
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were denoted as soluble protein and insoluble cell content, respectively. The SDS-PAGE result 
(Figure S2) showed that heating/cell lysis and contaminant precipitation using 1 M Na2SO4, at 90 
°C for 30 min yield more pure D4S2 protein as indicated by a clearer background on the gel 
(Figure S2, lane 9) than using lower Na2SO4 concentrations at the same incubation temperature 
and time period (Figure S2, lanes 3, 5, and 7). Therefore, Na2SO4 with a concentration of 1 M 
was used in the lysis buffer for future process of heating/cell lysis and contaminant precipitation. 
 
Figure S2. SDS-PAGE analysis after initial test of heating/cell lysis and contaminant 
precipitation using different Na2SO4 concentrations at 90 °C for 30 min. (Lane 1) Soluble protein 
and (Lane 2) insoluble cell content in the absence of Na2SO4; (Lane 3) Soluble protein and (Lane 
4) insoluble cell content at 0.3 M Na2SO4; (Lane 5) Soluble protein and (Lane 6) insoluble cell 
content at 0.5 M Na2SO4; (Lane 7) Soluble protein and (Lane 8) insoluble cell content at 0.8 M 
Na2SO4; (Lane 9) Soluble protein and (Lane 10) insoluble cell content at 1 M Na2SO4; (Lane 11) 
Novex® sharp pre-stain protein standard. 
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Heating/cell lysis, contaminant precipitation, and dilute precipitation: The cell pellet was re-
suspended in 80 mL lysis buffer (25 mM sodium phosphate, 1.2 M NaCl, 1 M Na2SO4, pH 7.5). 
The mixture was transferred into a 250 mL-conical flask and then incubated at 90 °C with 
stirring at 1000 rpm for 30 min in a thermostatic bath equipped with an electronic contact 
thermometer (IKA®-Werke GmbH & Co. KG, Germany). During the heating, the opening of the 
flask and the bath were covered with aluminium foil to minimize evaporation. The cell lysate 
was then centrifuged at 20 °C, 51500 ×g for 5 min. The supernatant was collected and diluted 5-
fold with water, and pH was adjusted to pH 3.5 by adding 10 N HCl to allow precipitation of 
D4S2 protein. Then, the mixture was centrifuged at 4 °C, 33750 ×g for 30 min. The precipitated 
sample was re-suspended in equilibrium buffer (25 mM sodium phosphate, 1.2 M NaCl, 20 mM 
imidazole, pH 7.5) and solubilized by adjusting the pH to pH > 10 using 5 N NaOH. Further 
purification was conducted to remove DNA contaminant (Table S1) by applying 
chromatography-based purification process (Figure S3). 
Table S1. Mass balance of the purification processes of D4S2. 
Process D4S2 conc.a  
(mg/mL) 
Volume 
(mL) 
D4S2 yield 
(mg) 
DNA conc. 
(ng/mg D4S2) 
Heating/cell lysis and 
contaminant precipitation 
0.26 140.0 36.40 1261 ± 38 
Dilute precipitation 0.56 22.0 12.32 63.18 ± 6.14 
Filtration 0.61 20.1 12.26 62.87 ± 5.62 
IMAC 0.66 14.0 9.24 1.90 ± 0.48 
Desalting 0.38 19.0 7.22 1.82 ± 0.46 
aD4S2 concentration was determined by reversed-phase high-performance liquid 
chromatography (RP-HPLC), except for D4S2 protein obtained after heating/cell lysis and 
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contaminant precipitation in which the concentration was measured by SDS-PAGE semi 
quantitation using ImageJ software.4 
 
 
Figure S3. Block flow diagram of chromatography-based purification process following the 
precipitation-based process to obtain high purity D4S2 protein. 
Chromatography: Immobilized-metal affinity chromatography (IMAC) was conducted by 
using an ÄKTA Explorer 10 system (GE Healthcare, Sweden) with Ni2+ charged IMAC 
Sepharose High Performance resin (GE Healthcare, UK) packed into a 15 mm diameter Omnifit 
glass column (Omnifit, NJ, USA) to a bed height of 75 mm which is equivalent to 5.5 mL 
column volume (CV). Prior to loading, the protein solution from a previous process was filtered 
using a 0.45 μm syringe filter with MF-Millipore® mixed cellulose ester membrane (Millipore, 
Australia), and the column was equilibrated with 3 CV of equilibrium buffer (25 mM sodium 
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phosphate, 1.2 M NaCl, 20 mM imidazole, pH 7.5). The protein solution was then loaded into 
the column at a flow rate of 1 mL/min, and set wavelengths of 280 nm and 260 nm to detect the 
presence of protein and DNA, respectively. Unbound components including DNAs as indicated 
by higher UV absorbance at 260 nm than at 280 nm were passed-through the column and then 
washed out with 2 CV of equilibrium buffer. Bound protein was then eluted using 2.5 CV of 
elution buffer (25 mM sodium phosphate, 1.2 M NaCl, 500 mM imidazole, pH 7.5) (Figure S4a). 
The flow-through fraction (Figure 1, lane 5) and wash fraction (Figure 1, lane 6) did not contain 
D4S2 protein, whereas the eluted fraction was mainly D4S2 protein (Figure 1, lane 7) based on 
the SDS-PAGE analysis. After the IMAC process, concentration of DNA in the eluted fraction 
was reduced significantly by 97% to 1.90 ± 0.48 ng DNA/mg D4S2 (Table S1). To chelate Ni2+ 
ions that might be leaked and bound to histidine (H) residues within D4S2 after the IMAC 
process, the pH of the collected fractions was adjusted to pH 5.8 by adding 10 N HCl to 
protonate the histidine (H) residues, and a chelating agent ethylenediaminetetraacetic acid 
disodium salt (EDTA) was added to a final concentration of 20 mM. Then, desalting of the 
protein solution with water was conducted by using an ÄKTA Explorer 10 system with a 
Sephadex G-25 resin (GE Healthcare, UK) packed into a 20 mm diameter Omnifit glass column 
to a bed height of 129 mm (CV = 22.8 mL). The protein solution was loaded into the column 
pre-equilibrated with water at a flow rate of 1 mL/min and a set wavelength of 280 nm coupled 
with a conductivity detector. The protein fraction after the desalting process was collected 
(Figure S4b) and lyophilized at –55°C, 0.08 mbar for 16 h. After the desalting process, the DNA 
fraction in D4S2 protein solution was 1.82 ± 0.46 ng DNA/mg D4S2 with a final yield of D4S2 
protein of approximately 7.22 mg (Table S1). 
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Figure S4. Representative chromatography profiles to obtain high purity of D4S2 protein. (a) 
Immobilized-metal affinity chromatography (IMAC). (b) Desalting chromatography. 
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Chapter 6 
 
Large-scale production of fipronil-encapsulated silica 
nanocapsules for termite field trial 
 
 
Abstract 
 
Development of the bifunctional modular protein, D4S2, for making oil-core silica-shell nanocapsules 
as described in Chapter 5 provided an opportunity for sustainable and cost-effective production of 
the protein via microbial cell-factory Escherichia coli. In this chapter, D4S2 was produced at 
approximately 1.4 g using the biological expression and purification methods developed in Chapter 
5. Prior to the emulsification using D4S2, fipronil (≈0.9 g) was dissolved in Miglyol® 812 oil at a 
concentration of 10 mg/mL. D4S2 (1.53 mg/mL) was used to emulsify the fipronil-loaded oil (10 
v/v%), and the resulted nanoemulsions were reacted with silica precursor tetraethoxysilane to form 
fipronil-encapsulated silica nanocapsules. The silica nanocapsules could then be used in 
combination with α-cellulose as feeding baits for termite field trial. The feeding baits placed in 
treatment-units were attached separately in mounds of termite Coptotermes lacteus. The activities 
of foraging worker termites toward the baits were examined. As the field trial entered the six week 
after treatment-units installation and is still on-going, this chapter presents preliminary results 
indicated that the termites responded well to the treated baits as they readily removed the baits from 
the treatment-units within three weeks of treatments, providing a chance that the baits would be 
transmitted to other termites within the mounds through horizontal transfer which could then lead to 
potential elimination of the termite colonies.   
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6.1 Introduction 
 
Termites are prevalent in tropical and subtropical environments where they assist in breaking down 
and recycling dead plant materials [1]. However, some termite species become pests when they 
feed on any plant materials and structural lumber causing substantial crop losses and building 
damages, hence economic losses [2]. In Australia only, an estimated 130,000 new infestations in 
houses are reported each year, and the average cost of rectification of termite-damaged properties 
is in excess of AU$7,000 per house [3]. The worldwide annual control and repair cost were estimated 
at US$40 billion in 2010 with subterranean termites accounting for approximately 80% of the costs 
[4]. Therefore, controlling termite pest populations are urgently important as to control global 
economic impact caused by the termite infestations. 
 
Preventative treatments against termite infestations have been conducted using chemical soil 
barriers [5, 6], in which an insecticide is applied to the soil forming an insecticide-treated layer of soil 
surrounding and under buildings [7]. Cyclodienes, including chlordane, heptachlor, aldrin and 
dieldrin, were used as the main active ingredients of the insecticides [8]. However, cyclodienes were 
withdrawn from the market due to increasing environmental and public-health concerns, primarily in 
relation to their persistence in the environment and their tendency to accumulate in the fat of animals 
and humans [9]. Insecticides used for termite control must undergo a rigorous approval and 
registration processes, including an assessment for possible effects on human health and the 
environment. In Australia, for example, use of insecticides is authorized by Australian Pesticides and 
Veterinary Medicines Authority (APVMA). Currently, several insecticides for termite control have 
been formulated as alternatives to the cyclodienes and approved for use under different commercial 
brands [9]. Various main active ingredients can be collectively classified based on their particular 
chemical structure, including pyrethroids (e.g., alpha-cypermethrin, permethrin, bifenthrin, 
deltamethrin), organophosphates (e.g., chlorpyrifos), neonicotinoid (e.g., imidacloprid), and 
phenylpyrazole (e.g., fipronil). These insecticides are less persistent than the cyclodienes, as they 
have shorter lifetime which can break down relatively quickly [9], and thus their periodic applications 
on the soils are necessary to provide long-term protection against termites [10]. Consequently, this 
action could cause enormous waste of the active molecules and allows non-target organisms, 
householders and pest control operators to be frequently exposed to the chemicals [5, 9]. Therefore, 
there has been an increasing emphasis in formulation development and application methods for the 
remedial treatments [11].  
 
Baiting technologies offer an alternative way for treating subterranean termites [4, 12, 13]. Several 
insecticides have been used in baiting systems including chitin synthesis inhibitor (e.g., 
hexaflumuron [14], chlorfluazuron [15, 16], noviflumuron [17], and diflubenzuron [16]), avermectins 
(e.g., ivermectin [18]), and phenylpyrazole (e.g., fipronil [19]). The methods have a number of 
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advantages as compared to the chemical soil barriers aforementioned: (1) baiting uses small 
amounts of active molecules that are administered in localized sites [10, 12, 20-22]; (2) active 
molecules are contained in a food matrix, e.g., paper, cardboard [23], wooden blocks [14, 23-25], 
cellulose powders [15], and straw pulp and white sugar [19]; (3) baits are usually confined within an 
impervious bait station; and (4) any remaining baiting materials can be removed and properly 
disposed after the control actions have been completed [26]. Termite control using baiting 
technologies exploits termite eusociality to deliver the insecticide from the site where it is applied to 
the sites where the termites live in colonies [27]. Termites live in complex societies and engage in 
constant, close-contact interactions with each other within the colonies. These interactions include 
mutual grooming, cooperative nest construction, larval care, and trophallaxis in which foraging 
worker termites feed other termites that do not or cannot forage on their own including larvae, 
reproductive, and soldier termites [28]. Ideally, when termites forage in insecticide-treated areas, 
they acquire and carry the insecticide, and inadvertently share it with their nestmates during 
grooming, trophallaxis or both (i.e., horizontal transfer). Subsequently, the horizontal transfer results 
in mortality at a situation where a lethal dose of the insecticide is transferred from the exposed donor 
termites to an unexposed recipient termite, and the insecticide is then consumed by the recipient 
termites. This horizontal transfer could cause colony elimination [26, 29], which is a strategy 
commonly being exploited for an effective termite control [30].  
 
In recent years, nanotechnology has been developed to manufacture nanocarrier systems for the 
encapsulation and delivery of insecticides [31-37]. The benefits of using such nanocarriers include: 
(1) protection of the insecticides from premature decomposition and loss; (2) enhancement of 
bioavailability especially for hydrophobic insecticides; and (3) delivery of high amounts of insecticides 
in a sustained manner. As mentioned in Chapter 1, some nanomaterials could possibly exert toxicity 
in the environment depending on many factors, e.g., chemical compositions, physical properties, 
exposure routes and doses [38, 39]. In order to minimize the risks of nanomaterials in the 
environment, it is imperative to ensure the development of nanomaterials through responsible 
nanomanufacturing practices, including minimizing the use of toxic chemicals and using benign 
conditions for the synthesis of nanomaterials [40, 41]. Previous chapters of this thesis have 
demonstrated the development of oil-core silica-shell nanocapsules in environmentally friendly 
conditions without using toxic organic solvents (Chapters 3–5). In the context of termite control, 
Chapter 4 has investigated the use of the silica nanocapsules as biocompatible nanocarriers of 
fipronil insecticide in a combination with α-cellulose as the feeding baits against termites. Orphaned 
colonies of ≈1500 termites comprising workers and soldiers were placed in a container. To deliver 
fipronil to the colonies, the fipronil-encapsulated silica nanocapsules were mixed with α-cellulose 
and then used as feeding baits which were connected to the container via a clear tube. The results 
proved that the treated baits could be taken up by foraging workers and brought back to the 
container. Eventually, the termite colonies were eliminated, probably through horizontal transfer of 
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the treated baits within the colonies, in 6 days after the applications, while the control group using 
water-treated baits showed negligible termite mortality during the 8 days of the tests.  
 
Although it has been established that fipronil-encapsulated silica nanocapsules mixed with cellulosic 
bait matrices can be used to eliminate termite colonies as demonstrated in Chapter 4, there is a 
need to implement termite controls at their natural feeding-sites. Termite species that build epigeal 
mounds, e.g., Coptotermes lacteus (C. lacteus) [42], can be useful for examining the efficacy of 
fipronil-encapsulated silica nanocapsules under field conditions due to easy access to their mounds. 
The mounds are characterized by an outer earthen wall enclosing a dense woody mass moulded to 
form an intricate system of galleries [42] containing all castes and stages of termites, including the 
reproductive, eggs and larvae, soldiers, and workers [25]. Number of termites in a mound was 
estimated around two millions or more [43]. In this chapter, the designed bifunctional modular 
protein, D4S2, developed in Chapter 5 is used for making fipronil-encapsulated silica nanocapsules. 
This study aims to demonstrate large-scale production of D4S2 protein (≈1.4 g) for making silica 
nanocapsules encapsulated fipronil (≈0.9 g) which could then be used for termite field trial on three 
C. lacteus mounds in tropical northern Queensland, Australia. The activities of foraging worker 
termite to remove the treated baits and bring the baits back to their mounds were examined. 
 
6.2 Materials and Methods 
 
6.2.1 Materials 
 
Miglyol® 812 purchased from AXO Industry S.A. (Wavre, Belgium) was passed through heat-
activated silica gel (Sigma-Aldrich) prior to use. Fipronil in a form of powder was obtained from 
Gulmohar Pty. Ltd. (Australia). Water with >18.2 M cm resistivity was obtained from a Milli-Q 
system with a 0.22 μm filter (Millipore, Australia). Other chemicals were of analytical grade 
purchased from either Sigma-Aldrich or Merck and used as received unless otherwise stated. 
 
6.2.2 Production of bifunctional modular protein  
 
6.2.2.1. Protein expression and purification 
 
Expression of the bifunctional modular protein, D4S2, in Escherichia coli (E. coli) BL21(DE3) and 
subsequent purification were conducted according to the methods described in Chapter 5 and briefly 
explained as follows. 
 
Expression: A single colony of E. coli containing plasmid DNA, pET-48(+), with inserted nucleotide 
sequence encoded for D4S2 protein was selected from a freshly-streaked plate and then inoculated 
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into 5 mL 2x yeast extract and tryptone (2YT) medium (5 g/L NaCl, 16 g/L tryptone, 10 g/L yeast 
extract, water) and incubated at 30 °C, 180 rpm for 16 h. Main culture of 800 mL was inoculated with 
800 μL of overnight culture and incubated at 37 °C, 180 rpm. When the OD600 reached approximately 
0.5, isopropyl β-D-1-thiogalactopyranoside (IPTG) (Astral Scientific, Australia) was added to the 
culture to a final concentration of 1 mM, and then incubated at 37 °C, 180 rpm for a further 4 h. A 
final OD600 of approximately 2 was routinely obtained. Cell pellet was harvested by centrifugation at 
4 °C, 6250 xg for 10 min, washed with the supernatant (40 mL) and then centrifuged at 4 °C, 4700 
xg for 10 min. The cell-pellet was collected and stored at –80 °C until further processing. All media 
for cultures were supplemented with 15 μg/mL kanamycin sulfate (Life Technologies, CA, USA). 
 
Purification: To recover D4S2, two cell-pellets were re-suspended and combined in 160 mL lysis 
buffer (25 mM sodium phosphate, 1.2 M NaCl, 1 M Na2SO4, pH 7.5). The mixture was transferred 
into a 250 mL-conical flask and then incubated at 90 °C with stirring at 1000 rpm for 30 min. The cell 
lysate was then centrifuged at 20 °C, 51500 xg for 5 min. The supernatant was collected and diluted 
5-fold with water, and pH was adjusted to pH 3.5 by adding 10 N HCl to allow precipitation of D4S2 
protein. Then, the mixture was centrifuged at 4 °C, 33750 xg for 30 min. The precipitated sample 
was re-suspended in equilibrium buffer (25 mM sodium phosphate, 1.2 M NaCl, 20 mM imidazole, 
pH 7.5) and solubilized by adjusting the pH to pH > 10 using 5 N NaOH.  
 
To remove DNA contaminations, the protein solution was purified through immobilized-metal affinity 
chromatography (IMAC). Prior to loading, the solution was filtered using a 0.45 μm syringe filter with 
MF-Millipore® mixed cellulose ester membrane (Millipore, Australia). The filtered solution was then 
loaded into IMAC column (Ni2+ charged IMAC Sepharose High Performance resin, GE Healthcare, 
UK) pre-equilibrated with 3 column volumes (CV) of equilibrium buffer (25 mM sodium phosphate, 
1.2 M NaCl, 20 mM imidazole, pH 7.5) at a flow-rate of 1 mL/min. The column was washed with 2 
CV of equilibrium buffer to remove unbound contaminants before the purified D4S2 was eluted with 
3 CV of elution buffer (25 mM sodium phosphate, 1.2 M NaCl, 500 mM imidazole, pH 7.5). The pH 
of the collected fractions was adjusted to pH 5.8 by adding 10 N HCl and ethylenediaminetetraacetic 
acid disodium salt (EDTA) was added to a final concentration of 20 mM in order to chelate Ni2+ ions 
that might be leaked and bound to histidine residues within D4S2 after the IMAC process.  
 
Following IMAC process, desalting chromatography of the protein solution was conducted using a 
Sephadex G-25 resin (GE Healthcare, UK). The protein solution was loaded into the column pre-
equilibrated with water at a flow rate of 1 mL/min. The protein fraction after the desalting process 
was collected and lyophilized at –55°C, 0.08 mbar for 16 h.  
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6.2.2.2 Protein analysis 
 
Qualitative analysis of D4S2 and measurement of D4S2 concentration were conducted by using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and reversed-phase high 
performance liquid chromatography (RP-HPLC), respectively. SDS-PAGE was performed using 
NuPAGE Bis-Tris 4–12% gels (Invitrogen), and Novex® sharp pre-stained ladder, using standard 
methods and staining. RP-HPLC equipped with a Jupiter C18 column (5 μm, 300 Å, 150 mm x 4.6 
mm) (Phenomenex, CA, USA) and connected to an LC-10AVP series HPLC system (Shimadzu, 
Japan) was used. Buffer A was 0.1 v/v% trifluoroacetic acid (TFA) in water, and buffer B was 90 
v/v% acetonitrile and 0.1 v/v% TFA in water. Gradient conditions applied in the analysis were from 
30 to 65% of buffer B in 35 min at a flow rate of 1 mL/min and a set detection wavelength of 214 nm. 
 
6.2.3 Synthesis and characterization of fipronil-encapsulated silica nanocapsules 
 
6.2.3.1 Synthesis 
 
Lyophilized D4S2 protein was dissolved in HEPES buffer (25 mM, pH 7.5) to prepare D4S2 solutions 
having a concentration of 1.53 mg/mL. Miglyol® 812 was added to the D4S2 solutions (3 mL) with 
an oil fraction of 10 v/v%, and homogenized using a Branson Sonifier 450 ultrasonicator for four 30 
s bursts at 20 W and interspersed in an ice bath for 60 s. The emulsification was repeated and the 
resulting nanoemulsions were combined to obtain a total of 900 mL nanoemulsion. The 
nanoemulsion (50 mL) was transferred into a beaker glass containing silica precursor 
tetraethoxysilane (TEOS, 96 μmol). Biosilicification reaction of the nanoemulsion with TEOS was 
conducted under magnetic stirring at room temperature for 20 h. The suspension of fipronil-
encapsulated silica nanocapsules was washed three times with water by centrifugation at 4 °C, 4500 
xg for 10 min, and the pellet was kept at 4 °C. Prior to the field trial, the pellet was re-suspended with 
water through sonication and subjected to characterization for quality control. 
 
6.2.3.2 Characterization 
 
Size distribution was determined by dynamic light scattering (DLS) using Malvern Zetasizer Nano 
ZS (Malvern Instrument, UK) at a scattering angle of 173° and a temperature of 25 °C. Samples 
were diluted by a factor of 100 prior to measurement to avoid multiple scattering effects.  
 
Morphology of the silica nanocapsules was visualized by transmission electron microscopy (TEM) 
using a JEOL 1010 (JEOL, Japan) operated at 100 kV. Samples (2 µL) were deposited onto 
Formvar-coated copper grids (ProSciTech, Australia). Size of the nanocapsules was analyzed by 
using iTEM software (version 3.2, Soft Imaging System GmbH).  
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6.2.4 Field trial 
 
6.2.4.1 Field site 
 
The termite field trial was conducted in an area located near to Compartment 47, State Forest 589, 
Twins Logging Area at Beerburrum (26°58'S., 152°54'E.), south east Queensland, which contains 
C. lacteus mounds (epigeous nests).  
 
6.2.4.2 Initial field trial 
 
On the 17 October 2014, six C. lacteus mounds were selected for field trial. Prior to the field trial, 
feeding-bait stations were installed to the mounds, aiming to heighten consistency of termite 
acceptance to the baits. In each mound, two holes having a diameter of 25 mm were drilled, and 
then two feeding-bait stations were attached to the mound via these holes (Figure 1a). Each feeding 
station (Figure 1b) consisted of a rectangular plastic container filled with two sapwoods of pine (200 
g each), a corrugated cardboard, and lidless plastic vial (100 mL) containing moist α-cellulose baits 
(15 g dry α-cellulose and 35 g water). The container was drilled (25 mm) so that a plastic conduit 
(400 mm x 25 mm) can be attached through the container’s holes with the open end of the conduit 
closed (distal from the mound). The conduit was filled with moist corrugated cardboard (450 mm x 
15 mm). Then, the container was closed with lid and covered with a black plastic with the conduit 
protruding toward the mound. Inspections were conducted to the feeding-bait stations after two-week 
of installation. Live termites were found in most of the feeding stations and termite activity was 
noticed as the containers contained mud materials built by the termites (Figure 1c). 
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Figure 1. Photographic images describing initial field trial. a) Typical assembly of feeding-bait 
stations near termite mound. b) A typical container of a feeding-bait station consisted of two 
sapwoods, a plastic vial containing moist α-cellulose bait, and a plastic conduit sealed at distal end. 
The conduit had three drill-holes which allowed termites for entering the container. c) Inspection of 
the container after two weeks of installation of the feeding-bait station confirmed the presence of live 
termites and termite activity. 
 
6.2.4.3 Field assay and treatment-units installation 
 
From the six C. lacteus mounds aforementioned, three mounds were used for controls (Mounds 1–
3) and the other three mounds were for treatment (Mounds 4–6) with the fipronil-encapsulated silica 
nanocapsules (Section 6.2.3.1). With the treatment-mounds, two assay chambers labelled as 
treatment- and monitoring-unit were attached to each mound (Mounds 4–6) via drill-holes (25 mm) 
on the 27 November 2014. Each unit of the assay chambers consisted of a plastic conduit (500 mm 
x 25 mm) attached through the lid to a clear plastic vial (100 mL) and secured with glue. The conduit 
and vial were filled with corrugated cardboard and moist α-cellulose, respectively, and the vial was 
closed with lid and covered with a black plastic with the conduit protruding. The treatment-units 
contained treated moist α-cellulose baits (15 g dry α-cellulose and 35 g fipronil-encapsulated silica 
nanocapsules), while the monitoring-units contained untreated moist α-cellulose baits (15 g dry α-
cellulose and 35 g water). The untreated baits were replaced, as necessary, at each inspection to 
keep the termites feeding on the untreated baits. After the treatment-units installation, inspections to 
the assay chambers were conducted weekly. 
  
6.2.4.4 Monitoring colony health 
 
During the treatment, a hole (25 mm) was drilled into the side of each mound using a portable drill, 
and a plastic conduit (300 mm x 20 mm) was inserted about two-thirds of its length into the hole. A 
400 mm-long hardwood dowel was inserted into the conduit, in which fresh dowels were used at 
each inspection. The presence of termites, faecal mottling, and feeding on the dowel was used as 
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an indicator of an active colony. Commencing at the second inspection (10 December 2014), a hole 
(25 mm) was drilled into the side of each mound using a portable drill. The hole was left open, and 
repairs by the termites were noted at the next inspection indicating an active colony.  
 
A Termatrac®T3i (Termatrac® Pty. Ltd., Australia) was used during each inspection to detect 
movement of live termites in the plastic units attached to the treatment-mounds. A wooden platform 
was clipped to the plastic conduit to stabilize the T3i sensor unit.  
 
The temperature in the termite mounds was monitored to track colony health as healthy termite 
colonies maintain relatively constant temperature in their mounds [44-46]. Ten iButton temperature 
loggers (Thermochron DS1920) (Alfa-Tek Australia Pty. Ltd.) were used to monitor temperature 
variation at two locations i.e., inside and outside the mounds. An iButton was secured into a plastic 
conduit (300 mm x 25 mm) and inserted proximal to each of the 6 mounds, whereas the other four 
temperature loggers were affixed to trees near the mounds to measure ambient temperature. The 
iButtons were programmed to record temperature once an hour. 
 
6.3 Results and Discussion 
 
In this study, three mounds were used for the termite field trial. Amount of fipronil needed for termite 
elimination in one mound was estimated at approximately 300 mg [47], and thus a total of 900 mg 
was required to treat three termite mounds. It was known that solubility of fipronil in Miglyol® 812 oil 
used to make nanoemulsions was 10 mg/mL (Chapter 3), and as much as 1.53 mg/mL of D4S2 can 
be used to stabilize nanoemulsions having Miglyol® 812 oil fraction of 10 v/v% (Chapter 5). 
Therefore, to load 900 mg fipronil in D4S2-stabilized nanoemulsions having oil fraction of 10 v/v%, 
900 mL of nanoemulsion was required, with total D4S2 of approximately 1.4 g. The nanoemulsions 
can then be encapsulated with silica shell forming fipronil-encapsulated silica nanocapsules upon 
addition of silica precursor tetraethoxysilane. 
 
6.3.1 Large-scale preparation of fipronil-encapsulated silica nanocapsules 
 
Bifunctional modular protein, D4S2, was used in this study for making silica nanocapsules that 
encapsulated fipronil insecticide. D4S2 was produced through biological expression in E. coli, as 
developed in Chapter 5. The expression of D4S2 in E. coli was induced by adding isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 37 °C when optical density of the microbial culture at 600 nm (OD600) 
reached at approximately 0.5. After the expression at 37 °C for about 4 h (OD600 ≈ 2) (Figure 2, lane 
3), the E. coli cells containing D4S2 protein were harvested, washed, and stored in a form of cell 
pellets at –80 °C for further use.  
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Figure 2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) result for 
the expression of D4S2 protein in E. coli. (Lane 1) Novex® sharp pre-stain protein standard; (Lane 
2) total protein before induction; and (Lane 3) total protein after induction at 37 °C for 4 h. 
 
Two-step purification processes were conducted to obtain D4S2 with high purity. At the first 
purification step, D4S2 was recovered from the E. coli cell pellets by heating/cell lysis and 
contaminant precipitation, and dilute precipitation. The heating/cell lysis and contaminant 
precipitation was conducted by firstly re-suspending the cell pellet in lysis buffer (25 mM sodium 
phosphate buffer pH 7.5, 1.2 M NaCl, 1 M Na2SO4) and then heating the suspension at 90 °C under 
constant stirring for 30 min. The heating process disrupted the cell walls and released the 
intracellular proteins including D4S2 and other contaminants (e.g., DNA) into the bulk phase, while 
precipitated most of the proteins and cell debris except D4S2 that remained soluble as concentrated 
Na2SO4 salted-in the protein. Simple centrifugation step removed almost all protein contaminants 
(Figure 3, lane 1) and yielded supernatant solution containing most of the D4S2 protein with little 
contamination (Figure 3, lane 2). The supernatant solution was then diluted five times with water 
and adjusted the solution pH to 3.5 to precipitate D4S2 protein, as such a low Na2SO4 concentration 
was insufficient to salt-in D4S2, and separate most medial salts and DNA contaminants that 
remained in the supernatant solution. 
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Figure 3. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) result after 
precipitation-based purification and immobilized-metal affinity chromatography (IMAC) 
processes. (Lane 1) Re-suspended precipitate and (Lane 2) supernatant after heating/cell lysis and 
contaminant precipitation step; (Lane 3) Solubilized precipitate after dilute precipitation step; (Lane 
4) Passed-through fraction, (Lane 5) washed fraction and (Lane 6) eluted fraction after IMAC 
process; (Lane 7) Desalted D4S2; (Lane 7) Novex® sharp pre-stain protein standard. 
 
At the second purification step, immobilized-metal affinity chromatography (IMAC) and desalting 
chromatography were conducted to obtain high purity of D4S2 (Figure 4). The precipitated sample 
was re-suspended in equilibrium buffer (25 mM sodium phosphate, 1.2 M NaCl, 20 mM imidazole, 
pH 7.5) and solubilized by adjusting the pH to pH > 10 using 5 N NaOH (Figure 3, lane 3). The 
solubilized sample was filtered and then loaded into the IMAC column (Figure 4a). During loading, 
D4S2 bound to the column through its histidine residues, and other unbound materials including 
DNA were passed through the column (Figure 3, lane 4). The column containing bound D4S2 was 
washed with 3 column volume (equivalent to 16.5 mL) of the equilibrium buffer to further remove 
unbound materials from the column (Figure 3, lane 5). D4S2 can then be eluted from the column 
using elution buffer containing high concentration of imidazole (25 mM sodium phosphate, 1.2 M 
NaCl, 500 mM imidazole, pH 7.5) (Figure 3, lane 6). To remove salts in the eluted fractions of the 
IMAC, desalting chromatography using G-25 column was used (Figure 4b). After the desalting 
process, a final yield of D4S2 protein of approximately 7 mg with DNA concentration lower than 2 ng 
DNA/mg D4S2 was obtained (Figure 5).  
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Figure 4. Representative chromatography profiles of D4S2 purification. a) Immobilized-metal 
affinity chromatography. b) Desalting chromatography. 
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Figure 5. Characterization of D4S2 using reversed-phase high-performance liquid 
chromatography (RP-HPLC) showing high purity of D4S2. 
 
In this study, fipronil was dissolved in Miglyol® 812 at a concentration of 10 mg/mL (Figure 6). The 
fipronil-loaded oil (0.3 mL) was mixed with HEPES buffer (25 mM, pH 7.5) in the presence of D4S2 
protein (3 mL) via sonication, and the nanoemulsions were obtained due to the presence of the 
surface active module in the emulsifying protein (Figure 7). As much as 50 mL of the nanoemulsions 
were combined and then reacted with silica precursor tetraethoxysilane (TEOS) (96 μmol) to form 
silica shell encasing the nanoemulsion core at near-neutral pH and room temperature without using 
any toxic chemicals (Figures 7 and 8). The biosilicification process at the oil–water interfaces was 
due to the catalytic role of densely packed cationic arginine (R) and lysine (K) residues of 
biosilicification-active module as well as polar residues of surface-active module exposed toward the 
bulk aqueous solution that can induce hydrolysis of TEOS and interfacial polycondensation of the 
hydrolysis products. Morphology of the silica nanocapsules was visualized by using transmission 
electron microscopy (TEM) which showed a core–shell structure (Figure 8). The measured shell 
thickness, as determined by using TEM, of the silica nanocapsules was 57 ± 9 nm, while the outer 
diameter was 302 ± 16 nm. 
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Figure 6. Reversed-phase high-performance liquid chromatography (RP-HPLC) analysis of 
fipronil-saturated Miglyol® 812 oil that was mixed with acetonitrile 60 v/v%. Miglyol® 812 oil was 
saturated with fipronil, and the oil was then centrifuged. The collected supernatant (2 μL) was mixed 
with acetonitrile 60 v/v% (998 μL) until it became homogeneous and then loaded into RP-HPLC (C18 
column). Phosphoric acid 0.1 v/v% (A) and 90 v/v% acetonitrile, 0.1 v/v% phosphoric acid (B) were 
used as the mobile phases. A linear gradient from 50 to 70% B in 20 min at a flow rate of 1 mL/min 
was used with a monitoring wavelength set at 220 nm. 
 
 
 
 
Figure 7. Representative size distribution profiles of nanoemulsions and silica nanocapsules 
encapsulating fipronil insecticide as measured by using dynamic light scattering. Fipronil-
loaded nanoemulsions (-----) and fipronil-encapsulated silica nanocapsules (––––). 
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Figure 8. Representative transmission electron microscopy (TEM) image of fipronil-
encapsulated silica nanocapsules formed using bifunctional modular D4S2 protein. Scale bar 
is 200 nm. 
 
6.3.2 Termite field trial 
 
Three treatment-units containing the treated baits (i.e., mixture of α-cellulose and fipronil-
encapsulated silica nanocapsules) were placed separately and connected to three mounds (Mounds 
4–6) via plastic conduits. At the side of each treatment-unit, a monitoring-unit containing untreated 
bait was also installed. It is generally agreed that follow-up monitoring of a site is usually necessary 
to ensure that a baiting program is successful [48]. Therefore, termite activities were inspected 
weekly. 
 
At the first inspection (6 December 2014), live termites were seen in at least one unit in each mound. 
The termites were actively feeding on the baits in which ≤50% of the baits in each unit were 
consumed within 9 days. This was important as neither the conduits nor the vials appeared to 
be “sealed-off” from the mound suggesting that the termites responded well to the baits. 
 
At the second inspection (10 December 2014), termites were actively moving in plastic conduits 
attached to Mounds 4 and 6 as indicated by Termatrac device. Live termites were also observed in 
the treatment- and monitoring-units placed in these mounds. The baits in the two treatment-units 
and one monitoring-unit were almost completely consumed by the termites as minimum amount of 
the baits were noticed in the units. There was little additional bait removal in the remaining 
monitoring-unit. In Mound 5, termites were not active in plastic conduit as indicated by Termatrac 
device, but termites were found in the treatment- and monitoring-units. Additional bait removal from 
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both of the units (Mound 5) was minimal. Mud materials built by the termites were also visible at the 
inside of most units. To monitor colony activity inside the mounds, two holes (22 mm) were drilled 
into each mound, and a plastic conduit (300 mm x 20 mm) and a timber dowel (400 mm x 19 
mm) were inserted into one hole, while the other hole was left open.  
 
At the third inspection (15 December 2014), termites were active in both plastic conduits attached to 
Mounds 5 and 6, as indicated by Termatrac, and live termites were seen in the treatment-units. The 
drill-hole in the mounds was filled and the dowel secured suggesting that the termite colonies in the 
mounds were alive. In Mound 5, little additional bait was removed before the termites plugged the 
conduit. In Mound 4, termites were not active in either plastic conduit, as indicated by Termatrac, 
and there were no live termites observed in the treatment-unit. The drill-hole in the mound had not 
been filled but the dowel secured suggesting that the termite colonies were alive. New drill-holes 
were made in Mounds 4–6.  
 
The inspections were continued on weekly basis. At six week after installation of the treatment-units, 
all mounds with the treated baits (Mounds 4–6) contained active termite populations. Unlike 
laboratory experiments, many variables can affect the viability of a termite colony at the field site, 
including seasonal weather patterns, the number of alternative food sources available nearby the 
mound [49], presence of predation (e.g., ants [15]), population density or age of colony [50], and 
different castes of termites that have difference susceptibility on insecticide [51]. Due to these 
challenges and the cryptic lifestyle of subterranean termites [52], many baiting programme can take 
up to nine months (e.g., 3–9 months [14], 7 months [53], 3–7 months [54]). In our case, a consistently 
significant reduction in consumption of the treated baits from the treatment-units was observed 
during the six weeks of treatments which leaded to removal of the entire baits by the termites in 
Mounds 4 and 6 within three weeks of treatments, while most treated baits still remained in the 
treatment-units in Mound 5.  
 
6.4 Conclusion 
 
In this chapter, D4S2 was produced at approximately 1.4 g by biological expression in E. coli and 
then purified using precipitation- and chromatography-based purification processes. Prior to 
emulsification using D4S2, fipronil (≈0.9 g) was dissolved in Miglyol® 812 oil at a concentration of 10 
mg/mL. D4S2 (1.53 mg/mL) was then used to emulsify the fipronil-loaded oil (10 v/v%), and the 
resulted nanoemulsions were reacted with silica precursor tetraethoxysilane to form fipronil-
encapsulated silica nanocapsules having outer diameter of 302 ± 16 nm and shell thickness of 57 ± 
9 nm. In termite field trial, the nanocapsules were mixed with α-cellulose baits placed in three 
treatment-units, in which the units were then attached separately to three mounds of termite C. 
lacteus in northern Queensland, Australia. At three week of the treatments, the result showed that 
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the treated baits were removed by the termites from the treatment-units, with no evidence of 
repellence. At six week of the treatments, the termite colonies in the three mounds are still alive, thus 
the field trial was continued and is still on-going. The time required for elimination of the colonies 
would be difficult to be predicted as it relies on the seasonal weather patterns, the number of 
alternative food sources available nearby the mound, presence of predation, population density or 
age of colony, and different castes of termites that have difference susceptibility on the insecticide. 
Nevertheless, the preliminary result indicated that the termites responded well to the treated baits as 
they readily removed the baits from the treatment-units within three weeks of treatments, providing a 
chance that the baits would be transmitted to other termites within the mounds through horizontal 
transfer which could then lead to potential elimination of the termite colonies. 
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Chapter 7 
 
Conclusions and future work 
 
 
This thesis aims to discover and develop new methods and knowledge for the manufacture of 
biocompatible oil-core silica-shell nanocapsules. The novelty of the approach developed in this 
thesis is to design bifunctional modular biomolecules (i.e., peptide and protein), in lieu of 
conventional chemical surfactants, which are designed at the amino-acid level to contain surface-
active module and biosilicification-active module. The modular design has enabled an 
environmentally-friendly (i.e., near-neutral pH, ambient temperature and pressure without using any 
of toxic organic solvents), sustainable and scalable approach for the synthesis of silica 
nanocapsules. This thesis also demonstrates the application of the silica nanocapsules for 
encapsulation and release of fipronil insecticide in a controlled manner in the context of termite 
control.  
 
7.1 Summary of research findings 
 
Through various strategies in biomimetic silicification, researchers have found ways to transfer the 
biological principles into synthetic processes to invent biomimetic approaches for the synthesis of 
silica-based nanomaterials under benign conditions. The use of biomolecules has the advantages 
of high biodegradability as well as a likely high biocompatibility. An additional advantage of using 
biomolecules is the ability to be produced renewably at large scale and relatively low cost using 
microbial cell-factory Escherichia coli (E. coli) [1, 2].  
 
Silica-based nanomaterials having various morphologies have been fabricated based on the self-
assembly of peptides in bulk aqueous solutions and at solid–liquid interface [3-5] (Figure 1). Yet, 
there is no current biomimetic approaches for making silica nanocapsules having oil-core silica-shell 
morphology. Although there is a number of peptides that are able to facilitate formation and 
stabilization of oil-in-water (O/W) nanoemulsions [6], they have never been demonstrated capable 
of inducing formation of silica at the oil–water interfaces.  
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Figure 1. Applications of biosilicification of biomolecules. Solid lines represent the flow of 
research that has been conducted to date from biosilicification of biomolecules in bulk aqueous 
solution (to yield silica nanotubes [7-9], silica nanoparticles [10-12], silica hexagonal plate [13]) and 
at solid–liquid interface (to yield silica coated silver nanoparticles [14] and silica nanospheres on 
holograms [15]). Dashed lines represent researches that have not been done prior to this PhD thesis. 
 
Figure 1 indicates a missing link of the biosilicification of biomolecules at liquid–liquid interface. This 
PhD thesis is aimed to bridge this gap, by designing bifunctional modular biomolecules comprising 
of surface-active module and biosilicification-active module. The design enables the designed 
biomolecules to facilitate formation and stabilization of nanoemulsion and to direct nucleation and 
growth of silica on the surface of the nanoemulsion under environmentally-friendly conditions. 
Therefore, a novel emulsion and biomimetic dual-templating approach has been developed in this 
thesis for the synthesis of biocompatible oil-core silica-shell nanocapsule. Furthermore, the silica 
nanocapsule was examined as a biocompatible nanocarrier of insecticide for agricultural 
applications, utilizing fipronil and subterranean termite as model insecticide and insect, respectively.  
 
There are four specific key points addressed through experimental work in this thesis:  
 
(1) Design of a bifunctional modular peptide (Chapter 3) – this study showed that modularization 
of a surface-active module with a biosilicification-active module in the designed bifunctional 
modular peptide was essential for the effective formation of silica at oil–water interfaces. The 
mechanistic actions of the dual-functionality of the designed peptide were discussed, including 
for stabilizing nanoemulsions core and directing interfacial biosilicification forming silica shell 
with tunable shell thickness. 
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(2) Application of silica nanocapsules to encapsulate and release fipronil insecticide for termite 
control in a laboratory scale (Chapter 4) – this study demonstrated facile encapsulation of 
fipronil with high-capacity loading in silica nanocapsules synthesized using the bifunctional 
modular peptide. The controllable releases of the insecticide in vitro in water and in vivo against 
termites in a laboratory scale were highlighted. 
 
(3) Design and microbial-production of a bifunctional modular protein (Chapter 5) – the bifunctional 
modular peptide was re-designed by joining its biosilicification-active module with a variant of 
DAMP4 protein module [16]. The modular combination design allowed the protein to be 
produced via E. coli expression system. The expression and purification processes to obtain the 
protein were evaluated. The dual functionalities of the protein to synthesize oil-core silica-shell 
nanocapsules were tested. 
 
(4) Large-scale production and field application of fipronil-encapsulated silica nanocapsules for 
termite field trial (Chapter 6) – this study was conducted to produce the bifunctional modular 
protein through E. coli in a large scale to synthesize fipronil-encapsulated silica nanocapsules 
which could then be used for termite field trial. 
 
The following sections discuss the key research findings of this project in more detail.  
 
7.1.1 Design of a bifunctional modular peptide 
 
(1) Peptide having surface activity is insufficient for effective formation of oil-core silica-shell 
nanocapsules 
 
Peptide surfactant AM1 (Ac-MKQLADS LHQLARQ VSRLEHA-CONH2) [17] known for its ability to 
facilitate formation and stabilization of nanoemulsions [18] was used to test whether it could 
accelerate hydrolysis and condensation of silica precursor tetraethoxysilane (TEOS) at oil–water 
interfaces. The biosilicification reaction between TEOS presence in bulk solutions and AM1 peptide 
molecules located at the surfaces of oil droplets compromised the ability of AM1 to stabilize the 
nanoemulsions. Silica nanocapsules could not be efficiently formed without a significant formation 
of bulk silica precipitates as the surface activity of AM1 is sacrificed when this module was used for 
inefficient interfacial biosilicification. Therefore, a bifunctional modular peptide was designed by 
modularizing part of AM1 sequence with a specialized sequence specific to silica.   
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(2) Design of a bifunctional modular peptide comprising a surface-active module and a 
biosilicification-active module is necessary to effectively form silica nanocapsules  
 
Based on the results of AM1 on the interfacial biosilicification, SurSi peptide (Ac-MKQLAHS 
VSRLEHA RKKRKKRKKRKKGGGY-CONH2) was designed by modularizing part of the peptide 
surfactant AM1 for surface activity [17] (Sur module, MKQLAHS VSRLEHA) with a sequence for 
biosilicification (Si module, RKKRKKRKKRKKGGGY). Sur was designed based on heptads of AM1 
(MKQLADS VSRLEHA), except that aspartic acid (D) at position 6 was replaced by histidine (H). Si 
module contained densely packed cationic lysine (K) and arginine (R) residues derived from high-
yield TiO2-precipitating dTi-1(RKK) peptide (RKKRKKRKKRKKGGGW) [19] except that the 
hydrophobic amino acid tryptophan (W) was replaced with tyrosine (Y). SurSi peptide has been 
demonstrated capable of facilitating formation and stabilization of nanoemulsions through 
amphiphilic nature of the Sur module. While hydrophobic residues in the Sur module faced toward 
oil phase, hydrophilic residues oriented away from the oil phase with the Si module projecting toward 
bulk aqueous phase. SurSi peptide was also shown capable of directing nucleation and growth of 
silica at the oil–water interfaces through Si module having the capacities to promote hydrogen-
bonding and electrostatic interactions with silica species. Hypothetically, based on the literature, 
polar amino acid residues within SurSi, including serine (S), tyrosine (Y), histidine (H) and glutamine 
(Q), promote nucleophilic attack on the silicon atom within TEOS [20, 21] and thus facilitate its 
hydrolysis to produce silanol and negatively-charged silanolate. Positively-charged arginine (R) and 
lysine (K) residues interact electrostatically with silanolate at near-neutral pH, while the hydroxyls of 
serine (S) and tyrosine (Y) promote hydrogen bonding with silanol [10], which in turn act as 
nucleation sites to direct silica growth through polycondensation of the silica species at the interface. 
As a result of the synergistic actions of these functionalities, SurSi peptide was able to facilitate 
formation and stabilization of nanoemulsions (comprising 2 v/v% Miglyol® 812 oil) and direct 
nucleation and growth of amorphous silica shells surrounding the nanoemulsion cores.  
 
(3) Silica shell thickness is tunable 
 
The silica shell thickness could be tuned simply by controlling reaction pH, reaction time and silica 
precursor tetraethoxysilane (TEOS) concentration. Reaction of SurSi-based nanoemulsions and 
TEOS having concentrations of 8 µmol, 16 µmol and 32 µmol in 25 mM HEPES buffer pH 7.5 for 30 
h resulted in the formation of nanocapsules having silica shell thicknesses of 5 ± 1 nm, 10 ± 2 nm 
and 16 ± 3 nm, respectively.  
 
 
 
- 136 - 
(4) Reaction conditions for making silica nanocapsules are environmentally friendly, and the 
resulting nanocapsules are composed of biocompatible components 
 
The key ingredient for the synthesis of oil-core silica-shell nanocapsules is the designed SurSi 
peptide. The use of SurSi peptide has enabled the synthesis process to be conducted under entirely 
benign reaction conditions, including at near-neutral pH, room temperature, and ambient pressure 
in the absence of toxic organic solvents. In addition, the resulted silica nanocapsules were composed 
of biocompatible components, including pharmaceutically-grade Miglyol® 812 oil, the peptide, and 
amorphous silica shell in which synthetic amorphous silica is categorized as a “Generally 
Recognized As Safe (GRAS)” material by the U.S. Food and Drug Administration [22]. 
 
(5) Silica nanocapsules can be used to easily encapsulate fipronil insecticide with high loading-
capacity (up to 10 mg/mL) and to slowly release fipronil to aqueous phase 
 
In Chapter 3, applications of the silica nanocapsules were investigated by encapsulating an 
insecticide fipronil. Approximately 10 mg fipronil could be directly dissolved in 1 mL of Miglyol® 812 
oil and then, upon sonication, fipronil-loaded nanoemulsions could be formed. Addition of silica 
precursor tetraethoxysilane (TEOS) to the nanoemulsions induced reaction of TEOS with the peptide 
residing at the oil–water interfaces which then directed the growth of silica shell encapsulating the 
fipronil-loaded nanoemulsions. In vitro release studies of fipronil from the silica nanocapsules in 
water showed a decreased release rate with increasing shell thickness (i.e., 8–44 nm) indicating that 
the controlled release of fipronil in water from the silica nanocapsules was tunable through control 
of the silica shell thicknesses. These results suggested that biosilicification reaction occurred 
preferentially at the oil–water interface, and thus the intact structure of the oil droplets could be 
preserved and used to encapsulate hydrophobic actives. On the other hand, the silica shell could 
serve as a diffusion barrier for the controlled release of active molecules in a sustained manner.  
 
7.1.2 Controlled-release applications of silica nanocapsules  
 
In Chapter 4, biocompatible oil-core silica-shell nanocapsules developed in Chapter 3 were 
investigated in a more detail as nanocarriers for controlled release of fipronil insecticide in vitro and 
in vivo. The loading of fipronil in the oil core prior to biomimetic growth of a layer of silica shell 
surrounding the core, as demonstrated in Chapter 3, is known as a pre-loading technique. This pre-
loading technique is beneficial as to reduce the possibility of attachment of fipronil at the external 
surfaces of the shells, thus increasing the high-loading capacity and flexibility to protect and release 
the actives. To demonstrate efficacy of the fipronil-encapsulated silica nanocapsules, the 
nanocapsules were used to treat termites – a model insect used in this thesis. 
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(1) Fipronil-encapsulated silica nanocapsules show in vivo efficacy against termites by slowly 
releasing fipronil at a rate that depends on the silica shell thickness which in turn controlling 
killing rates of the termites 
 
Fipronil at concentrations of 0.5 and 1 mg/mL in Miglyol® 812 oil could be encapsulated in the silica 
nanocapsules having different shell thicknesses (i.e., 8–44 nm), with encapsulation efficiency as 
high as 73%. In vivo efficacy of fipronil-encapsulated silica nanocapsules was tested against termites 
by using two different treatment-methods, i.e. direct treatment and feeding treatment. Direct 
treatment experiments were applied by dropping silica nanocapsules on the dorsal thorax of worker 
termites, in comparison with fipronil-loaded nanoemulsions (having no silica shells) and commercial 
Termidor® containing fipronil. Direct treatment using silica nanocapsules having three different shell 
thicknesses (8 nm, 25 nm and 44 nm) demonstrated that the time interval between the application 
of the nanocapsules and the occurrence of the termite mortality could be prolonged in a way 
dependent on silica shell thickness. Further, the in vivo efficacy of 44 nm-shell nanocapsules against 
orphaned groups of ≈1500 worker and soldier termites was tested by feeding treatment. The 
treatment used α-cellulose mixed with fipronil-encapsulated silica nanocapsules as feeding baits that 
were placed in vials. The vials were connected via clear plastic tubes to the boxes containing the 
groups of termites. The treatment results showed that the baits could be taken up from the vials by 
foraging workers, transmitted to recipient termites in the groups, probably through horizontal transfer, 
and eventually caused 100% mortality of the termite groups in 6 days after the applications which 
were 3 days longer than the commercial Termidor®. The more delaying insecticidal effect 
demonstrated by the silica nanocapsules as compared to the commercial fipronil formulation would 
be highly desirable as it increases the likelihood of horizontal transfer of fipronil, and hence allowing 
improved area-wide control of larger populations of termite colonies.  
 
7.1.3 Design and microbial-production of a bifunctional modular protein 
 
Results presented in Chapter 3 have demonstrated design of the SurSi peptide that was able to 
stabilize nanoemulsion core and form silica shell surrounding the core. The SurSi peptide-based 
silica nanocapsule was used as a biocompatible nanocarrier of fipronil insecticide for its controlled 
release as shown in Chapter 4. The successful use of the silica nanocapsules certainly opens 
opportunities to other applications that demand biocompatibility, minimal environmental-risks, high-
capacity loading, and controlled-release properties, including for biomedical and agricultural 
applications. Aligned with this, sustainable and scalable productions of the peptide are required. The 
peptide developed in Chapter 3 is useful for research but limiting for large-scale applications as it is 
technically difficult and too costly for large-scale production [23] using current method which is based 
on solid-phase chemistry [24]. An alternative way to produce functional biomolecule as in SurSi 
peptide in sustainable and scalable manners is thus the objective of Chapter 5. 
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(1) Bifunctional modular proteins comprising a surface-active module and a biosilicification-active 
module can be designed to allow production of the proteins via microbial cell-factory E. coli  
 
Recombinant DNA technology offers a method to synthesize proteins by designing a synthetic DNA 
encoding for proteins, and then linked the recombinant DNA to bacterial DNA and inserted into 
bacterial cell factory system. In this regards, E. coli expression systems are commonly used to 
express the recombinant proteins due to its low-cost of fermentation and ease of cultivation. 
However, expression of short recombinant peptides, though possible, is very challenging as it may 
be unstable in E. coli [25-27], and thus would significantly reduce the expression yields. To 
addresses these challenges, a bifunctional modular protein, D4S2 (M DPS 
MKQLADSLHQLARQVSRLEHA DPS MKQLADSLHQLARQVSRLEHA DPS 
MKQLADSLHQLARQVSRLEHA DPS MKQLADSLHQLARQVSRLEHA EPS 
RKKRKKRKKRKKGGGY), having 116 amino acid residues was rationally designed in Chapter 5. 
D4S2 was designed by modularizing DAMP4 variant module (M DPS 
MKQLADSLHQLARQVSRLEHA DPS MKQLADSLHQLARQVSRLEHA DPS 
MKQLADSLHQLARQVSRLEHA DPS MKQLADSLHQLARQVSRLEHA EPS) with Si peptide module 
(RKKRKKRKKRKKGGGY). Si peptide rich in cationic amino acid side chains known for its 
biosilicification activity was derived from SurSi peptide (Chapter 3). The DAMP4 variant module was 
derived from a four-helix bundle protein DAMP4 (MD(PS MKQLADS LHQLARQ VSRLEHAD)4) [16] 
known for its surface activity except that the aspartic acid (D) residue at C-terminal DAMP4 was 
replaced with glutamic acid (E) residue followed by addition of proline (P) and serine (S) residues in 
order to provide molecular flexibility to the Si module projecting toward the bulk aqueous phase. The 
modular combination design of D4S2 allowed the protein to be synthesized in E. coli. D4S2 could 
be extracted from the cells by heating and mixing with high concentration of Na2SO4 to disrupt the 
cells releasing the intracellular protein and to precipitate most protein contaminants but maintain 
D4S2 solubility. The stability properties of D4S2 to high temperature and chemical denaturant were 
related to its four-helix bundle structure in bulk [28], as designed. Further purification via 
chromatography was necessary to obtain high purity of D4S2 (M 13308.2 Da). Culturing E. coli 
BL21(DE3) expressing D4S2 protein in 800 mL-media and then purifying the D4S2 using precipitate- 
and chromatography-based purification processes could yield approximately 7 mg D4S2. 
 
(2) Presence of DNA in solutions at some concentrations can inhibit biosilicification reaction  
 
As aforementioned, purification of D4S2 involved a two-step process based on precipitation (i.e., 
heating/cell lysis, contaminant precipitation, and dilute precipitation) and then followed by 
chromatography (i.e., immobilized-metal affinity chromatography and desalting chromatography). 
After the precipitation-based purification step, D4S2 protein solution contained high levels of DNA at 
a concentration of approximately 63 ng DNA/mg D4S2, which could be derived from either the 
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expression construct or the genomic DNA [29]. Protein and DNA may form non-covalent complexes 
via electrostatic interactions between anionic phosphate groups on the DNA and cationic functional 
groups on protein at physiological pH [30, 31]. When the D4S2 was used to form nanoemulsions, 
the nanoemulsions were negatively charges, probably because the anionic DNA residues were still 
present in an amount sufficient to cover the cationic protein side chains at the oil–water interfaces. 
Therefore, chromatography-based purification step was conducted. Thereafter, D4S2 solutions 
contained DNA concentration of less than 2 ng DNA/mg D4S2. At this concentration, positively-
charged nanoemulsions could be produced and thus, upon biosilicification reaction with silica 
precursor tetraethoxysilane, silica shell could be formed. 
 
(3) The bifunctional modular protein produced in E. coli demonstrates surface activity and 
biosilicification activity which can be used to synthesize oil-core silica-shell nanocapsules 
 
Surface activity of D4S2 was evidenced as it substantially lowered the dynamic interfacial tension of 
freshly formed Miglyol® 812 oil droplet upon interfacial adsorption. Thin film of D4S2 demonstrated 
stability against rupture when compressed at increasing pressure likely due to high electrostatic 
repulsion of D4S2 at the pH that imparted mechanical resistance to the film. With the surface activity 
demonstrated by D4S2, D4S2 was then used for making oil-core silica-shell nanocapsules. D4S2 
was shown able to facilitate formation and stabilization of nanoemulsions (comprising 10 v/v% 
Miglyol® 812 oil in D4S2 protein solutions) through its surface-active module and, upon addition of 
silica precursor tetraethoxysilane (TEOS), direct nucleation and growth of a silica layer encasing the 
nanoemulsion core through its biosilicification-active module under near-neutral pH and ambient 
temperature without using any toxic organic solvents. The outer diameter and shell thickness of the 
nanocapsules as measured by TEM were 249  29 nm and 26  2 nm. 
 
7.1.4 Large-scale production and field application 
 
In this thesis, the recombinant bifunctional modular protein, D4S2, was produced at approximately 
1.4 g using the expression and purification processes developed in Chapter 5. D4S2 was used for 
stabilizing fipronil-loaded nanoemulsions, which comprised 10 v/v% Miglyol® 812 oil loaded with 
fipronil (≈0.9 g) at a concentration of 10 mg/mL, and inducing silica shell formation surrounding the 
nanoemulsions. The resulting fipronil-encapsulated silica nanocapsules—having outer diameter of 
302 ± 16 nm and shell thickness of 57 ± 9 nm—were then used for termite field trial by mixing the 
nanocapsules with α-cellulose bait placed in three treatment-units which were then attached 
separately to three mounds of Coptotermes lacteus in Beerburrum (Queensland, Australia). The 
preliminary result showed that the treated baits were removed by the termites from the treatment-
units within three weeks after treatment-units installation, with no evidence of repellence. The termite 
colonies are still alive after six weeks of treatments, thus the field trial was continued and is still on-
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going. The time required for elimination of the colonies in mounds would be difficult to be predicted 
as it relies on the seasonal weather patterns, the number of alternative food sources available nearby 
the mound, presence of predation, population density or age of colony, and different castes of 
termites that have difference susceptibility on the insecticide. Nevertheless, the preliminary result 
indicated that the termites responded well to the treated baits as they readily removed the baits from 
the treatment-units within three weeks of treatments, providing a chance that the baits would be 
transmitted to other termites within the mounds through horizontal transfer which could then lead to 
potential elimination of the termite colonies. 
 
7.2 Future work 
 
This thesis has contributed to the development of bifunctional modular peptide and protein 
comprising a surface-active module and a biosilicification-active module capable of stabilizing 
nanoemulsion core and forming silica shell under room temperature and nearly neutral pH without 
using any toxic chemicals. This synthesis method offers biocompatibility and environmentally-
friendly processes with an additional advantage of renewability and scalability for large-scale 
production of the biomolecules using biological expression [1, 2]. Furthermore, this emulsion and 
biomimetic dual-templating approach offers easy pre-loading of active components by simple 
dissolution in the oil phase with a high loading-capacity without the need for template removal, thus 
increasing the flexibility to protect and release the active. These research outcomes collectively show 
the potential of designed peptide/protein as a platform for making silica nanocapsules. However, the 
realization of the platform requires further study: 
 
(1) The design of protein in Chapter 5 allowed the protein to be synthesized in microbial cell-factory 
E. coli, promising for scalability and sustainability processes. To further demonstrate the 
scalability of D4S2, high-cell-density pH-stat fed-batch fermentation culture in E. coli [32] could 
be developed for large-scale production of D4S2 achieving process scale-up.  
 
(2) Chapter 5 has demonstrated that DNA could be problematic for the D4S2 functionality as DNA 
attachment on the protein could alter the charge of the protein, and thus negatively affects 
biosilicification reaction with the silica precursor. In this case, DNA could be removed by using 
immobilized-metal affinity chromatography. To achieve lower production cost, purification 
process to remove DNA might be optimized probably by utilizing cationic chemicals like 
polyethyleneimine (PEI) that could bind to DNA through electrostatic interactions [33].  
 
(3) Following the fed-batch fermentation of E. coli producing D4S2 and optimized DNA removal for 
D4S2 purification process aforementioned, cost analysis of D4S2 production could be evaluated 
using a process simulation package, SuperPro Designer [34, 35]. This analysis could provide a 
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quantitative data of the possible economics of process scale-up of D4S2 proteins in comparison 
with SurSi peptide (Chapter 3), which was commercially produced based on solid-phase 
chemistry [24], for making silica nanocapsules. 
 
(4) The use of silica nanocapsules as a biocompatible nanocarrier in agricultural applications, as 
demonstrated in Chapter 4, could be extended for biomedical applications to demonstrate the 
robustness and flexibility of the nanocapsules platform. For example, encapsulation of model 
antigen ovalbumin in silica nanocapsules and injection into mice could be conducted to 
investigate whether the presence of silica shell could control release of the antigen in a sustained 
manner thus inducing immune response of the mice.  
 
(5) Size of nanoemulsions could be increased by decreasing the D4S2 concentrations using the 
same ultrasound energy, as demonstrated in Chapter 5. By changing the nanoemulsion size, 
the size of nanocapsules could also possibly be tuned to achieve micro-sized capsules. Silica 
microcapsules have found many applications especially for encapsulation and controlled 
release of fragrance and flavour in perfume and food industries [36]. Therefore, the feasibility of 
bifunctional modular biomolecules to synthesize silica microcapsules could be tested for future 
work. 
 
(6) As reviewed in Chapter 2, peptides have unique sequence-specific self-assembly and 
recognition properties to silica material thus play critical roles in controlling the mineralization of 
silica nanostructures. There are also particular amino acid residue sequences that are specific 
to various inorganic materials beyond silica [3], e.g., FDFDFDFD that is able to direct 
mineralization of calcium carbonate [37]. Using the design principles of bifunctional modular 
biomolecules developed in Chapter 3, the work contained in this thesis could be extended to 
manufacture a calcium carbonate nanocapsule composed of an oil core and calcium carbonate 
shell. The nanocapsules could be useful in food industries for the encapsulation and release of 
flavour [38]. 
 
7.3 Concluding thoughts 
 
Nature’s ability to form silica with controlled structure and properties as in diatoms, sponges, and 
plants [39] under aqueous conditions at ambient temperatures and pressures, near-neutral pH in the 
absence of toxic organic solvents [40] have great impact from the intersection of molecular and 
inorganic chemistry. The biological principle in biosilicification has been an inspiration to direct 
“bottom-up” synthesis of silica-based nanomaterials in vitro by mimicking functionality of the 
mineralizing proteins in the living organisms [41]. Although a lot of research has directed to use 
peptide/protein to form silica-based nanomaterials based on bulk reaction and at solid–liquid 
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interfaces, there is no current biomimetic approach at oil–water interfaces to make silica 
nanocapsules having oil-core silica-shell architecture. Thus, this thesis has contributed to the 
development of a novel dual-templating biomimetic approach and new design of modular 
peptide/protein, SurSi peptide and D4S2 protein, for biosilicification at oil–water interfaces, offering 
opportunities to develop nanocarriers of various hydrophobic actives having biocompatibility, high 
encapsulation-efficiency, and controlled-release properties. Both biomolecules have similar concept 
of design, that is, linking a surface-active module and a biosilicification-active module, thus enabling 
stabilization of nanoemulsion core and formation of a silica shell for making oil-core silica-shell 
nanocapsules. Furthermore, the use of D4S2 protein taking advantage of the bioprocessing 
production route through E. coli expression systems has opened opportunities for sustainable, 
scalable and environmentally-friendly processes to produce silica nanocapsules, and thus making 
the platform developed in this thesis suitable for large-scale applications of the silica nanocapsules 
in fields of biomedical and agricultural applications.  
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Appendix A 
 
Experimental set-up for termite control experiments in a 
laboratory scale 
 
 
The following Appendix contains several photographic images describing method section, in vivo 
study against termites, in Chapter 4. 
 
 
Figure A1. Photographic images of the collection of Coptotermes acinaciformis from Esk, 
Queensland, Australia. a–c) Technique to collect termites: trench was constructed and filled with 
timbers (a); moist woods covered with insulating material were placed in plastic containers and 
then secured with soil (b); and the plastic containers (lid off) were inverted and placed onto the 
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timber-filled trench (c). d, e) Difference in physical appearance of the moist woods: before (d) and 
after (e) termite infestations. f–h) Termites isolated from the infested woods: Magnification figure of 
the infested wood shows the presence of galleries built by the termites (f); collected worker and 
soldier termites by gently tapping them out from the infested woods (g); actively moving worker 
termites were carefully selected from the colonies and placed in a petri dish containing a filter 
paper for direct treatment (h)—this figure shows a piece of the filter paper consumed by the worker 
termites which demonstrated that the filter paper could be utilized as a food source for termites 
during direct treatment. i) Nasutitermes magnus mound materials used for feeding treatment. 
 
 
Figure A2. Experimental units for in vivo efficacy test of nanocapsules against termites on 
direct treatment (a) and feeding treatment (b). 1) Chamber; 2) Heater; 3) 11.5-L metal 
container; 4) Water; 5) Thermometer; 6) Petri dish containing a filter paper and 10 Coptotermes 
acinaciformis worker termites; 7) Feeding vial containing moist α-cellulose bait, 8) Vinyl tubing, and 
9) Container containing mound materials, water and ≈1,500 Coptotermes acinaciformis worker and 
soldier termites. 
